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harbouring	 the	 Zic2	 severe	 loss-of-function	Kumba	 allele)	 shows	 they	 arise	 due	 to	 a	 loss	 of	
asymmetric	gene	expression	at	the	early-somite	node	and	in	the	left	 lateral	plate	mesoderm.	
Furthermore,	ZIC2	acts	upstream	of,	and	is	required	for,	the	correct	formation	and	function	of	
cilia	 in	the	mid-gastrula	node.	This	 is	 the	same	region	of	the	murine	embryo	 in	which	ZIC2	 is	
required	during	normal	development	to	prevent	HPE,	suggesting	a	common	tissue	of	origin	for	
the	 observed	 brain	 and	 cardiac	 defects,	 and	 that	 ZIC2	 mutation	 is	 a	 risk	 factor	 for	 the	
development	of	left-right	defects.	





























































































































































































































































































































































































































































































































































































































a	 single	 group	 of	 cells.	 The	 embryological	 process	 that	 leads	 to	 hemisphere	 separation	 is	
estimated	to	completely	or	partially	fail	in	approximately	1/250	human	conceptuses,	resulting	
in	 the	 most	 common	 structural	 defect	 of	 the	 human	 forebrain;	 Holoprosencephaly	 (HPE)	
(Matsunaga	and	Shiota,	1977).	The	crucial	nature	of	hemisphere	separation	is	evidenced	by	the	
positive	 correlation	 between	 the	 degree	 of	 brain	 malformation	 and	 HPE-induced	 mortality	
(Solomon	et	 al.	 2010b)	 and	 the	 reduction	 in	HPE	 frequency	 to	1/10	000	by	birth	 (Orioli	 and	
Castilla,	 2010).	 The	 high	 rate	 of	 HPE	 occurrence	 suggests	 that	 the	 hemisphere	 separation	
process	 is	 incredibly	 fragile,	 comprised	 of	 multiple	 interconnected	 steps	 and	 vulnerable	 to	
interference.	 Furthermore,	 the	 phenotypic	 heterogeneity	 characteristic	 of	 this	 condition	
suggests	that	interference	can	come	from	a	variety	of	sources	(i.e.	environmental	and/or	genetic	
factors)	and	that	multiple	factors	act	co-operatively	in	at	least	some	HPE	cases.	The	degree	of	





HPE	 (Table	 1.1,	 Figure	 1.1),	 of	 which	 alobar	 HPE	 (a	 monoventricle	 with	 no	 hemispheric	
separation)	 is	 the	most	 severe	 form,	 followed	 by	 semilobar	 (partial	 hemispheric	 separation,	
resulting	in	fused	left	and	right	frontal	and	parietal	lobes	but	retaining	the	posterior	portion	of	
the	 interhemispheric	 fissure)	 and	 lobar	 HPE	 (hemispheric	 and	 lateral	 vesicle	 separation	 is	
retained,	 except	 for	 in	 the	 rostral	 and	 ventral	 frontal	 lobes)	 (reviewed	 in	 Marcorelles	 and	
















































Figure	 1.1:	A	 comparison	of	 the	 four	 subclasses	 of	Holoprosencephaly.	 (a-d)	 Brain	MRIs	 of	
human	 probands	 with	 (a)	 alobar,	 (b)	 semilobar,	 (c)	 lobar	 and	 (d)	 MIHV	 holoprosencephaly	
demonstrating	 the	 degree	 of	 separation	 between	 left	 and	 right	 hemispheres.	 (e-h)	 Facial	








severity	of	 brain	 and	 craniofacial	 symptoms	 in	HPE	 is	 the	basis	 for	 the	notion	 that	 ‘the	 face	
predicts	 the	 brain’,	 as	 observed	 by	 DeMeyer	 and	 colleagues	 in	 1964	 (DeMyer	 et	 al.,	 1964).	
Craniofacial	 phenotypes	 accompanying	 severe	 HPE	 often	 include	 microcephaly,	 cyclopia	 or	
synophthalmia,	 and	 a	 proboscis.	 Less-severely	 affected	 cases	 present	 with	 microcephaly,	













Additional	 structures,	 such	 as	 the	 caudate	 nuclei,	 thalami	 and	 mesencephalon	 can	 also	 be	
affected	in	MIHV	cases.	Whilst	some	similarities	occur	between	classic	and	MIHV	HPE	(namely	




When	 considered	 as	 a	 single	 disorder,	 HPE	 genetics	 exhibits	 extreme	 heterogeneity	 with	
multiple	classes	of	causative	mutations	and	numerous	modes	of	heredity.	Up	to	50%	of	HPE	
cases	 are	 attributable	 to	 chromosomal	 abnormalities,	 while	 a	 further	 25%	 of	 cases	 are	
syndromic	 and	 25%	 occur	 in	 isolation.	 While	 some	 autosomal	 recessive	 cases	 of	 non-
chromosomal,	non-syndromic	HPE	have	been	reported,	the	condition	is	generally	considered	to	
be	autosomal	dominant	(Barr	and	Cohen,	2002;	Mercier	et	al.,	2011;	Ming	et	al.,	2002;	Mouden	





a	 result	of	variable	expressivity.	There	 is	evidence	 from	human	and	animal	studies	 that	both	
genetic	 and	 environmental	 factors	 influence	 the	 HPE	 end-phenotype	 (Hong	 et	 al.,	 2012;	
Kietzman	et	al.,	2014;	Mouden	et	al.,	2016),	therefore	the	ultimate	consideration	when	studying	
HPE	is	the	total	activity	achieved	along	the	particular	embryonic	signalling	pathways	that	direct	
hemisphere	 separation	 (Roessler	 and	Muenke,	 2010).	 Evidently,	 some	 cases	 of	 HPE	 have	 a	
digenic	basis	 (Dubourg	et	al.,	2016;	Mouden	et	al.,	2016).	For	 the	majority	of	HPE	probands,	
however,	the	putative	second	hit	factors	remain	unidentified	and	it	seems	a	model	of	autosomal	
dominant	 with	 modifier	 effects	 most	 aptly	 describes	 HPE	 heritability	 (Odent	 et	 al.,	 1998;	
Roessler	et	al.,	2012b).	
One	clear	source	of	HPE	genetic	variability	is	locus	heterogeneity	(a	single	disorder	is	caused	by	






are	classified	as	either	 ‘large	effect’	 (major)	or	 ‘small	effect’	 (minor)	HPE	genes,	according	to	
how	 often	 they	 are	mutated	 in	 the	 disorder.	 In	 classic	 HPE,	 the	 two	 genes	most	 commonly	
mutated	are	SHH	 (12%)	and	ZIC2	 (9%),	which	 together	account	 for	~85%	of	solved	probands	
(Dubourg	et	al.,	2016,	2011;	Roessler	et	al.,	2009a).	Additional	genes	have	been	associated	with	





















SIX3	 and	 TGIF)	 (Dubourg	 et	 al.,	 2016;	 Solomon	 et	 al.,	 1993).	 This	 restricted	 panel	 is	 due	 to	
logistical	considerations,	such	as	the	limited	availability	of	DNA	(particularly	in	in	cases	where	
the	patient	is	deceased)	and	the	frequency	with	which	mutations	in	these	gene	are	identified	in	











in	 the	developing	 forebrain	via	binding	of	 the	 transcription	 factor	SIX3.	A	 rare	variant	 in	 this	




associated	genes	has	 remained	elusive.	 In	 this	 thesis,	 I	will	 attempt	 to	elucidate	whether	a	










the	ZIC	proteins	are	defined	by	 the	presence	of	a	 zinc	 finger	domain	 (ZFD)	consisting	of	 five	
tandem	Cys2His2	zinc	fingers	 (Aruga	et	al.,	2006)(Figure	1.2).	The	ZFD	mediates	DNA	binding	



















Zic2,	 Zic3	 and	 Zic5	 are	 expressed	 in	 the	 ectoderm	 of	 the	 extra-embryonic	 and	 embryonic	
portions	of	 the	egg	cylinder	 (Elms	et	al.,	2004;	Furushima	et	al.,	2000).	Transcripts	have	also	
been	 identified	 in	 the	 mesoderm	 that	 ingresses	 through	 the	 primitive	 streak,	 however	




































the	 expression	 in	 the	 node	 has	 ceased.	 ae:	 anterior	 definitive	 endoderm,	 am:	 anterior	
mesoderm,	hp:	head	process,	n:	node,	paf:	posterior	amniotic	fold.	Scale	bar,	50	mm	(a	–	d),	100	




the	posterior	embryo	proper	and	becomes	restricted	 to	 the	anterior	neuroectoderm.	By	 this	
time,	 Zic3	 and	 Zic5	 are	 also	 restricted	 to	 this	 region.	 The	 expression	 of	 the	 Zics	 in	 the	



















mutation	 is	 more	 frequently	 associated	 with	 sevre	 structural	 brain	 anomalies,	 (alobar	 or	
semilobar),	which	account	for	75%	of	the	ZIC2–associated	HPE	cases	in	which	phenotype	class	
is	 recorded	 (Table	 1.2).	 In	 contrast,	 a	 similar	 analysis	 of	 92	 individuals	 (probands	 and	 family	
members)	with	clinically	apparent	HPE	and	SHH	mutations	found	that	39%	exhibited	Alobar	or	




Another	 striking	 observation	 based	 on	 the	 molecular	 subtyping	 of	 HPE	 cases	 is	 that	 ZIC2	
mutation	breaks	the	mantra	‘the	face	predicts	the	brain’,	with	the	craniofacial	defects	typically	
associated	with	classic	HPE	absent	in	those	patients	assessed	(Brown	et	al.,	1998;	Solomon	et	
al.,	 2010a,	 2010b).	 In	 particular,	 Solomon	 et	 al	 (2010a)	 found	 no	 ZIC2-associated	 HPE	 case	







	 Unknown	 Alobar	 Semilobar	 Lobar	 Mic	 MIHV	
Missense	 18	(10.34%)	 7	(4.02%)	 7	(4.02%)	 4	(2.30%)	 2	(1.15%)	 0	(0.00%)	
Nonsense	 7	(4.02%)	 5	(2.87%)	 8	(4.60%)	 2	(1.15%)	 1	(0.57%)	 0	(0.00%)	
Frameshift	 19	(10.92%)	 10	(5.75%)	 23	(13.22%)	 2	(1.15%)	 5	(2.87%)	 0	(0.00%)	
Insertion	 1	(0.57%)	 0	(0.00%)	 1	(0.57%)	 0	(0.00%)	 0	(0.00%)	 0	(0.00%)	
Deletion	 2	(1.15%)	 1	(0.57%)	 1	(0.57%)	 1	(0.57%)	 0	(0.00%)	 1	(0.57%)	
Duplication	 8	(4.60%)	 5	(2.87%)	 9	(5.17%)	 1	(0.57%)	 1	(0.57%)	 3	(1.72%)	
Splice	variant		
(intron)	 6	(3.45%)	 2	(1.15%)	 3	(1.72%)	 0	(0.00%)	 0	(0.00%)	
1	(0.57%)	
SNV	(3’UTR)	 3	(1.72%)	 1	(0.57%)	 1	(0.57%)	 0	(0.00%)	 2	(1.15%)	 0	(0.00%)	
Total	(n=174)	 64	(36.78%)	 31	(17.82%)	 53	(30.46%)	 10	(5.75%)	 11	(6.32%)	 5	(2.87%)	






flat	 nasal	 bridge,	 short	 nose	 with	 anteverted	 nares,	 a	 broad	 and	 deep	 philtrum	 and	 the	
appearance	of	large	ears.	Whilst	facial	clefts	occurred	in	both	non-ZIC2	and	ZIC2-associated	HPE,	




HPE	patients	with	 intragenic	ZIC2	mutations	have	been	 found	 to	exhibit	neural	 tube	defects	
(4%),	 hydrocephalus	 (12%),	 skeletal	 anomalies	 (14%),	 cardiac	 anomalies	 (9%)	 and	 renal	
anomalies	(7%)	(Solomon	et	al.,	2010a).	Mouse	models	that	recapitulate	ZIC2-associated	HPE	
also	display	a	subset	of	these	co-morbidities.	Both	severe	and	mild	Zic2	loss-of-function	leads	to	












For	 example,	 family	 analysis	 has	 shown	 that	 ZIC2	 mutations	 are	 largely	 de	 novo,	 with	 an	
inheritance	 rate	 of	 only	 27-30%	 (Mercier	et	 al.,	 2011;	Mouden	et	 al.,	 2016;	 Solomon	et	 al.,	
2010b).	In	contrast,	70%	of	SHH	and	SIX3	mutations	are	inherited	(Solomon	et	al.,	2010a).	Of	the	
inherited	ZIC2	cases,	two-thirds	were	maternally	inherited	and	one-third	paternally	inherited.	
Additionally,	 families	 with	 ZIC2	mutations	 in	 greater	 than	 two	 generations	 have	 not	 been	
reported.	A	small	subset	of	ZIC2-associated	HPE	cases,	however,	appear	to	occur	due	to	allelic	









cases	 of	 ZIC2	 CDS	 mutations	 in	 conjunction	 with	 other	 major	 HPE	 genes	 (ZIC2/SHH	 and	















readily	 available	 and	 the	 unique	 ZIC2–associated	 HPE	 phenotype	 is	 refined.	 Among	 the	 105	
documented	HPE	cases	with	mutations	in	the	ZIC2	coding	sequence,	the	majority	are	predicted	
to	 substantially	 alter	 the	 ZIC2	 transcript	 (44.76%	 are	 frameshift,	 14.29%	 nonsense,	 4.76%	
duplication,	 4.76%	 deletion	 and	 2.86%	 insertion)	 rather	 than	 a	 single	 amino	 acid	 (28.57%	
missense)	(Table	1.3,	Figure	1.4).	Similarly,	of	the	13	mutations	in	ZIC2	non-coding	DNA,	53.85%	
are	 splice	 variants	 and	 predicted	 to	 substantially	 alter	 the	 transcript.	 Consistent	 with	 the	
mutational	 landscape	 of	 ZIC2,	 analysis	 by	 Solomon	 et	 al	 (2010a)	 found	 that	 98%	 of	 all	 ZIC2	
mutations	were	predicted	or	proven	to	be	loss-of-	function.	
Analysis	of	mutation	type	and	location	underscores	the	functional	importance	of	the	ZFD.	For	

















CDS	 	 	 	 	
Missense	 30	 28.57%	 	 25.42%	
Nonsense	 15	 14.29%	 	 12.71%	
Frameshift	 47	 44.76%	 	 39.83%	
Duplication	 5	 4.76%	 	 4.24%	
Insertion	 3	 2.86%	 	 2.54%	
Deletion	 5	 4.76%	 	 4.24%	
Total	 105	 	 	 	
Non-coding	DNA	 	 	 	 	
Splice	variant	(intron)	 7	 	 53.85%	 5.93%	
SNV	(3’UTR)	 6	 	 46.15%	 5.08%	






Figure	 1.4:	 The	 genomic	 and	 protein	 structure	 of	 ZIC2,	 showing	 the	 known	 human	 HPE-










outside	 of	 the	 ZFD	where	 86%	 of	 known	 variants	 are	 predicted	 to	 drastically	 alter	 the	ZIC2	

















• Classic	 HPE	 brain	 abnormalities	 can	 occur	 with	 or	 without	 associated	 facial	
abnormalities.	
• For	 some	molecular	 subclasses	 of	 HPE,	 classic	 or	MIHV	HPE	 brain	 abnormalities	 can	
occur	alongside	abnormalities	not	associated	with	the	face	and	forebrain	(e.g.	Zic2).	
	
To	 consider	 how	 ZIC2	 mutation	 causes	 the	 typical	 brain	 abnormalities	 of	 HPE	 requires	
understanding	 how	 D-V	 forebrain	 pattern	 is	 established.	Much	 of	 our	 knowledge	 regarding	




The	 generation	 of	 a	 correctly	 patterned	 embryo	 is	 dependent	 upon	 inductive	 interactions	
between	progenitor	 tissues	 that	direct	differentiation,	 regionalisation	and	morphogenesis.	 In	







Protein	Domain	 Location	(aa)	 Missense	 Nonsense	 Frameshift	 Duplication	 Insertion	 Deletion	 Total	(n=105)	
Histidine	Repeat	 20-24	 	 	 	 	 	 	 0	(0.00%)	
Alanine	Repeat	 24-34	 	 	 1	 	 	 	 1	(0.95%)	
Alanine	Repeat	 89-98	 	 	 	 	 	 	 0	(0.00%)	
ZOC	 115-126	 	 	 1	 	 	 	 1	(0.95%)	
Alanine	Repeat	 226-231	 	 	 	 	 	 	 0	(0.00%)	
Histidine	Repeat	 231-240	 	 	 	 	 	 	 0	(0.00%)	
ZF-NC	 241-256	 	 1	 	 	 	 	 1	(0.95%)	
C2H2	 Zinc	 Finger	
Domain	
258-416	 22	 8	 16	 1	 1	 	 48	(45.71%)	
Alanine	Repeat	 456-471	 	 	 	 3	 1	 4	 8	(7.62%)	
Serine/Glycine	Repeat	 477-516	 1	 	 8	 	 	 	 9	(8.57%)	
Non-domain	 	 7	 6	 21	 1	 1	 1	 37	(35.24%)	
Total	(n=105)	 	 30	(28.57%)	 15	(14.29%)	 47	(44.76%)	 5	(28.57%)	 3	(2.86%)	 5	(4.76%)	 	
		 39	
anterior	 neurectoderm	 and	 the	 underlying	 prechordal	 plate	 (PrCP)	 (reviewed	 in	 Placzek	 and	
Briscoe	2005).	Both	of	these	tissues	arise	during	gastrulation	(reviewed	in	Arkell	and	Tam	2012),	
prior	 to	which	 the	neurectoderm	precursor	cells	are	 located	within	 the	distal	epiblast	where	
they	are	encased	by	the	distal	visceral	endoderm	cells	(Figure	1.5A).	These	visceral	endoderm	
(VE)	 cells	 secrete	 factors	 that	 antagonize	TGF-β	and	WNT	 signalling	activities,	 protecting	 the	
distal	 ectoderm	 cells	 of	 the	 epiblast	 from	 the	 signals	 that	 would	 otherwise	 cause	 them	 to	
differentiate.	By	the	time	gastrulation	begins,	the	future	neurectoderm	cells	are	found	at	the	
anterior	of	the	epiblast	where	they	continue	to	be	protected	from	differentiation	into	endoderm	
or	mesoderm	by	antagonists	 secreted	 from	 the	enveloping	endoderm,	which	at	 this	point	 is	






































Figure	 1.5:	 The	 origin	 of	 the	 prechordal	 plate	 and	 other	 tissues	 involved	 in	 dorsal-ventral	




endoderm	 (DE)	and	anterior	prechordal	plate	 (PrCP)	 is	 shown.	 (b)	 Cut-away	diagrams	of	 the	
embryonic	portion	of	the	early	(6.5	dpc),	mid	(7.0	dpc)	and	late	(7.5	dpc)	gastrulas.	The	anterior	
(A)	and	posterior	(P)	of	the	embryo	are	marked	and	the	dotted	line	indicates	the	A-P	axis.	Wild	



























in	 Xavier	 et	 al.	 2016).	 As	 described	 previously,	 mutation	 of	 not	 only	 SHH	 itself	 but	 also	
components	of	the	HH	transduction	pathway	have	been	found	to	be	mutated	in	HPE	probands,	
indicating	HH	signalling	is	also	required	for	human	forebrain	ventral	patterning.	Shh	transcripts	
are	 initially	 found	 in	 the	 PrCP	 itself	 and	 subsequently	 in	 the	 overlying	 rostral-ventral	 neural	
midline	 (RVNM).	 The	 downstream	 components	 and	 target	 genes	 of	 the	 SHH	 transduction	
pathway	 are	 expressed	 in	 the	 RVNM.	 Mutations	 in	 the	 response	 components	 of	 the	 SHH	
pathway	produce	neurectoderm	that	is	incompetent	to	respond	to	the	SHH	signal,	resulting	in	
HPE	(Fuccillo	et	al.,	2004;	Spoelgen	et	al.,	2005).	
In	 the	 TGF-β	pathway	 (Figure	 1.6A	 and	C),	 ligands	 bind	 to	 and	 activate	 a	 Type	 I	 and	 Type	 II	
receptor	complex,	causing	phosphorylation	of	some	members	of	 the	SMAD	family	called	 the	
receptor-associated	 SMADs	 (R-SMADS).	 This	 enables	 their	 interaction	 with	 the	 common	


























translocates	 to	 the	 nucleus	 and	 interact	 with	 the	 transcription	 factor	 FOXH1	 and	 promote	
transcription	of	TGFb	 target	genes,	or	with	ZIC2	 to	promote	 transcription	of	FOXA2.	 (b)	SHH	






phosphorylation	 of	 DNA	 binding	 proteins	 SMAD1/5/8,	 which	 complex	 with	 SMAD4.	 The	
SMAD1/5/8-4	 complex	 translocates	 to	 the	 nucleus	 and	 via	 interactions	 with	 co-factors,	
regulates	transcription	of	TGFb	target	genes	they	regulate	transcription	of	BMP	target	genes.	In	
the	 extracellular	 space,	 the	 secreted	 antagonists	 Chordin	 (CHRD)	 and	Noggin	 (NOG)	 directly	
interact	with	 BMP	 ligands	 to	 prevent	 the	 activation	 of	 downstream	 effectors	whilst	 twisted	
gastrulation	(TWSG1)	can	act	as	both	an	antagonist	or	agonist	of	BMP	signalling	in	a	cells-specific	
manner.	(d)	WNT	signalling.	 In	the	absence	of	 ligand/presence	of	 inhibitors	such	as	DKK1,	b-
catenin	 is	phosphorylated	(P)	by	the	kinase	activity	of	 the	destruction	complex	 (consisting	of	
Axin,	APC,	and	GSK3),	polyubiquitylated	(U)	by	the	SCF	(SKP1,	Cullin,	F-box)/BTrCP	complex	and	
degraded	by	the	proteasome.	ZIC2	acts	as	a	transcriptional	co-repressor,	complexing	with	TCF	













2002).	 SHH	 expression	 in	 the	 RVNM	 then	 leads	 to	 neuronal	 patterning	 and	maintenance	 of	
ventral	 forebrain	tissue.	The	anterior	mesendoderm	of	 the	 late	gastrula	 is	also	the	source	of	
WNT	antagonism	due	to	the	expression	of	Dkk1	under	the	control	of	the	transcription	factor	
Otx2.	When	Otx2	is	conditionally	inactivated	in	the	AME,	Dkk1	expression	is	not	activated	in	the	
same	 tissue,	 and	head	 truncations	 characteristic	 of	 elevated	WNT	 signalling	 result	 (Ip	et	 al.,	
2014).	Shh	expression	is	not	perturbed	by	the	lack	of	Dkk1	expression	and	HPE	does	not	arise,	
clearly	indicating	that	WNT	ligands	do	not	direct	morphogenetic	activity	required	for	forebrain	
separation.	None-the-less,	classic	HPE	 is	associated	with	 loss	of	 forebrain	 tissue	 (i.e.	anterior	
truncation).	 It	 is	 possible	 that	 this	 is	 a	 consequence	 of	 loss	 of	 midline	 tissue	 which,	 at	 the	
anterior,	expresses	FGF	ligands	from	the	anterior	neural	ridge	(ANR)	as	part	of	Anterior-Posterior	
neural	patterning.	Depletion	of	midline	FGF	will	cause	posteriorisation	and	forebrain	hypoplasia.	
Thus,	 anterior	 truncation	 often	 occurs	 as	 a	 secondary	 consequence	 of	 an	 aberrant	 ventral	








































rule	out	 the	possibility	 that	 the	ZIC2	 transcription	 factor	directly	 regulates	Shh	 expression	 in	
either	the	PrCP	or	RVNM	since	neither	tissue	is	a	site	of	Zic2	expression	at	the	appropriate	stage	
(Elms	et	al.,	2004;	Nagai	et	al.,	1997).	Similarly,	the	lack	of	RVNM	expression	at	the	time	at	which	




could	 act	 downstream	 of	 SHH	 signalling	 in	 the	 forebrain	 (Roessler	 and	Muenke,	 2001).	 This	
hypothesis	was	directly	tested	by	cross	of	the	Ku	allele	of	Zic2	(Zic2Ku	MGI:106679)	with	the	Shh	
null	 allele	 (Shhtm1Chg	 MGI:	 1857796)	 (Warr	 et	 al.,	 2008).	 The	 Ku	 mutant	 carries	 a	 missense	
mutation	 in	 the	4th	zinc	 finger	 that	abolishes	 the	DNA	binding	and	 transcriptional	activation	
ability	of	ZIC2	(Elms	et	al.	2003,	Brown	et	al,	2005).	When	intercrossed,	 it	was	observed	that	
neither	gene	was	sensitive	to	a	decreased	dose	of	the	other,	and	double	homozygous	embryos	
exhibited	 a	 novel	 phenotype	 demonstrating	 that	 ZIC2	 does	 not	 act	 downstream	 of	 SHH	 in	




















of	NODAL	activity	on	 the	Zic2Ku/Ku	background	shifts	 the	Nodal	phenotype	 towards	 the	more	








in	 Zic2Ku/Ku	 embryos	 is	 depleted	 (Barratt	 et	 al.,	 2014;	 Warr	 et	 al.,	 2008).	 Cell	 death	 and	



























When	 overexpressed	 in	 mammalian	 cell	 lines,	 ZIC2	 is	 able	 to	 physically	 interact	 with	 both	
SMAD2	 and	 SMAD3	 (the	 receptor	 activated	 proteins	 that	 control	 transcription	 in	 a	 NODAL	
dependent	manner)	(Figure	1.5A).	When	bound	to	SMAD	proteins,	ZIC2	opposes	SMAD	activity	
(it	 dampens	 SMAD	 dependent	 transcription	 or	 overcomes	 SMAD	 dependent	 repression).	 In	
cultured	human	cells,	ZIC2	can	act	in	concert	with	SMAD3	to	promote	FOXA2	expression,	but	




to	 expression	 activation	 in	 the	 presence	 of	 SMAD/ZIC2	 complexes.	 The	 proposed	molecular	
interactions	between	ZIC2	and	SMAD	molecules,	 and	between	 this	 complex	and	SMAD	DNA	
binding	elements,	are	yet	to	be	demonstrated	in	vitro.	
1.8 Dorsal	forebrain	patterning	during	murine	development		
Initial	 dorsal	 forebrain	 patterning	 is	 a	 consequence	 of	 inductive	 interactions	 between	 the	
anterior	 neurectoderm	 and	 the	 adjacent	 surface	 ectoderm	 (Furuta	 et	 al.,	 1997;	 Liem	 et	 al.,	
1995).	Both	of	these	tissues	arise	during	gastrulation	(for	review	see	Arkell	and	Tam	2012)	with	
the	 origin	 of	 the	 anterior	 neurectoderm	 already	 described	 above.	 Prior	 to	 gastrulation,	
precursor	cells	for	the	surface	ectoderm	are	found	at	the	future	anterior	side	of	the	embryo,	
about	half	way	down	the	embryonic	portion	of	the	epiblast	(Figure	1.5A).	Like	the	prospective	
neurectoderm,	 these	 cells	 do	 not	 pass	 through	 the	 primitive	 streak	 during	 gastrulation	 but	
differentiate	 in	 situ	 into	 surface	 ectoderm.	 During	 gastrulation,	 the	 cells	 are	 arranged	 an	
anterior-posterior	 order,	 but	 in	 a	 more	 lateral	 position	 than	 the	 neurectoderm	 cells.	 The	
progenitors	of	another	non-neural	ectoderm	derivative,	the	neural	crest	cells	(which	gives	rise	
to	 the	 ecto-mesenchyme	 and	 cranial	 ganglia	 in	 the	 head),	 are	 juxtaposed	 between	 the	
neurectoderm	and	surface	ectoderm	cells	at	a	region	known	as	the	neural	plate	border	(Figure	




adopt	 a	 dorsal	 position.	 Once	 the	 process	 of	 neurulation	 is	 complete,	 the	 forebrain	









studies	 of	 the	 spinal	 cord	 (reviewed	 in	 Le	 Dréau	 and	Martí	 2012),	 but	 aspects	 of	 forebrain	
neurectoderm	patterning	 involve	 distinct	mechanisms.	 For	 example,	 in	 the	 forebrain,	 dorsal	
patterning	occurs	in	close	proximity	to	the	ANR,	a	source	of	morphogenetic	signals	which	sits	at	
the	rostral	junction	of	the	neural	and	surface	ectoderm	(Crossley	and	Martin,	1995;	Shimamura	
and	 Rubenstein,	 1997).	 The	 establishment	 of	 forebrain	 dorsal-ventral	 pattern	 therefore	
intersects	 and	 interacts	 with	 the	 anterior-posterior	 patterning	 system.	 Additionally,	 the	
forebrain	 neurectoderm	 arises	 earliest	 of	 all	 the	 neurectoderm	 subdivisions	 and	 dorsally	
restricted	gene	expression	patterns	 (such	as	 that	of	Pax3	 [Goulding	et	al.	1991])	are	evident	
from	the	time	of	somite	formation.	Despite	this,	the	first	overt	signs	of	dorsal	differentiation	in	
the	 forebrain	 (i.e.	 roof-plate	 thinning)	 occur	 in	 embryos	 with	 approximately	 20	 somites.	 In	
contrast,	dorsal	development	is	evident	in	the	hindbrain	24	hours	earlier	when	the	neural	crest	
first	emerges	from	the	dorsal	neurectoderm	of	the	5-somite	embryo	(Serbedzija	et	al.,	1990).	
The	 influences	 that	 promote	 dorsal	 differentiation	 in	 the	 hindbrain	 region	must	 operate	 in	
concert	with,	or	very	soon	after,	the	signals	late	in	gastrulation	that	induce	the	anterior	epiblast	
to	adopt	a	neural	fate.	Presumably	dorsal-ventral	patterning	of	the	forebrain	also	begins	during	













due	 to	 the	 influence	 of	 WNT	 and	 BMP	 signals	 from	 the	 border	 region,	 the	 forebrain	
neurectoderm	is	initially	dorsal	in	character,	as	shown	by	Zic2	expression	throughout	most	of	
the	neurectoderm.	SHH	signals	ventrally	from	the	PrCP	to	the	overlying	neurectoderm.	Step	2:	
Shh	 expression	 is	 established	 in	 the	 rostral-ventral	 neural	 midline,	 which	 overlays	 ventral	
identity	 information	 onto	 the	 neurectoderm.	WNT	 and	 BMP	 signalling,	 and	 Zic2	 expression	
become	restricted	to	the	dorsal	half	of	the	neurectoderm.	Step	3:	once	neurulation	is	complete	




plate.	Zic2	expression	 initiates	 in	 the	ventral	midline.	Step	5:	BMP	and	WNT	signalling	 in	 the	
invaginated	tissues	induce	the	cortical	hem,	choroid	plexus	epithelium	and	the	hippocampus.	




11.5	 dpc,	 dorsal	 midline	 structures	 are	 absent	 or	 hypoplastic,	 resulting	 in	 MIHV.	 PrCP:	
prechordal	 plate,	 NE:	 neurectoderm,	 SE:	 surface	 ectoderm,	 FPl:	 floor-plate,	 PhE:	 pharangeal	






























the	 axis	 prior	 to	 neural	 tube	 closure,	 and	 in	 the	 roof-plate	 following	 closure	 (Megason	 and	





WNT	 signalling	was	 shown	 to	alter	progenitor	 gene	expression	along	 the	dorsal-ventral	 axis,	




























Rubenstein,	 1997).	 Human	 genetics	 indicates	 that	 anterior	 FGF	 signalling	 impacts	 dorsal	
forebrain	patterning	(Dubourg	et	al.,	2016)	but,	despite	evidence	that	FGF	signalling	can	control	




ZIC2	 protein	 in	 dorsal	 neural	 patterning	 and	 differentiation	 (Nagai	 et	 al.	 2000).	 Late	 in	
gastrulation,	as	the	neural	plate	is	forming,	Zic2	expression	recedes	from	the	posterior	embryo	
proper	 and	 becomes	 restricted	 to	 the	 anterior	 neuroectoderm.	 By	 this	 time,	 Zic3	 and	 Zic5	
expression	is	also	restricted	to	this	region.	The	expression	of	each	of	these	genes	then	subsides	
in	 the	 medial	 neural	 plate,	 becoming	 progressively	 confined	 to	 the	 lateral	 (future	 dorsal)	
		 55	
neuroectoderm	and	the	flanking	surface	ectoderm	(Elms	et	al.,	2004;	Houtmeyers	et	al.,	2013).	








transcript	 are	 produced	 (Nagai	et	 al.,	 2000)	 lack	 a	 telencephalic	 roof-plate	 at	mid-gestation.	
After	 neural	 tube	 closure	 in	 wild	 type	 embryos,	 the	 dorsal	 midline	 of	 the	 telencephalon	
immediately	becomes	devoid	of	mitotic	cells	and,	within	24	hours,	apoptosis	 in	 this	 tissue	 is	
noticeably	higher	than	in	the	surrounding	tissues	(Figure	1.8A).	Zic2kd/kd	embryos	exhibit	neither	






of	 HPE,	 but	 many	 questions	 remain	 unanswered	 regarding	 the	 role	 of	 ZIC2	 in	 roof-plate	
formation.	For	example,	 it	 is	not	known	precisely	when	the	process	of	dorsal	patterning	and	
roof-plate	induction	fails	 in	Zic2kd/kd	embryos.	This	may	reflect	a	role	for	ZIC2	in	earlier	dorsal	














gastrulation,	 ZIC2	 functions	 at	 the	 node	 to	 shape	 the	 NODAL	 gradient.	 Severe	 Zic2	 loss-of-
function	mutations	lead	to	a	transient	failure	in	the	production	of	the	ANC	and,	consequently,	
PrCP	 fate	 is	not	stabilised.	As	such,	 the	SHH	signal	 is	not	sent	 from	the	PrCP	and	the	ventral	
forebrain	signalling	centre	is	not	established,	resulting	in	gross	perturbations	in	forebrain	D–V	
pattern	 and	 classic	 HPE.	 This	 requirement	 appears	 well	 buffered,	 as	mild	 loss-of-function	 is	
compatible	with	correct	function	of	the	ventral	forebrain	signalling	centre	in	man	and	mouse.	A	
second	 requirement	 for	 ZIC2	 function	 occurs	 in	 the	 dorsal	 neurectoderm	 of	 the	 developing	
telencephalon	where	it	acts	to	promote	formation	of	the	dorsal	signalling	centre	responsible	for	
roof-plate	 and	 choroid	 plexus	 development.	 It	 is	 clear	 that	 a	 failure	 of	 ZIC2	 function	 in	 the	







In	 contrast	 to	 the	 coding	 genome,	 the	 size	 of	 the	 non-coding	 genome	 scales	 with	 organ	
complexity	 (Levine	and	Tjian,	2003),	and	researchers	have	begun	to	elucidate	the	role	of	the	
non-coding	 genome	 in	 regulating	 gene	 expression.	 Comparative	 genomics	 can	 be	 used	 to	
identify	coding	regions	that	may	be	important	for	the	control	of	gene	expression.	Since	DNA	that	









al.,	 2005).	 Up	 to	 92%	 of	 these	 conserved	 sequences	 exhibit	 enhancer	 activity	 in	 zebrafish	
reporter	assays,	and	50%	exhibit	activity	in	mouse	reporter	assays	(Visel	et	al.,	2008;	Woolfe	et	
al.,	2005).	A	large	portion	of	NCEs	identified	so	far	are	associated	with	transcription	factors	and	
signalling	molecules	essential	 for	embryo	development	 (Bejerano	et	al.,	 2004;	Woolfe	et	al.,	
2005).	Similar	to	developmental	genes,	both	vertebrate	and	invertebrate	NCEs	tend	to	cluster	
		 57	
together	 in	 genomic	 regions	 on	 chromosomes	 (Bejerano	 et	 al.,	 2004;	 Vavouri	 et	 al.,	 2007;	
Woolfe	 et	 al.,	 2005),	 with	 their	 target	 genes	 commonly	 within	 a	 few	 megabases	 distance	
(Vavouri	et	al.,	2006).	ZIC1,	ZIC2	and	ZIC4	have	all	previously	been	associated	with	such	clusters	
of	NCEs	in	vertebrates,	nematodes	and	arthropods	(Vavouri	et	al.,	2007).		
In	2012,	Roessler	et	al.	at	 the	National	Human	Genome	Research	 Institute	 (NHGRI),	National	
Institute	 of	 Health	 (NIH)	 used	 EvoPrint	 and	 ECRbase	 to	 screen	 for	 NCEs	 in	 ZIC2	 and	 the	
surrounding	10	 kb	of	DNA,	 identifying	 an	804	bp	 conserved	 structure	within	 the	ZIC2	 3’UTR	
(Figure	 1.9)	 (Roessler	 et	 al.,	 2012a).	 Furthermore,	 the	 study	 identified	 six	 single	 nucleotide	
variants	(SNVs)	in	the	NCE	of	seven	HPE	probands	(Figure	1.9,	Table	1.5),	none	of	which	were	
found	 in	 control	 populations,	 indicating	 the	 region	 was	 under	 selective	 pressure.	 It	 was	
therefore	 hypothesised	 that	 this	 NCE	 regulates	 ZIC2	 expression	 during	 embryogenesis	 and	
prevents	 HPE	 development.	 The	 exact	 nature	 of	 this	 regulation,	 however,	 remains	 to	 be	
determined,	and	could	occur	at	either	the	transcription	or	the	post-transcription	stages	of	gene	
expression.	 The	 NCE	 could	 act	 as	 an	 enhancer/repressor	 element	 (ER	 element),	 regulating	
transcription	of	a	target	gene	via	the	binding	of	protein	complexes	to	transcription	factor	binding	
sites	(TFBSs)	within	the	NCE.	The	NCE	may	also	transcribe	non-coding	RNAs	(ncRNAs)	such	as	
MicroRNAs	 (miRNA),	 Long	 Non-Coding	 RNAs	 (lncRNA)	 or	 Small	 Interfering	 RNAs	 (siRNA;	
Kaikkonen	et	al.,	2011).	Finally,	as	the	NCE	is	situated	within	the	3’UTR,	it	could	direct	mRNA	
transcript	stability	and	decay,	transcript	polyadenylation,	or	mRNA	localisation	and	translation	
(Barrett	 et	 al.,	 2012).	 It	 is	 likely	 that	 a	 combination	 of	 these	 processes	 are	 to	 regulate	 ZIC2	
transcription	during	embryogenesis.		
1.12 Scope	of	this	Thesis	
This	 study	 used	 a	 combination	 of	 mouse	 genetics	 and	 heterologous	 reporter	 assays	 to	
investigate	two	unexplored	areas	of	ZIC2-associated	HPE:	




































N.A.	 N.A.	 N.A.	 Unknown	 NA	 33.00	



















M2	 c.1599*836C>T	 Brz2172	 N.A.	 c.1215dupC	p.Ser406Glnfs*11c	 N.A.	 Unknown	 0.095	 0.00	












M5	 c.1599*954T>A	 Brz37	 N.A.	 N.A.	 N.A.	 Unknown	 0.095	 0.00	
M6	 c.1599*966A>G	 LCL7828	 Mat	positive	
Pat	N.A.	




















2010)	using	oligonucleotides	 containing	KpnI	 and	NotI	 restriction	 sites	 (RA1545	and	RA1546;	
Appendix	Table	A1.2).	Following	ammonium	acetate	clean	up,	the	Foxj1	fragment	and	Gateway	




pV5-Foxj1	 –	 pV5-Foxj1	 was	 generated	 via	 Gateway	 LR	 cloning	 of	 the	 pcDNA3.1-nV5-DEST	
(Invitrogen)	 Destination	 vector	 and	 pENTR1A-Foxj1.	 The	 Foxj1	 fragment	 was	 inserted	 into	
pcDNA3.1-nV5-DEST	3’	to	the	V5	epitope	tag.		
pENTR2B-NOGGIN	–	The	699	bp	human	NOGGIN	CDS	 (Accn.	No.	NM_005450)	was	amplified	
from	 HEK293T	 genomic	 DNA	 via	 oligonucleotides	 containing	 KpnI	 and	NotI	 restriction	 sites	
(RA1776	 and	 RA1777;	 Appendix	 Table	 A1.2).	 Following	 ammonium	 acetate	 clean	 up,	 the	



























pGL4.20-DEST-luc	 –	 pGL4.20-luc	 was	 converted	 into	 a	 Destination	 vector	 via	 the	 Gateway®	
Vector	Conversion	System	(Invitrogen).	pGL4.20-luc	was	digested	with	EcoRV	to	 linearize	 the	
vector	and	purified	via	ammonium	acetate	clean	up.	It	was	then	taken	through	the	Gateway®	
Vector	 Conversion	 System	 to	 ligate	 the	Destination	Reading	 Cassette	A	 into	 the	 pGL4.20-luc	
multiple	cloning	site	(MCS).		














acetate	 clean	 up.	 The	 Hsp68	 fragment	 was	 ligated	 into	 the	 linearised	 pGL4.20-DEST-luc	 via	
traditional	ligation	methods.	
pGL-pZIC3-DEST-luc-	pGL4.20-DEST-luc	and	pGl-pZIC3-luc	were	digested	with	HindIII	and	KpnI	to	





NCE.	The	ZIC2	NCE	 fragment	was	 inserted	 into	pGL-b-globin-DEST-luc	5’	to	the	promoter	and	
luciferase	gene.	
pGL4.20-Hsp68-NCE	(wildtype)	–	pGL4.20-Hsp68-NCE	with	the	wildtype	NCE	was	generated	via	

















































was	 digested	 with	 NotI	 and	 XhoI	 to	 linearize	 the	 vector.	 p1229,	 a	 Bluescript	 II	 KS	 vector	
containing	a	4354	bp	 lacZ	 reporter/SV40	PolyA	cassette,	was	digested	with	NotI	 and	XhoI	 to	




















this,	 incubated	 on	 ice	 again	 for	 2	minutes.	 250	 μL	 of	 SOC	 broth	 (Super	 Optimal	 broth	with	












as	 described	 in	 Section	2.2.16,	with	 5	µL	of	 the	 suspended	bacteria	 used	 as	 template.	Once	
prepared,	the	reaction	mixture	was	treated	as	a	normal	PCR.	The	remaining	bacterial	suspension	
was	stored	at	4	°C	until	analysis	was	complete.	Colonies	positive	for	the	required	DNA	were	used	





lacZ	 transgene.	 The	 surface	of	 fresh	 LB	agar	plates	 containing	100	mg/mL	of	 antibiotic	were	
treated	with	80	μL	of	a	solution	containing	0.1	M	Isopropyl	b-D-1-thiogalactopyranoside	(IPTG;	
Sigma	Aldrich)	and	20	mg/mL	X-Gal	(5-bromo-4-chloro-3-indolyl	β-D-galactopyranoside;	Sigma	
Aldrich)	 and	 incubated	 in	 the	 dark	 for	 30	minutes.	 50	μL	 of	 electroporated	or	 heat	 shocked	
bacteria	 were	 plated	 and	 incubated	 at	 37	 °C	 for	 16	 hours	 to	 allow	 colonies	 to	 grow.	 Cells	





Small	 quantities	 (<2	 μg)	 of	 plasmid	DNA	was	 isolated	 from	 a	 2-3	mL	DH5a	E.	 coli	 overnight	
culture	with	appropriate	antibiotics	using	 the	High	Pure	Plasmid	 Isolation	kit	 (Roche).	 Larger	
quantities	 (>2	 μg)	 of	 plasmid	 DNA	 was	 isolated	 from	 100-200	 mL	 overnight	 culture	 with	
appropriate	 antibiotics	 using	 the	 Nucleobond	 Xtra	Miniprep	 kit	 (Scientifix)	 according	 to	 the	
manufacturer’s	instructions.	In	both	cases	DNA	was	resuspended	in	ddH2O	and	stored	at	-20	°C.	
2.2.6 Agarose	Gel	Electrophoresis	
DNA	 fragments	 were	 separated	 through	 horizontal	 gel	 electrophoresis.	 Agarose	 gels	 were	
created	using	Ultrapure	Agarose	(Life	Technologies)	and	1X	TBE	buffer	(0.1	M	Tris-HCl,	0.09	M	
boric	 acid	 and	 0.001	M	ethylenediaminetetraacetic	 acid	 [EDTA];	 Amresco).	DNA	 that	 ranged	
between	10000	bp	and	500	bp	was	run	on	a	1%	gel,	whilst	DNA	between	500	bp	and	100	bp	was	
run	 on	 a	 2%	 gel.	 RedSafe	 DNA	 Stain	 (1:20	 000	 dilution;	 ChemBio)	 was	 used	 to	 allow	 for	














buffers	 appropriate	 for	 the	DNA	 in	 question	 (Table	 2.1).	 For	 the	 best	 results,	 the	 restriction	
enzymes	were	used	at	a	concentration	of	5	enzyme	unites	(U)/μg	of	DNA	being	digested	(~500	
ng	 plasmid	 DNA	 for	 analysis,	 2-10	 µg	 for	 cloning	 and	 riboprobe	 digestion)	 in	 2	 µL	 of	 the	
appropriate	NEB	buffer	(10X),	2	µL	Bovine	Serum	Albumin	(BSA;	10X),	and	enough	AnalaR	H2O	
to	give	a	total	volume	of	20	µL.	Digest	reactions	were	incubated	at	either	37	°C	or	65	°C	for	1-2	




In	 cases	 where	 only	 one	 restriction	 enzyme	 was	 used	 to	 linearize	 plasmid	 DNA,	 Antarctic	

























AccI	 NEB	CutSmart	 37°C	 80°C	
BglII	 NEB	3.1	 37°C	 No	
EcoRI	 NEB	CutSmart	 37°C	 65°C	
EcoRV	 NEB	3.1	 37°C	 80°C	
HindIII	 NEB	CutSmart	 37°C	 80°C	
KpnI	 NEB	1.1	 37°C	 No	
NcoI	 NEB	3.1	 37°C	 80°C	
NotI	 NEB	3.1	 37°C	 65°C	
SacI	 NEB	1.1	 37°C	 65°C	
SacII	 NEB	CutSmart	 37°C	 65°C	
SalI	 NEB	3.1	 37°C	 65°C	
XbaI	 NEB	CutSmart	 37°C	 65°C	
XhoI	 NEB	CutSmart	 37°C	 65°C	





DNA	 that	 did	 not	 need	 to	 be	 isolated	 on	 an	 agarose	 gel	 was	 precipitated	 using	 a	 final	
concentration	of	2.5	M	ammonium	acetate.	10X	volume	of	cold	100%	ethanol	(EtOH)	was	then	
added.	 Following	 centrifuging	 at	 18500	 x	 g,	 4	 °C	 for	 20	 minutes	 to	 pellet	 the	 DNA,	 the	
supernatant	was	removed	and	the	pellet	washed	with	180	μL	of	70%	cold	EtOH	for	two	minutes	
















was	 discarded,	 with	 any	 remaining	 EtOH	 allowed	 to	 air	 dry	 off.	 Once	 dry,	 the	 pellet	 was	
resuspended	 in	 10	 μL	 of	 AnalaR	 H2O	 and	 either	 heat-shocked	 or	 electrotransformed	 into	
competent	bacteria.	
2.2.12 In-Fusion	Cloning	
In-Fusion	 cloning	 allows	 for	 directional	 cloning	 of	 DNA	 fragments	 into	 any	 vector,	 via	 a	
proprietary	enzyme	that	recombines	DNA	fragments	containing	at	least	15	bp	of	homology	with	












Scientific;	 Cat.	 No.	 11828-029)	 was	 used	 to	 convert	 pGL4.20	 to	 pGL4.20-DEST	 (Section	 2.1).	
Briefly,	5	µg	of	pGL4.20	was	linearized	with	the	restriction	enzyme	EcoRV	to	create	blunt	ends,	
and	 treated	 with	 Antarctic	 Phosphatase	 to	 remove	 5’	 phosphatases	 and	 prevent	 vector	
religation.	50	ng	of	the	dephosphorylated	vector	was	incubated	with	10	ng	of	Gateway	Reading	





DNA	 sequences	 were	 transferred	 from	 Entry	 vectors	 (pENTR)	 into	 Destination	 expression	
vectors	 (DEST)	 using	 Gateway	 LR	 reactions.	 Gateway	 BP	 and	 LR	 reactions	 are	 used	 by	
bacteriophage	 Lambda	 phage	 to	 insert	 and	 excise	 DNA	 sequences	 into/from	 bacterial	





selected	 by	 a	 combination	 of	 antibiotic	 resistance	 and	 the	 negative	 selection	 of	 the	 original	
Destination	vector	based	on	the	presence	of	the	lethal	ccdB	gene.	
Multiple	DNA	sequences	were	transferred	from	pENTR1A,	2B	and	3C	entry	vectors	into	various	












PCR	 was	 carried	 out	 using	 a	 Mastercycler®	 Vapo.protect™	 or	 Mastercycler®	 Epgradient	 S™	
(Eppendorf).	PCR	oligonucleotides	were	designed	for	sequencing,	colony	PCR	and	general	PCR	
amplification	 (Appendix	 Table	 A1.2).	 To	 promote	 specificity,	 each	 oligonucleotide	 had	 a	G/C	
clamp	 at	 the	 3’	 end	 such	 that	 three	 of	 the	 five	 3’	 most	 bases	 were	 G	 or	 C.	 The	 melting	
temperature	 (Tm)	 of	 the	 oligonucleotides	 was	 designed	 to	 be	 within	 45–65	 °C	 and	
oligonucleotide	pairs	were	designed	to	have	a	Tm	within	5	°C	of	each	other.		
PCR	products	were	 amplified	 from	approximately	 20-40	ng	 of	 plasmid	DNA	or	 20	 ng	 of	 PCR	
fragments	using	two	oligonucleotides	at	a	final	concentration	of	0.6	μM	each,	and	a	commercial	




on	 the	 source	 of	 the	 template	 DNA	 and	 the	 annealing	 and	 melting	 temperatures	 of	 the	
oligonucleotides	in	each	reaction.	Success	of	the	PCR	was	analysed	via	gel	electrophoresis.	
2.2.17 DNA	sequencing	
The	 BigDye®	 Direct	 Cycle	 Sequencing	 Kit	 (Life	 Technologies)	 was	 used	 to	 sequence	 DNA	
fragments	or	plasmids.	Purified	products	were	amplified	using	3.5	μL	5X	sequencing	buffer	(400	
mM	Tris	pH	9.0,	10	mM	MgCl2),	1	μL	BigDye	Terminator	v3.0	Cycle	Sequencing	Ready	Reaction	








any	 additional	 EtOH.	 Genomic	 sequencing	 was	 performed	 using	 the	 ABI	 3730	 sequencer	
(Applied	Biosystems)	by	the	Biomolecular	Resource	Facility	(BRF;	John	Curtin	School	of	Medical	
















ThermoPrime	 Taq	 polymerase,	 75	 mM	 Tris-HCl	 (pH	







ThermoPrime	 Taq	 polymerase,	 75	 mM	 Tris-HCl	 (pH	













Kit	 (Qiagen;	Cat.	No.	74004)	according	 to	 the	manufacturer’s	 instructions,	and	quantified	via	
nanodrop.	Additional	DNase	 I	 treatment	(Cat.	No.	04716728001,	10U,	Roche)	at	37	°C	for	20	
minutes	 was	 performed	 to	 ensure	 no	 genomic	 DNA	 contamination	 was	 present.	 This	 was	
confirmed	 via	 standard	 PCR	with	 oligonucleotides	 that	 spanned	 intron	 1	 of	 Shh	 (RA748	 and	
RA749;	Appendix	Table	A1.2),	whereby	no	amplification	indicated	the	samples	were	free	from	
genomic	DNA.	RNA	integrity	was	confirmed	via	agarose	gel	electrophoresis.		
The	 total	 RNA	 from	 transfected	 cells	 was	 extracted	 24	 hours	 post-transfection	 via	 the	




of	ZIC2	 (RA1595	 and	RA1622;	Appendix	 Table	A1.2),	whereby	no	 amplification	 indicated	 the	






line,	 were	 cultured	 in	 Dulbecco’s	 Modified	 Eagle	 Medium	 (DMEM;	 Life	 Technologies)	





Nutrient	 Mixture	 F12	 (Sigma	 Aldrich)	 and	 DMEM	 (Life	 Technologies)	 that	 had	 been	
supplemented	with	2	mM	L-glutamine	 (Life	 Technologies),	 0.1	mM	non-essential	 amino	acid	









°C	 for	 5	minutes.	 Supplemented	 DMEM	 or	 F12:DMEM	was	 added	 to	 inhibit	 the	 trypsin.	 An	
appropriate	 amount	 of	 the	 cell	 suspension,	 as	 determined	 by	 end	 use	 requirements,	 was	
transferred	to	new	tissue	culture	plastic	ware.	Additional	supplemented	media	was	added	to	
reach	the	minimum	volume	requirements	per	tissue	culture	flask	or	dish.	Luciferase	assays	were	
only	 performed	 on	 cells	 between	 passage	 11	 and	 passage	 15	 to	 ensure	 the	 consistency	 of	
experimental	repeats.	
2.3.3 Transfection	of	Mammalian	Cell	Lines	
Cells	were	 transiently	 transfected	with	 various	plasmids	using	 LipofectamineTM	2000,	 a	 lipid-
based	transfection	agent	(Life	Technologies).	Cells	to	be	transfected	were	plated	into	6	well	or	
12	 well	 sterile	 tissue	 culture	 dish	 (Corning;	 Table	 2.3).	 If	 the	 cells	 were	 to	 be	 used	 for	




was	 diluted	 in	 unsupplemented	 DMEM	 or	 unsupplemented	 F12:DMEM,	 mixed	 with	
Lipofectamine™	2000	and	incubated	as	per	the	manufacturer’s	 instructions.	During	this	time,	






of	DMEM	added	was	calculated	based	on	 the	confluency	of	 the	cells	per	well,	with	 the	 final	




solid	 white	 tissue-culture	 treated	 96-well	 plate	 (Corning,	 Cat.	 No.	 CLS3917)	 to	 create	 three	
independent	 internal	 replicates	 for	each	 sample.	The	 intensity	of	 luminescence	produce	was	





















12	well	plate	 3.8	x	105	 4	µL/well	 1.6	 1.0	mL	











To	 increase	the	number	of	cilia	 in	LLC-PK1	cells,	 the	cells	were	serum	starved.	24	hours	post	











quantification,	 the	 assay	 for	 each	 gene	 consisted	 of	 three	 internal	 replicates	 per	 gene	 per	
sample.	 At	 least	 three	 independent	 experiments	 were	 performed	 for	 each	 RT-qPCR.	 Mean	




experiment	 was	 calculated	 using	 Microsoft	 Excel.	 Pooled	 data	 was	 analysed	 using	 Genstat	













Gene	 	 Oligonucleotide	 Species	 Product	size	(bp)	 Slope	 R2	 Efficiency	
H2afz	 F	 RA1719	 Mouse	 202	 -3.30	 0.99	 101.00%	
R	 RA1720	
mP0	 F	 RA1780	 Mouse	 109	 -3.35	 0.99	 99.00%	
R	 RA1781	






101/105	 -3.23	 0.99	 103.88%	
R	 RA1715	
mP3	 F	 RA1716	 Mouse	 109	 -3.30	 0.99	 100.85%	
R	 RA1717	
Ubc	 F	 RA1730	 Mouse	 112	 -3.33	 0.99	 99.47%	
R	 RA1731	
Zic2	 F	 RA252	 Mouse	 178	 -3.27	 0.98	 102.34%	
R	 RA96	
ABCE1	 F	 RA1606	 Human	 234	 -3.25	 0.98	 103.06%	
R	 RA1607	
FOXA2	 F	 RA1766	 Human	 90	 -3.16	 0.98	 107.25%	
R	 RA1767	
FOXJ1	 F	 RA1768	 Human	 93	 -3.24	 0.99	 103.63%	
R	 RA1769	
PPP1R8	 F	 RA1604	 Human	 123	 -3.33	 0.99	 99.70%	
R	 RA1605	


















































































blocked	 for	 one	 hour	 at	 room	 temperature	 in	 a	 skim	 milk	 blocking	 solution	 (5%	 skim	 milk	
powder,	Diploma;	1	X	PBS)	at	4	°C.		













Target	Protein	 Company;	Cat.	No.	 Species	 Dilution	used	
V5	 Sapphire	Biosciences;	R960-25	 Rabbit,	polyclonal	 1:500	
Acetylated	Tubulin	 Sigma	Aldrich;	T7451	 Mouse,	monoclonal	 1:200	













Alexa488		 Donkey		 Rabbit	 Thermo	 Fisher	 Scientific;	
A21206	
1:500	 495	nm	



















(cOmplete,	 EDTA-free	 Protease	 Inhibitor,	 Roche)	 and	 Phosphatase	 Inhibitor	 (PhosStop	
Phosphatase	Inhibitor	Cocktail,	Roche)	added	at	final	concentrations	of	1X.	Cells	were	vortexed	


















hydrated	 butanol	 (Sigma-Aldrich)	 and	 left	 at	 room	 temperature	 to	 polymerise	 for	 1	 hour.	























































The	membrane	was	 then	washed	with	blocking	buffer	six	 times,	with	each	wash	 lasting	5-10	











Target	Protein	 Company;	Cat.	No.	 Species	 Dilution	used	
GAPDH	 Abcam;	ab8245	 Mouse,	monoclonal	 1/1000	
HA-probe	(Y-11)	 Santa	Cruz;	sc-805	 Rabbit,	polyclonal	 1/200	
Tata	binding	protein	(TBP)	 Abcam;	ab818	 Mouse,	monoclonal	 1/2000	






Species	 Target	Species	 Company;	Cat.	No.	 Dilution	used	
Rabbit		 Mouse		 Invitrogen;	616520		 1/5000		















et	al.,	 2008)	was	maintained	on	 two	distinct	 backgrounds	by	 continuous	backcross	 to	 either	
C3H/HeH	or	129/SvEv	mice.	 In	both	cases,	mice	 from	backcross	10	or	beyond	were	used	 for	
analysis.	 Gene	 expression	 and	 phenotype	 were	 found	 to	 be	 identical	 between	 the	 two	
backgrounds	 for	 both	 Zic2Ku/+	 and	 Zic2Ku/Ku	embryos	 at	 embryonic	 stages	 7.0	 –	 9.5	 dpc	 and	





uterus	 and	 decidua	 in	 a	 solution	 of	 10%	 FBS	 (Life	 Technologies)	 in	 1X	 PBS.	 All	 membranes	























oligonucleotide	 RA1547	 (pBB262-NCE-lacZ	 wildtype	 and	mutant),	 RA1548	 (pBB262-lacZ)	 and	




PCR-96-FLT-C).	 All	 PCRs	 were	 performed	 in	 an	 Eppendorf	 Mastercycler®	 using	 the	 TD70	
Touchdown	 PCR	 programs	 (Table	 2.12)	 and	 the	 products	 run	 on	 a	 1.5%	 agarose	 gel.	 The	
production	of	a	443	bp	 (pBB262-mNet-lacZ),	561	bp	 (pBB262-NCE-lacZ	wildtype	and	mutant)	
and	366	bp	(pBB262-lacZ)	were	deemed	a	positive	genotype.		
Genotyping	 of	 CRISPR	 3’UTR	 mutant	 embryos	 was	 performed	 by	 Nay	 Chi	 of	 the	 JCSMR	





manufacturer’s	 instructions.	 The	products	 run	on	a	1%	agarose	 gel;	 an	 amplicon	of	 1019	bp	
indicated	a	wildtype	embryo.		
2.9.3 High	Resolution	Melt	Assay	(HRMA)	
Genomic	DNA	extracted	 from	ear	notches	of	 adult	mice	and	embryo	 tissue	were	genotyped	
using	HRMA,	 as	 described	by	 (Thomsen	et	 al.,	 2012).	 PCRs	were	 carried	out	using	 ImmoMix	
(Bioline;	Cat.	No.	BIO-25020)	and	included	the	LC	Green®	Plus+	Melting	Dye	(Idaho	Technology	
Inc.;	Cat.	No.	BCHM-ASY-0005).	All	reactions	were	carried	out	in	a	final	volume	of	10	μL	with	~30	




















ADA	 was	 used	 to	 genotype	 Kumba	 embryo	 DNA,	 as	 Zic2Ku/Ku	 homozygotes	 cannot	 be	
distinguished	 via	 HRMA.	 A	 TaqMan®	 Universal	 PCR	Master	Mix	 (Life	 Technologies;	 Cat.	 No.	
4304437),	along	with	TaqMan®	MGB	probes	(Applied	Biosystems)	corresponding	to	the	wildtype	













50	 cycles.	 A	 post-PCR	 read	 was	 performed	 at	 60°	 C	 for	 30	 seconds	 to	 collect	 data	 after	
completion	of	the	PCR.	Data	was	analysed	using	the	same	software	that	records	the	pre-	and	
post-PCR	reads	and	calculates	normalized	dye	fluorescence	(∆Rn)	from	the	wildtype	and	mutant	





Program:	 TD60	 TD65	 TD70	
Initial	
denaturation	



















































Polish	 72	°C	7	minutes	 	 72	°C	7	minutes	 	 72	°C	7	minutes	 	






Probe	name	 5’	Tag	 Probe	sequence	 3’	Quencher	
Zic2	WT	 6-FAM	 CGA	GGG	CTG	TGA	CC	 MGBNFQ	























WMISH	 was	 performed	 as	 previously	 described	 in	Wilkinson	 (1992)	 using	 the	 hybridization	
conditions	of	Rosen	and	Beddington	(1993)	(Rosen	and	Beddington,	1993;	Wilkinson,	1992).	For	
12.5	dpc	embryos,	wash	times	were	extended	to	15	minutes	and	WMISH	was	performed	on	a	




Dissected	 embryos	 were	 fixed	 in	 4%	 PFA	 in	 1X	 PBS	 for	 20	 minutes	 at	 room	 temperature.	
Following	this,	embryos	were	rinsed	 in	1X	PBS	and	equilibrated	 in	a	sodium	phosphate	wash	
buffer	(2	mM	magnesium	chloride,	0.01%	deoxycholate,	0.02%	NP40,	98	mM	sodium	phosphate	
buffer	 [23	 mM	 monobasic	 sodium	 phosphate,	 77	 mM	 dibasic	 sodium	 phosphate,	 pH	 7.3,	
Sigma]).	 X-Gal	 stain	 (10	 mg/mL	 5-bromo-4-chloro-3-indolyl	 β-D-galactopyranoside	 in	











Cdx2	 EcoRV	 T7	 Stefan	Broer,	ANU	
Dand5	 SacII	 SP6	 (Barratt	et	al.,	2014)	
Dkk1	 SalI	 T7	 (Ip	et	al.,	2014)	
Foxa2	 HindIII	 T7	 (Sasaki	and	Hogan,	1993)	
Foxj1	 SalI	 T3	 (Cruz	et	al.,	2010)	
Lefty1/2	 XhoI	 T7	 (Meno	et	al.,	1996)	
Lhx1	 HindIII	 T7	 (Shawlot	and	Behringer,	1995)	
Nodal	 EcoRI	 T3	 (Conlon	et	al.,	1994)	
Noto	 SalI	 T7	 (Barratt	et	al.,	2014)	
Nppa	 EcoRI	 T3	 Dominic	Norris,	MRC	Harwell,	UK	
Pitx2	 SacI	 T3	 (Ryan	et	al.,	1998)	
Pkd1l1	 EcoRI	 T7	 (Field	et	al.,	2011)	
Rfx3	 NcoI	 SP6	 (Barratt	et	al.,	2014)	
Shh	 XbaI	 T7	 (Echelard	et	al.,	1993)	
Sox2	 AccI	 T3	 (Wood	and	Episkopou,	1999)	
Sox3	 NotI	 T7	 (Wood	and	Episkopou,	1999)	
Sox17	 NotI	 T7	 Dominic	Norris,	MRC	Harwell,	UK	
Zic2	 SalI	 T7	 (Elms	et	al.,	2003)	
Zic3	 NcoI	 SP6	 (Elms	et	al.,	2004)	





potassium	 ferricyanide,	 Sigma	 Aldrich;	 200	 mM	 Tris-HCl	 pH	 7.4)	 was	 diluted	 in	 the	 sodium	
phosphate	wash	buffer	and	embryos	were	incubated	in	stain	overnight	in	a	dark	37	°C	shaking	
incubator.	Embryos	were	destained	in	1X	PBT	(1X	PBS;	Tween	20)	and	post-fixed	in	4%	PFA	in	





XbaI	 (Table	 2.1).	 The	 transposase	 mRNA	 was	 transcribed	 with	 T3	 RNA	 Polymerase	 and	 the	
mMessage	mMachine	T3	Kit	 (Ambion)	no	more	than	24	hours	before	zygote	microinjections.	
The	resulting	mRNA	was	purified	with	the	MEGAclear	Transcription	Clean-Up	kit	(Ambion),	and	




Embryo	 donor	 FVB/NJ	 mice	 were	 first	 injected	 with	 Pregnant	 Mare	 Serum	 Gonadotrophin,	






























followed	by	Human	Chorionic	Gonadotrophin	48	hours	 later	 to	 induce	super	ovulation.	They	
were	then	immediately	placed	with	fertile	stud	males	and	fertilised	zygotes	were	harvested	12	
hours	 post-conception.	 CRISPR	 guide	mRNA	or	 plasmid	DNA,	 and	50-100	ng/µL	 CRISPR-Cas9	

























cacodylate	buffer,	 embryos	were	postfixed	 in	1%	osmium	 tetroxide/0.1	M	cacodylate	 for	 20	
minutes	at	room	temperature.	They	were	dehydrated	through	a	graded	EtOH	series	and	dried	





genotype	 (Zic2+/+,	 Zic2Ku/+	 and	 Zic2Ku/Ku).	 Node	 circumference	 and	 the	 length	 of	 the	 anterior-
posterior	axis	were	measured	using	LAS	V4.3	software.	Cilia	frequency	and	length	were	counted	
in	 three	 embryos	 from	 each	 genotype	 (Zic2+/+,	 Zic2Ku/+	 and	 Zic2Ku/Ku)	 using	 SEM.	 For	 cilia	







To	 measure	 the	 rate	 of	 ZIC2	 mRNA	 decay,	 cells	 were	 either	 transfected	 with	 constructs	
containing	V5-ZIC2-3’UTR	or	V5-ZIC2.	24	hours	post	transfection,	the	media	was	aspirated	from	
cells	and	replaced	with	either	supplemented	DMEM	(1	mL)	containing	200	μM	5,6-dichloro-beta	














!"/$ 	= log(2)log{LOGEST[(56, 86) 	 ∶ 	 (5:, 8:)]}	
The	LOGEST	function	estimates	the	slope	of	all	points	over	the	time	course	using	a	nonlinear	




and	 the	 total	 RNA	 extracted	 as	 per	 Section	 2.2.18.	 A	 dT-adapter	 oligonucleotide	 (RA1703;	
Integrated	DNA	Technologies)	was	used	with	the	SuperScipt	 III	One-Step	RT-PCR	system	with	
Platinum	 Taq	 kit	 (Invitrogen,	 Cat.	 No.	 12574018)	 to	 convert	 the	 embryonic	mRNA	 to	 cDNA,	
according	to	the	manufacturer’s	instructions.	The	presence	of	the	‘TTT’	string	ensures	only	RNA	






















experiment	 was	 calculated	 using	 Microsoft	 Excel.	 Pooled	 data	 was	 analysed	 using	 Genstat	
software	 to	 perform	 either	 an	 unpaired	 Student’s	 T-Test	 or	 two-way	 Analysis	 of	 Variance	
(ANOVA)	with	Fischer’s	unprotected	post	hoc	test	on	a	minimum	of	three	external	repeats,	and	
to	calculate	the	standard	error	of	the	mean	(S.	E.	M.).		
RT-qPCR	 analysis:	 Genstat	 software	 was	 used	 perform	 a	 one-way	 ANOVA	 with	 Fischer’s	
unprotected	post	hoc	test	on	a	minimum	of	two	external	repeats,	and	to	calculate	the	S.E.M.	
Statistical	analysis	was	performed	on	normalized	CT	means.	
Cilia	 analysis:	 Genstat	 software	 was	 used	 to	 perform	 a	 two-way	 ANOVA	 with	 Fischer’s	
unprotected	post	hoc	test	on	ten	cilia	each	for	three	embryos	per	genotype,	and	to	calculate	the	
S.E.M.		
Bioinformatics:	 For	 histone	 modification	 enrichment,	 values	 taken	 from	 Layered	 Tracks	
(ENCODE)	were	assigned	 to	a	nucleotide	 location	within	 the	ZIC2	3’UTR	 in	Excel.	Enrichment	
within	the	3’UTR	was	compared	via	a	one-way	ANOVA	with	Fischer’s	unprotected	post	hoc	test	















CLUSTAL	Omega	 Pairwise	identity	percentage	calculations	 (Goujon	 et	 al.,	 2010;	 Sievers	 et	 al.,	
2011)	
DIANA-microT-CDS	 miRNA	binding	site	prediction	 (Paraskevopoulou	 et	 al.,	 2013;	
Reczko	et	al.,	2012)	
EMAGE	 Gene	expression	analysis	in	embryos	 (Richardson	et	al.,	2014)	





















































expression	and	 function	 is	 transient.	Given	 that	 ZIC2	 is	 required	 to	execute	 the	A-P	and	D-V	
components	of	node	function,	it	is	hypothesised	that	the	node	and	midline	formation	defects	in	
Zic2Ku/Ku	 embryos	 would	 also	 interfere	 with	 L-R	 axis	 formation.	 This	 is	 supported	 by	 the	
observations	that	some	homozygous	embryos	have	incorrect	heart	morphology	at	9.5	dpc	(see	





of	 organs:	 the	 breaking	 of	 embryonic	 symmetry,	 the	 establishment	 of	 leftward	 nodal	 flow,	
asymmetric	gene	expression	and	the	nodal	cascade,	and	the	placement	of	developing	organs.	It	





plate	 mesoderm	 (LPM)	 which	 contributes	 to	 asymmetric	 organ	 structure	 after	 axis	
		100	
establishment	 (Norris,	 2012)	 (Figure	 3.1).	 At	 the	mid-streak	 stage,	 the	 outer	 surface	 of	 the	
embryo	is	covered	by	squamous	endoderm	cells,	with	APS	cells	arranged	as	a	sheet	beneath	the	
endoderm	 layer	 (Yamanaka	et	al.,	2007).	 Lineage	 tracing	 found	 that	 these	APS	cells	begin	 to	




apical	 surfaces	 and	 cilia	 have	 emerged	between	 the	 endoderm	 cells	 and	 can	 be	 seen	 into	 a	




















tilt	 anteriorly	 instead	 of	 posteriorly,	 a	 vortex	 is	 created	 above	 the	 cilia	 that	 results	 in	
randomisation	 of	 nodal	 flow	 (Maisonneuve	 et	 al.,	 2009;	 Okada	 et	 al.,	 2005,	 1999).	 It	 is	
disruptions	 such	 as	 these	 in	 the	 formation	 or	 function	 of	 node	 cilia	 that	 lead	 to	 the	 loss	 of	












Figure	3.1:	Schematic	of	 L-R	axis	 formation	 in	 the	murine	embryo.	 (a)	 The	embryonic	node	
contains	ciliated	pit	cells	surrounded	by	ciliated	crown	cells.	Endoderm	and	paraxial	mesoderm	
cells	 flank	 the	 node,	 with	 mesoderm	 forming	 the	 right	 (not	 shown)	 and	 left	 lateral	 plate	
mesoderm	(LPM)	down	the	sides	of	the	embryo.	(b)	Steps	involved	in	L-R	axis	formation.	1:	The	
node	is	induced	to	form	at	mid-gastrulation	(7.0	dpc)	and	in	the	next	24	hours	develops	into	a	
shallow,	 crescent	 shaped	 depression	 on	 the	 ventral	 side	 of	 the	 embryo.	 2:	 A	 monocilium,	
extending	into	the	extracellular	space,	forms	on	the	apical	surface	of	each	pit	and	crown	cell;	




cells	which	modifies	gene	expression.	By	the	end	of	 this	24	hour	period	 (at	8.0	dpc)	 the	 first	
known	asymmetries	in	gene	expression	are	detected	within	node	crown	cells	(Dand5,	and	soon	




5:	NODAL	signalling	 in	the	 left	LPM	controls	 its	own	expression,	and	that	of	other	molecules,	







formation	 of	 immotile	 and	 motile	 cilia	 in	 the	 node.	 The	 forkhead	 homeobox,	 FOXJ1,	 in	
combination	with	members	 of	 the	Not	 homeobox	 (NOTO)	 and	 the	 regulatory	 factor	 X	 (RFX)	
families	(Beckers	et	al.,	2007;	Didon	et	al.,	2013;	Thomas	et	al.,	2010),	control	ciliogenesis	in	the	
embryonic	 node.	 NOTO,	 acting	 upstream	 of	 FOXJ1	 and	 RFX3,	 regulates	 expression	 of	
components	involved	in	cilia	axonemal	assembly	and	function	(Beckers	et	al.,	2007).	In	contrast,	
RFX3	regulates	growth	of	cilia	and	FOXJ1	is	responsible	for	the	differentiation	of	motile	ciliated	
cells	 (Bonnafe	 et	 al.,	 2004).	 Failure	 of	 any	 of	 the	 three	 TFs	 results	 in	 abnormal	 L-R	 axis	





al.,	 2013).	 Together	 FOXJ1	 and	 RFX3	 induce	 basal	 progenitor	 cells	 to	 differentiate	 into	 a	
multiciliated	cell	lineage.	
The	detection	of	the	leftward	flow	across	the	node	requires	the	concerted	efforts	of	polycystins	
PKD2	and	PKD1L1.	PKD2	is	ubiquitously	 localised	to	 immotile	cilia	 in	the	crown	cells,	not	 just	
restricted	to	the	cilia	on	the	left	of	the	node,	and	is	thought	to	be	responsible	for	detecting	the	
Ca2+	 spike.	 This	 ubiquitous	 localisation	 around	 the	 entire	 node	 is	 perhaps	 due	 to	 the	
asymmetrical	 expression	 of	 Dand5	 (formally	 Cerl2)	 on	 the	 right	 of	 the	 node,	 which	 is	 a	
downstream	 target	 of	 flow-induced	 PKD2	 signals	 (Yoshiba	 et	 al.,	 2012).	 PKD2,	 acting	 as	 an	
effector,	forms	a	complex	with	PKD1L1,	acting	as	a	sensor,	to	create	a	flow-sensing	complex	not	
just	in	the	embryonic	node	but	also	in	the	kidney	(Norris,	2012;	Pennekamp	et	al.,	2002).	The	
actual	 mechanisms	 of	 how	 this	 PKD2/PKD1L1	 complex	 senses	 the	 fluid	 flow	 is	 yet	 to	 be	
identified,	 with	 suggestions	 of	 chemosensation	 and	 mechanosensation	 currently	 being	





Sufficient	nodal	 flow	can	be	created	with	as	 little	as	two	rotating	cilia	 in	the	node	of	mutant	





















time	 that	 Ca2+	 becomes	 elevated	 at	 the	 left	 boundary	 of	 the	 node	 (McGrath	 et	 al.,	 2003).	
Subsequently,	 asymmetric	 signals	 are	 propagated	 from	 the	 node	 to	 the	 left	 LPM	 via	 an	
unresolved	mechanism.	By	the	3-somite	stage	of	development	(8.25	dpc),	Nodal	signalling	in	the	
left	LPM	has	induced	its	own	expression,	as	well	as	that	of	the	Nodal	antagonist	Lefty2,	along	














studies	 have	 suggested	 that	 Ca2+	 signals	 are	 transferred	 from	 the	 node	 to	 the	 LPM	 via	 gap	
junctions	in	the	definitive	endoderm,	and	it	is	these	signals	that	contribute	to	the	activation	of	







Vertebrate	 organ	 asymmetry	 is	 highly	 conserved	 (Norris,	 2012),	 indicating	 a	 fundamental	
function	 for	 the	placement	and	orientation	of	each	organ.	Though	defects	 in	organ	 situs	 are	
relatively	rare	in	humans,	they	are	most	commonly	associated	with	congenital	heart	disease	and	
ciliopathies	(Norris,	2012).	Alterations	in	the	L-R	axis	are	defined	as	situs	inversus,	whereby	the	
organs	 are	 arranged	 as	 the	 complete	 mirror	 image	 compared	 to	 an	 unaffected	 person,	 or	
heterotaxy	 (situs	ambiguous	 and	 isomerisms),	whereby	 there	 is	a	 lack	of	 concordance	 in	 the	
placement	of	organs,	or	mirror	image	duplication	of	paired	organs	(such	as	two	lungs	that	both	
contain	three	lobes).	Though	pure	situs	inversus	is	not	commonly	associated	with	intracardiac	
cases,	 heterotaxy	 accounts	 for	 3%	 of	 congenital	 heart	 defects	 (Brueckner,	 2007;	 Zhu	 et	 al.,	
2006).	 Additionally,	 defects	 in	 the	 L-R	 patterning	 have	been	 linked	 to	 a	 range	of	 other	 situs	
abnormalities	 such	 as	 biliary	 atresia,	 intestinal	 malrotations,	 stomach	 curvature,	 vertebral	
anomalies	and	 respiratory	distress	 from	primary	ciliary	dyskinesia	 (Cohen,	2012;	Davis	et	al.,	
2017;	Zhu	et	al.,	2006),	as	well	as	alteration	in	the	directionality	of	embryo	turning	(Collignon	et	















expressed	 in	 the	 right	 atrium	 and	 left	 ventricle	 of	 the	 developing	 heart	 (Moorman	 and	
Christoffels,	 2003),	 it	 was	 used	 to	 confirm	 the	 identity	 of	 heart	 regions.	 All	 wildtype,	







to	 L-R	 axis	 establishment	 and	 can	 be	 independent	 of	 heart	 looping.	 For	 example,	 defects	 in	















and	 by	 the	 establishment	 of	 a	midline	 barrier.	 At	 the	 3-6	 somite	 stage	 of	 development	 the	
secreted	 molecule	 Nodal,	 its	 secreted	 antagonist	 Lefty2	 and	 the	 downstream	 transcription	
factor	Pitx2	are	all	expressed	in	the	left	LPM	and	the	Nodal	antagonist	Lefty1	is	expressed	at	the	











embryo	with	dextral	 looping.	 (e)	A	25	 somite	Zic2Ku/Ku	 embryo	with	 sinistral	 looping.	 (f)	A	16	








Figure	 3.3:	 Cardinal	 vein	 situs	 is	 randomized	 in	 Zic2Ku/Ku	 embryos.	 Lateral	 view	 of	 embryos	
following	WMISH	 to	Pitx2.	 (a)	A	10	 somite	Zic2+/+	 embryo	with	Pitx2	 transcription	 in	 the	 left	
cardinal	vein	(arrowhead).	(b)	A	10	somite	Zic2Ku/Ku	embryo	lacking	Pitx2	cardinal	vein	expression	
(arrowhead).	 (c)	 A	 16	 somite	Zic2+/+	 embryo	with	Pitx2	 transcription	 in	 the	 left	 cardinal	 vein	
(arrowhead).	(d)	A	16	somite	Zic2Ku/Ku	embryo	with	sinistral	heart	looping,	Pitx2	transcription	in	










Nodal	 cascade	 (i.e.	 bi-lateral	 expression	 of	 Nodal,	 Lefty2	 and	 Pitx2)	 (Meno	 et	 al.,	 1998;	
Yamamoto	et	al.,	2003).		
The	expression	of	Pitx2	was	detected	throughout	the	entire	A-P	extent	of	the	LPM	in	wildtype	




































Lefty1	 expression	 is	 depleted	 and	 Lefty2	 expression	 lost	 in	 Zic2Ku/Ku	 embryos.	 (e,	 f)	 Pitx2	 is	
























no	 asymmetric	 expression	 was	 observed	 (Figure	 3.6E-H).	 These	 data	 indicate	 that	 Zic2	 is	
genetically	upstream	of	asymmetric	gene	expression	at	the	node.	
To	determine	whether	the	effects	on	gene	expression	at	the	node	result	from	aberrant	node	
development	 we	 examined	 the	 node	 of	 3-5	 somite-stage	 embryos	 by	 light	microscopy	 (DIC	

















in	the	gastrula.	The	Arkell	 lab	has	previously	shown	that	the	expression	of	Foxa2	 in	 the	mid-
gastrula	node	is	severely	depleted	(Warr	et	al.,	2008)	and	it	is	known	that	embryos	lacking	FOXA2	
are	unable	to	form	a	functional	node	(Ang	and	Rossant,	1994).	To	determine	whether	this	early	
defect	 in	node	 function	may	also	 influence	 L-R	 axis	 formation,	 I	 examined	 the	expression	of	
genes	 required	 for	node	ciliogenesis	 (Noto,	Rfx3,	Foxj1)	 (Beckers	et	al.,	2007;	Bonnafe	et	al.,	
2004;	M.	Zhang	et	al.,	2004)	and	sensory	function	(Pkd1l1)	(Field	et	al.,	2011).	The	expression	of	





























Figure	3.9:	Aberrant	gene	expression	 in	 the	mid-gastrula	node	of	Zic2Ku/Ku	 embryos.	Lateral	
views	of	embryos	following	WMISH	to	the	genes	shown	on	embryos	of	the	genotypes	shown.	
Anterior	is	to	the	left.	(a,	c,	e,	g)	7.0	dpc,	pre-allantoic	bud	stage.	(b,	d,	f)	7.5	dpc,	early-mid	bud	
stages,	 (h)	 7.75	 dpc,	 late	 bud	 stages.	 (a-b)	 Rfx3	 node	 expression	 is	 diminished	 in	 Zic2Ku/Ku	





















with	 (a-c)	 V5-ZIC2-wt,	 (d-f)	 V5-ZIC2-kumba	 or	 (g-i)	 PKD2-Myc	and	 immunostained	with	a-V5	
(green;	a,	c,	d	and	f),	a-C-Myc	(green;	g,	i)	or	a-Acetylated	Tubulin	(red;	b,	c,	e,	f,	h	and	i).	(a-f)	










dysmorphic	 cilia	 relative	 to	 their	 wildtype,	 stage-matched	 littermates	 and	 the	 molecular	




required	 for	 the	 formation	and	 function	of	node	cilia.	Each	of	 the	other	 transcription	factors	
known	 to	 be	 involved	 in	 this	 process	 (Noto,	 Foxj1	 and	 Rfx3)	 uniquely	 affects	 the	 L-R	 axis	

















dpc	mouse	embryos	 that	 lack	 the	homeobox	TF	Noto,	with	Noto-/-	 embryos	exhibiting	 short,	
malformed	and	immotile	cilia	(Beckers	et	al.,	2007).	Moreover,	the	cilia	phenotype	of	Noto	null	
embryos	can	be	rescued	by	Foxj1	insertion	into	the	Noto	locus	(Alten	et	al.,	2012),	suggesting	
that	 NOTO	 acts	 upstream	 of	 Foxj1	 and	 Rfx3.	 Mutation	 of	Noto	 does	 not	 affect	 A-P	 or	 D-V	
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patterning	 and	 its	 function	 seems	 specific	 to	 the	 L-R	 axis	 component	 of	 node	 activity.	 In	
combination	with	the	compromised	expression	of	Noto,	Rfx3	and	Foxj1	in	Zic2Ku/Ku	embryos,	this	




mutants	 generate	 at	 least	 a	 small	 amount	 of	 nodal	 flow).	 This	 could	 occur	 because	 of	 a	
difference	 in	 the	 target	 gene	 sets	 of	 these	 transcription	 factors,	 or	 because	 of	 genetic	
background	effects.	Experiments	that	examine	the	precise	structure	of	the	dysmorphic	cilia	or	








that	of	embryos	 lacking	Noto,	Foxj1	 or	Rfx3	 can	be	elucidated	 from	similarities	between	 the	
phenotype	of	Zic2Ku/Ku	embryos	and	that	of	embryos	with	loss-of-function	mutations	of	either	
Pkd1l1	 or	 Pkd2	 (Ermakov	 et	 al.,	 2009;	 Field	 et	 al.,	 2011;	 Pennekamp	 et	 al.,	 2002).	 Loss-of-
function	mutations	in	either	of	these	genes	result	in	a	failure	of	the	Nodal	cascade,	rather	than	




mutants	 are	 morphologically	 normal	 and	 cilia	 are	 motile,	 in	 sufficient	 numbers	 and	 of	





























co-factor,	 similar	 to	 PKD2	 and	 PKD1L1	 which	 both	 show	 increased	 cilia	 localisation	 when	
expressed	 together	 (Kamura	 et	 al.,	 2011).	 As	 yet,	 no	 candidates	 for	 a	 ZIC2	 co-factor	 in	 this	
process	 have	 been	 identified.	 It	 is	 more	 likely,	 however,	 that	 ZIC2	 acts	 upstream	 of	 genes	
involved	 in	 cilia	 formation.	 As	 ciliogenesis	 occurs	 in	 four	 stages	 (generation	 of	 centrioles,	
migration	of	duplicated	centrioles,	formation	of	basal-body	structures	and	elongation	of	cilia;	
Hagiwara	et	al.	2004),	the	short	length	and	bulging	of	Zic2Ku/Ku	cilia	suggests	an	error	is	occurring	
in	 the	 final	 process:	 cilia	 elongation.	 Short	 and	 bulging	 cilia	 appear	 to	 be	 common	 when	
retrograde	transport	is	defective,	with	mutations	in	IFT144	and	DYNC2H1	resulting	in	bulges	due	
to	accumulation	of	 IFT	particles	at	 the	ciliary	 tip	 (Liem	et	al.,	2012;	Ocbina	et	al.,	2009).	The	
bulging	 seen	 in	 Zic2Ku/Ku	 cilia	 is	 most	 likely	 ‘swollen	 cilia’,	 where	 excess	 cytoplasmic	 matrix,	
tubulin	molecules	 and	axoneme	materials	 accumulate	 in	 various	parts	of	 the	 ciliary	 shaft.	 In	
normal	cilia,	these	swollen	portions	tend	to	disappear	as	the	cilium	elongates	(Hagiwara	et	al.,	
2004),	 however,	 if	 ZIC2	 acts	 upstream	 to	 regulate	 the	 expression	 of	 genes	 involved	 in	 cilia	
retrograde	transport	this	may	not	be	possible	due	to	the	shorter	cilia	length	in	the	absence	of	
ZIC2.		
The	 creation	 of	 a	 Zic2-Ku	 LLCPK1	 cell	 line	 via	 CRISPR-Cas9	 mutagenesis	 would	 allow	 for	
continued	analysis	of	the	Kumba	phenotype.	It	is	expected	that	a	Kumba	cell	line	would	replicate	









earlier	 in	 embryonic	 node	 and	 cilia	 development	 than	 the	 stages	 examined	here.	 Therefore,	
future	 investigation	should	aim	to	 identify	 the	 influence	of	ZIC2	on	genes	upstream	of	 those	
already	examined	to	pinpoint	at	what	time	point	ZIC2	is	essential	for	L/R	axis	establishment.	The	
induction	 of	Nodal	 expression	 in	 the	 crown	 cells	 occurs	 via	 the	 interactions	 of	NOTCH1	 and	
NOTCH2	 receptors	 with	 upstream	 components	 TBX6	 and	 DLL1	 in	 the	 primitive	 streak	 and	
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presomitic	mesoderm,	with	Tbx6-/-	and	Dll1-/-	mice	exhibiting	multiple	L-R	defects	(Hadjantonakis	











but	 also	 hearts	 that	 looped	 ventrally.	 As	 60-100%	 of	 Heterotaxy	 patients	 present	 with	






The	 reduction	 in	 the	 Nodal	 cascade	 and	 the	 defects	 seen	 in	 node	 cilia	 in	 Zic2Ku/Ku	 embryos	
suggests	 that	 the	 inability	 to	establish	a	correct	L-R	axis	 is	not	restricted	to	the	heart.	This	 is	
further	 reinforced	 by	 the	 randomized	 Pitx2	 expression	 seen	 in	 the	 cardinal	 vein.	 Thus,	
investigation	 into	 the	 asymmetries	 of	 other	 organs	 should	 be	 investigated.	 Though	 Zic2Ku/Ku	
embryos	die	at	13.5	dpc,	the	positioning	of	the	spleen	and	liver	in	respect	to	the	midline	can	be	














via	 SHH	 signalling	 (Murdoch	 and	 Copp,	 2010),	 along	 with	 specification	 of	 neural	 cell	 fates	
(reviewed	in	Bay	&	Caspary	2012).	Neural	tube	closure	is	initiated	at	~5	somites	at	the	future	










Though	 there	 is	 currently	 no	 evidence	 explicitly	 linking	 spina	 bifida	 to	 cilia	 defects,	 the	 link	
between	 cilia	 defects	 and	 neural	 tube	 defects	 via	 abrogated	 signalling	 pathways	 is	 strong.	
Conditional	Arl13b	mutants	have	been	shown	to	exhibit	spina	bifida,	most	likely	due	to	abnormal	
















Ybot-Gonzalez	 et	 al.,	 2007).	 Furthermore,	 Zic1+/-;Zic2Kd/+	 compound	 heterozygotes	 exhibit	
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hydrocephalus	(Aruga	et	al.,	2002;	Inoue	et	al.,	2004).	As	the	underlying	molecular	cause	of	spina	
bifida	 in	Zic2	mutants	 is	unknown,	 there	 is	an	opportunity	 to	 investigate	whether	cilia	 in	 the	
Kumba	neural	tube	resemble	those	of	wildtype	embryos.		
3.3.5 HPE	and	Heterotaxy	




known,	 but	 it	 is	 commonly	 observed	 that	mice	 are	 less	 sensitive	 to	 haploinsufficiency	 than	
humans	(Bogani	et	al.,	2005).	As	50%	of	patients	with	immotile	or	abnormal	cilia	motility	exhibit	
situs	inversus	(Norris,	2012),	it	seems	likely	that	at	least	a	subset	of	human	HPE	patients	with	
mutation	 of	 ZIC2	 will	 have	 cardiac	 and/or	 other	 defects	 of	 L-R	 axis	 formation	 and	 this	 is	





ZIC2-associated	 cardiac	 defects	 would	 likely	 increase	 if	 this	 feature	 is	 specifically	 examined.	
Children	presenting	with	ZIC2-associated	HPE	require	examination	for	cardiac	and	other	visceral	









providing	 an	 aetiology	 for	 the	 cardiac	 defects	 seen	 in	 HPE	 patients	 and	 a	 new	 aim	 for	
phenotyping	and	genetic	 screens	of	human	HPE	and	Heterotaxy	probands.	As	 ZIC2	does	not	
appear	 to	 directly	 localise	 to	 the	 cilium,	 it	most	 likely	 regulates	 components	 involved	 in	 L-R	







As	 described	 in	 the	 Introduction	 (Section	 1.11),	 in	 2012	 Roessler	 et	 al.	 used	 comparative	
genomics	to	identify	a	NCE	(and	thus	a	putative	regulatory	element)	within	the	ZIC2	3’UTR.	A	
case-control	 study	 of	 variant	 sequences	 across	 the	NCE	 demonstrated	 the	 element	 is	 under	
strong	selective	pressure	and	supported	the	hypothesis	 that	 it	 regulates	ZIC2	expression	 in	a	
manner	that	prevents	HPE	occurrence	(Roessler	et	al.,	2012a).	Gene	expression	can	be	regulated	
by	controlling	the	rate	of	transcription,	a	process	that	is	dependent	upon	the	interaction	of	the	





















kidney	 protects	 the	 mouse	 from	 developing	 insulin-like	 growth	 factor	 1	 mediated	 insulin-




In	 eukaryotes,	 a	 typical	 gene	possesses	multiple	 ER	 elements	which	 contribute	 to	 its	 overall	
spatial	and	temporal	expression	throughout	development	(Blackwood	and	Kadonaga,	1998;	Ong	
and	Corces,	2011).	Each	ER	element	itself	can	contain	both	enhancer	and	repressor	domains,	
with	 the	 net	 regulatory	 output	 of	 the	 element	 determined	 by	 integration	 of	 these	 domains	
(Arnosti	and	Kulkarni,	2005).	This	was	elegantly	demonstrated	in	transgenic	Drosophila	embryos	






The	 TF	 proteins	 bound	 directly	 to	 the	 DNA	 of	 ER	 elements	 act	 as	 a	 foundation	 for	 protein	
complexes	termed	enhanceosomes	or	repressosomes.	These	‘-somes’	include	the	co-activators	
or	 co-inhibitors	 that	 control	 interactions	 with	 the	 general	 transcriptional	 machinery	 (Carey,	
1998;	Merika	and	Thanos,	2001).	By	receiving	signals	from	multiple	regulatory	cascades,	they	







activating	TFs	bind	 to	 the	ER	element	and	 then	 to	 co-activators	 to	 create	a	protein	 complex	
(Merika	and	Thanos,	2001).	Enhanceosome	formation	is	reliant	on	a	stereotypical	arrangement	









effort	 of	 lineage	 specific	 proteins	 (Palstra	 and	 Grosveld,	 2012).	 At	 this	 time,	 nucleosomes	
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flanking	the	ER	element	mask	the	TATA	box	at	the	transcription	start	site.	Once	enhanceosome	
formation	 is	 complete,	 however,	 the	 nucleosomes	 become	 acetylated	 and	 the	 chromatin	 is	
remodelled,	resulting	in	the	repositioning	of	the	nucleosomes	so	the	TATA	box	and	transcription	
start	 site	 are	 accessible	 to	 TATA-binding	 protein	 (TBP),	 RNA	 polymerase	 II	 and	 other	




two	 components	 loops	 out	 (Carter	 et	 al.,	 2002;	 Tolhuis	 et	 al.,	 2002).	When	 an	 ER	 element-
enhanceosome	complex	 is	pre-looped	to	a	target	promoter	yet	unable	to	actively	drive	gene	
expression,	 it	 is	 considered	 poised	 and	 can	 modulate	 target	 transcription	 in	 response	 to	
environmental	 cues.	Poised	enhancers	are	primarily	 linked	 to	early	embryogenetic	processes	
such	as	gastrulation,	neurulation	and	mesoderm	formation,	and	are	hypothesised	to	acquire	an	
active	state	upon	cell	differentiation	to	a	specific	fate	(Rada-Iglesias	et	al.,	2011).	Though	other	
models,	 such	 as	 DNA	 scanning	 and	 facilitated	 tracking	 (Zhu	 et	 al.,	 2007),	 have	 also	 been	
hypothesised	to	bring	an	ER	element	and	‘-some’	to	a	target	promoter,	there	is	less	experimental	
evidence	in	support	of	these.	 It	 is	most	 likely	a	combination	of	all	three	theories	occurring	 in	
cells,	dependant	on	the	ER	element,	co-factors	and	target	genes	in	question.	
In	contrast	to	enhanceosomes,	a	repressosome	prevents	the	recruitment	of	the	transcriptional	








bacteria	are	assayed	 for	b-galactosidase	 (Geanacopoulos	et	al.,	1999).	 It	has	been	suggested	
that	 the	 limits	 of	 gene	 expression	during	 embryogenesis	 are	 determined	by	 the	 activities	 of	







Figure	 4.1:	 Enhanceosome	and	 repressosome	 formation	 and	 function.	Transcription	 factors	
and	co-activators	are	recruited	to	an	ER	element	to	form	either	an	enhanceosome	complex	or	a	
repressosome	complex.	At	the	same	time,	chromatin	remodelling	proteins	and	transcriptional	
machinery	 (TBP,	RNA	polymerase	 II)	are	recruited	to	a	 target	promoter.	The	ER	element	and	
bound	 protein	 complex	 loops	 around	 to	 interact	 with	 the	 target	 promoter	 and	 machinery.	





provide	 information	 about	 whether	 the	 element	 is	 active,	 potential	 interacting	 TFs	 or	 the	





to	a	 region	of	DNA	 is	usually	 insufficient	 to	activate	or	 repress	 transcription	 (Shlyueva	et	al.,	
2014).	 Second,	 by	 analysing	 the	 location	 and	 type	 of	 TFBSs	 it	 is	 possible	 to	 estimate	 how	
mutations	in	the	element	may	alter	putative	DNA/TF	interactions.	The	introduction	of	SNVs	into	
an	 ER	 element	may	 lead	 to	 the	 failure	 to	 form	 an	 enhanceosome	 and	 instead	 promote	 the	
formation	of	a	repressosome.	This	was	demonstrated	via	the	disruption	of	binding	sites	in	the	
Ciona	Otx-a	enhancer.	The	core	4	bp	sequences	of	GATA	and	ETS	binding	sites	were	preserved,	





will	 have	 a	 large	 number	 of	 binding	 sites	 for	 developmentally	 essential	 TFs.	 Genome-wide	












































• To	 determine	 if	 the	 ZIC2	 3’UTR	 contains	 the	 hallmarks	 of	 an	 active	 ER	 element	 via	
bioinformatics	analyses.	












comparison	 of	 the	 human	 ZIC2	 3’UTR	 to	 a	 range	 of	 different	 species	 was	 performed	 by	







percentage	 was	 calculated	 by	 aligning	 the	 Zic2	 or	 zic2a	 3’UTR/NCE	 human,	 mouse	 (Mus	
musculus),	 zebrafish	 (Danio	 rerio),	 Xenopus	 laevis,	 pufferfish	 (Takifugu	 rubripes),	 and	 the	
predicted	chicken	(Gallus	gallus)	sequences	in	CLUSTAL	Omega	(Goujon	et	al.,	2010;	Sievers	et	
al.,	 2011)	 (Table	4.1,	 Figure	4.2).	As	expected,	 the	mouse	demonstrated	 the	highest	 level	 of	
sequence	conservation	with	human	ZIC2.	In	all	species	examined,	pairwise	identity	percentage	














Table	 4.1:	 Pairwise	 Identity	 Percentage	 comparison	 of	 the	ZIC2	 CDS,	 3’UTR	 and	 conserved	
regions	(NCE,	UCR)	in	multiple	species.	Percent	identity	was	calculated	via	sequence	alignment	





	 Accession	#	 CDS	 3’UTR	 NCE	 UCR	
Human	ZIC2	 NM_007129	 100%	 100%	 100%	 100%	
Mouse	Zic2	 NM_009574	 90.31%	 82.85%	 90.4%	 79.27%	
Xenopus	zic2	 NM_001087724	 72.96%	 56.98%	 69.17%	 64.94%	




74.18%	 48.94%	 56.36%	 67.86%	
Chicken	ZIC2	 XM_015274914	
Predicted	sequence	









Figure	 4.2:	 Conserved	domains	between	multiple	 species	 in	 the	ZIC2	 3’UTR.	Zic2	 and	 zic2a	
3’UTR	 sequences	 from	 the	mouse	 (orange),	 chicken	 (yellow),	Xenopus	 (dark	 blue),	 zebrafish	
(green)	and	Fugu	(Takifugu	rubripes,	pink)	were	taken	from	NCBI	and	Ensembl	and	aligned	to	
the	 human	 ZIC2	 3’UTR	 (grey)	 in	 Geneious	 Pro	 (V5.5.9)	 to	 identify	 conserved	 domains.	 The	
majority	 of	 conservation	was	 found	 in	 the	NCE	 region	 (light	 blue),	with	only	 the	mouse	 and	
zebrafish	 sequences	 aligning	 to	 the	 human	 sequence	 outside	 the	 NCE.	 One	 86	 bp	 region,	































in	 embryo	 development	 have	 been	 documented	 (reviewed	 in	 Houtmeyers	 et	 al.	 2013).	 It	 is	
therefore	possible	that	the	conserved	regions	in	the	ZIC2	and	ZIC3	3’UTRs	stem	from	a	common	
ancestor	 gene,	 resulting	 in	 similar	 sequences	 and	 functions.	 A	 pairwise	 identity	 percentage	








Figure	 4.3:	 Phylogenetic	 comparison	 of	 Zic2	 sequences	 between	 species.	 Sequences	 were	
aligned	 in	 Phylogenetic.fr	 and	 a	 maximum-likelihood	 phylogenetic	 tree	 generated.	 (a)	
Relationship	 between	 the	 Zic2	 CDS,	 (b)	 Zic2	 3’UTR	 and	 (c)	 Zic2	 NCE	 in	 the	multiple	 species	
indicated.	 Scale	 bar	 represents	 the	 average	 rate	 of	 nucleotide	 substitutions	 per	 site,	 with	 a	
longer	branch	indicating	a	larger	number	of	substitutions	between	species	compared.	Bootstrap	








example,	 the	 human	ZIC2	 3’UTR	 shares	 86.43%	 sequence	 conservation	with	 the	mouse	Zic2	
3’UTR,	but	<49%	conservation	with	the	3’UTR	of	the	other	ZICs.	Whilst	a	comparison	of	NCEs	
identified	a	small	 increase	 in	conservation	between	Zic2	 and	Zic3	 in	both	human	and	mouse	
sequences	 in	 comparison	 to	 the	 overall	 3’UTR,	 the	 pairwise	 identify	 percentage	 remained	
relatively	 low	 (~50%	 for	 both)	 and	 both	 regions	 were	 pointedly	 more	 conserved	 between	
species,	which	is	also	reflected	by	their	grouping	and	branch	lengths	of	the	phylogenetic	trees.	
Overall,	 the	 low	 level	of	 sequence	conservation	amongst	 the	3’UTR	of	 the	ZIC	members	and	










the	 number	 of	 binding	 sites	 was	 significantly	 enriched	 in	 the	 NCE	 compared	 to	 the	 non-
conserved	3’UTR	region	(p<0.01;	Table	4.4	A),	correlating	with	the	observation	that	TF	binding	
sites	 cluster	 within	 ER	 elements	 and	 are	 not	 distributed	 randomly	 within	 the	 3’UTR.	
Furthermore,	 binding	 site	 enrichment	 was	 seen	 at	 the	 nucleotides	 for	 five	 of	 the	 six	 HPE-
associated	 SNVs	when	 compared	 to	 the	 remaining	 3’UTR	 nucleotides	 (p<0.01;	 Table	 4.4	 B),	
suggesting	these	mutations	may	occur	in	TF	binding	hot	spots	within	the	NCE.	The	majority	of	
predicted	TFs	were	from	developmentally	important	families	such	as	SOX,	FOX,	CDX	and	HOX.		
Upon	 introduction	 of	 the	 six	 HPE-associated	 SNVs	 into	 the	 ZIC2	 NCE,	 32	 binding	 sites	 were	
estimated	to	be	lost	(Table	4.3,	Appendix	Figure	A2.2),	with	some	SNVs	having	a	greater	impact	
than	 others.	 The	 introduction	 of	 M3	 resulted	 in	 the	 loss	 of	 14	 predicted	 binding	 sites,	 in	











































































































































Table	 4.2:	 Percent	 Identity	 Matrix	 showing	 sequence	 similarity	 of	 annotated	 DNA.	 (a)	
Comparison	of	the	human	and	mouse	3’UTR	sequences	of	all	ZIC	genes.	(b)	Comparison	of	the	
human	and	mouse	NCE	sequences	of	Zic2	and	Zic3.	Percent	identity	was	calculated	via	sequence	






	 mZic2	NCE	 hZIC2	NCE	 mZic3	NCE	 hZIC3	NCE	
mZic2	NCE	 100.00	 93.58	 53.83	 52.61	
hZIC2	NCE	 93.58	 100.00	 54.92	 53.91	
mZic3	NCE	 53.83	 54.92	 100.00	 93.65	










Figure	 4.4:	 Phylogenetic	 comparison	 of	 the	 3’UTR	 and	 NCE	 of	 ZIC	 genes.	 Sequences	 were	
aligned	 in	 Phylogenetic.fr	 and	 a	 maximum-likelihood	 phylogenetic	 tree	 generated.	 (a)	
Relationship	between	the	mouse	and	human	3’UTRs	of	all	ZIC	family	members.	(b)	Relationship	
between	the	mouse	and	human	ZIC2	NCE	and	ZIC3	NCE.	Scale	bar	represents	the	average	rate	
of	 nucleotide	 substitutions	 per	 site,	 with	 a	 longer	 branch	 indicating	 a	 larger	 number	 of	
substitutions	between	species	compared.	Bootstrap	values	(red	numbers)	represent	confidence	
in	 that	node	arrangement,	with	value	of	1.0	signifying	 that	 that	node	arrangement	occurs	 in	
100%	of	trees	computed	for	these	sequences.	Bootstrap	values	<50%	(0.5)	are	indicated	with	a	












SNVs,	 also	 indicated	by	 ‘+’.	Binding	 sites	were	predicted	by	ENCODE,	 JASPAR	and	TRANSFAC	




































































AFP	 1	 	 	 	 ER	 5	 +	 	 	
AML	 3	 +	 	 	 ERG	 1	 +	 	 	
AP	 6	 +	 	 	 ETF	 5	 +	 M5	 	
AR	 7	 +	 	 	 ETS	 2	 +	 M1	 +	
ARI	 5	 +	 M3,	M4,	M5	 +	 EZF	 1	 	 	 	
ARID	 1	 +	 	 	 FOR	 1	 +	 	 	
ARNT	 1	 	 	 	 FOS	 4	 +	 M3,	M4	 +	
ARP	 2	 	 	 	 FOX	 16	 +	 M4,	M5	 	
BRCA	 2	 +	 	 	 FREACT	 1	 +	 M5	 	
BRN	 1	 +	 M3	 	 GABPA	 1	 	 	 	
CAC	 4	 +	 	 	 GATA	 26	 +	 M4,	M5	 	
CAR	 1	 +	 	 	 GBX	 3	 +	 	 	
CBF	 1	 +	 M6	 	 GR	 16	 +	 M3	 +	
CDX	 5	 +	 M3,	M4,	M5	 +	 HES	 3	 +	 	 	
CEBP	 5	 +	 M6	 +	 HIF1	 1	 	 	 	
COUP	 2	 +	 	 	 HLTF	 13	 +	 M1	 	
CP	 1	 	 	 	 HMG	 1	 	 	 	
CREB	 2	 +	 M3,	M4	 +	 HNF	 23	 +	 	 	
CRX	 2	 +	 M3	 	 HOX	 3	 +	 M3,	M6	 +	
CTCF	 3	 	 	 	 HRP	 5	 	 	 	
DLX	 1	 +	 M3	 	 IL	 2	 +	 	 	
DUX	 2	 +	 M3,	M4	 +	 IPF	 4	 +	 	 	
E2F	 3	 	 	 	 IRF	 2	 	 	 	
EBP	 4	 +	 	 	 ISGF	 2	 +	 	 	
EGR	 1	 	 	 	 JUN	 5	 +	 M3,	M4	 +	
ELF	 1	 +	 	 	 KLF	 4	 	 	 	
ELK	 3	 +	 	 	 LBP	 5	 +	 	 	
EMF	 3	 +	 M6	 +	 LEF	 2	 	 	 	











































































LHX	 1	 +	 M3,	M4	 +	 RFX	 1	 +	 M5	 	
LUN	 2	 	 	 	 RUNX	 2	 +	 M6	 	
LXR	 2	 +	 	 	 RXR	 16	 +	 	 	
MAFB	 1	 +	 	 	 SAP	 2	 +	 	 	
MAX	 1	 +	 	 	 SMAD	 1	 	 	 	
MAZ	 1	 	 	 	 SOX	 11	 +	 M5,	M6	 +	
MBP	 1	 	 	 	 SP	 13	 +	 	 	
MEF	 1	 +	 M5	 	 SPIB	 4	 +	 M1	 	
MIT	 1	 +	 	 	 SRF	 5	 +	 M6	 	
MYB	 5	 +	 	 	 SRY	 8	 +	 M3,	M5,	M6	 +	
MYOD	 4	 +	 M6	 +	 STAT	 5	 +	 	 	
MZF1	 1	 +	 	 	 T3R	 7	 +	 	 	
NF	 18	 +	 M2,	M3	 +	 TBP	 18	 +	 M5	 +	
NKX	 6	 +	 M5,	M6	 +	 TCF	 2	 +	 	 	
NOBOX	 1	 +	 M3	 +	 TFIID	 15	 +	 M5	 +	
PAX	 4	 +	 M4	 	 THAP	 2	 +	 	 	
PDX	 1	 +	 M3,	M4	 +	 TME	 1	 +	 M5	 +	
PEA	 2	 +	 	 	 TME	 1	 +	 M5	 +	
PEBP	 1	 +	 	 	 TMF	 1	 +	 	 	
PITX	 2	 	 	 	 TR2	 1	 	 	 	
POU	 9	 +	 M5	 +	 USF	 1	 +	 	 	
POU1F1	 1	 +	 	 	 VDR	 6	 +	 	 	
PPUR	 1	 	 	 	 XFD	 1	 +	 	 	
PR	 2	 +	 	 	 XRP	 5	 +	 	 	
PRRX	 4	 +	 M3,	M4,	M6	 +	 YY	 10	 +	 M4	 	
PU	 1	 +	 	 	 ZFX	 1	 	 	 	
PXR	 1	 +	 	 	 ZIC	 1	 +	 	 	
RAR	 3	 +	 	 	 ZNF354C	 6	 +	 	 	






within	 the	 3’UTR.	 Significance	 of	 p<0.05	 (*)	 or	 p<0.01	 (**)	 indicates	 predicted	 binding	 site	
enrichment	in	the	region	being	tested.	(a)	Binding	site	enrichment	in	the	non-coding	conserved	
element	(NCE;	540	bp)	compared	to	the	non-conserved	region	(559	bp)	of	the	ZIC2	3’UTR.	(b)	










Total:	 465	 465	 	 	
	 	 	 	 	
B	 Observed	(n)	 Expected	 !2	 P	
M1	 3	 0.42	 15.86	 0.0001**	
M2	 1	 0.42	 0.80	 0.3706	
M3	 17	 0.42	 655.11	 0.0001**	
M4	 13	 0.42	 377.14	 0.0001**	
M5	 15	 0.42	 506.59	 0.0001**	
















































p300	 binding	 enrichment	 was	 analysed	 in	 GM12878	 cells	 via	 the	 USCS	 Genome	 and	 Table	
Browser	 (Rosenbloom	 et	 al.	 2015;	 SC584	 Standard	 ChIP-seq	 ENCODE/SYDH).	 Binding	 was	
enriched	in	the	NCE	region	only,	with	the	highest	peak	occurring	in	the	3’	end	of	the	NCE	(Figure	
4.5	A).	This	peak	 in	p300	binding	coincides	with	a	peak	 in	monomethylation	(Figure	4.5	C),	a	







modifications.	 It	 should	 be	 noted,	 however,	 that	 none	 of	 the	Genome	 Browser	 annotations	


























M2,	M3	 and	M4	 (yellow).	 (c)	Monomethylation	 (H3K4me1,	 blue),	 trimethylation	 (H3K4me3,	
orange)	 and	 acetylation	 (H3K27Ac,	 green)	 rates	 were	 analysed	 in	 H1-hESC	 using	 the	 USCS	








Figure	 4.6:	 Histone	 modification	 enrichment	 in	 the	 ZIC2	 3’UTR.	 Comparison	 of	 histone	
modifications	 in	 the	 entire	 ZIC2	 3’UTR.	Mean	 enrichment	 for	monomethylation	 (H3K4me1),	
trimethylation	(H3K4Me3),	and	acetylation	(H3K27Ac)	in	the	ZIC2	3’UTR	and	NCE	in	H1-hESC	was	
quantified	via	Layered	Tracks	(ENCODE)	in	the	USCS	Genome	and	Table	Browser	(Rosenbloom	
et	 al.	 2015).	 A	 high	 level	 of	 enrichment	 is	 represented	 as	 10	 and	 a	 low	 level	 of	 enrichment	
represented	 as	 0.	 Enrichment	 within	 the	 NCE	 only	 was	 not	 significantly	 different	 from	
enrichment	in	the	3’UTR	(not	shown).	Error	bars	=	S.E.M.	Letters	denote	statistical	significance	
of	p<0.05	 calculated	via	a	one-way	ANOVA	with	Fischer’s	unprotected	post	 ad	hoc	 test.	 The	
letter	a	denotes	statistical	significance	to	b	and	so	on.		 	
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The	 TFs	 predicted	 to	 bind	 the	ZIC2	 NCE	 in	 Section	 4.2.2	 are	 a	 source	 of	 interest	 for	 further	
studies.	It	is	not	feasible,	however,	to	test	the	binding	of	every	potential	family	member	to	the	
NCE.	Instead,	functional	candidates	can	be	narrowed	down	further	via	their	spatial	and	temporal	
co-expression	 with	 Zic2	 during	 embryo	 development.	 As	 HPE	 develops	 from	 the	 defective	
activity	of	Zic2	in	the	embryonic	node	(Warr	et	al.,	2008)	gastrulation	was	chosen	as	the	time	
point	in	which	to	analyse	the	expression	patterns	of	TFs.		
A	 combination	of	EMAGE	gene	expression	databases	 (Richardson	et	al.,	 2014)	and	MGI	GXD	







candidate	 family	 as	 not	 all	 expression	 patterns	 have	 been	 published.	 Additionally,	 some	
candidates	exhibited	overlapping	expression	with	Zic2	at	8.5	dpc	and	9.5	dpc	but	not	at	7.25	dpc	
when	defective	Zic2	is	known	to	result	in	HPE.	Whilst	this	suggests	that	these	candidates	may	
interact	with	 the	Zic2	NCE	 to	 regulate	gene	expression	during	organogenesis,	 they	were	not	
considered	substantial	candidates	for	influencing	HPE	development	at	gastrulation.	
	
Table	 4.6:	 Proteins/genes	 that	 exhibit	 overlapping	 expression	 with	 Zic2	 during	 murine	















































































Zic2	 +	 +	 +	 +	 +	 +	 +	 +	 +	 +	 (Elms	et	al.,	2004)	
ATP9A	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
Bicc1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
Bmp7	 	 	 	 	 +	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CAPSL	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
CAR3	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CELSR1	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
CERL1	 	 +	 	 	 +	 +	 	 	 	 	 (Barratt	et	al.,	2014)	
CERL2	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
CDX1	 	 	 	 	 	 	 	 +	 	 +	 EMAGE/MGI	GXD	
CDX2	 	 	 	 	 	 	 	 	 	 +	 Arkell	lab	(Figure	4.7)	
CFC1	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
CHRD	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
CYB561	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
DKK1	 	 +	 	 	 +	 +	 	 	 	 	 EMAGE/MGI	GXD	
DMGDH	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
EOMES	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
EPHA2	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
FAM183B	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
FGF8	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
FGFR1	 +	 	 	 	 +	 +	 +	 +	 	 +	 EMAGE/MGI	GXD	
FOXA1	 +	 +	 +	 	 +	 	 +	 +	 	 +	 EMAGE/MGI	GXD	
FOXA2	 	 	 	 +	 	 +	 	 	 +	 	 Arkell	lab	(Figure	4.7)	
FOXC1	 	 	 	 	 +	 	 	 	 	 +	 EMAGE/MGI	GXD	
FOXC2	 	 	 	 	 	 	 	 +	 	 	 EMAGE/MGI	GXD	
FOXD3	 	 	 	 	 	 +	 	 	 	 	 EMAGE/MGI	GXD	
FOXD4	 	 	 	 	 	 +	 	 	 +	 	 EMAGE/MGI	GXD	
FOXJ1	 	 	 	 	 +	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
FURIN	 	 +	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
GAL	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
GOOSECOID	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
HDC	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
HESX1	 	 	 	 	 	 +	 	 	 	 	 EMAGE/MGI	GXD	
HHEX	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
HOXB1	 	 	 	 	 +	 	 	 	 +	 +	 EMAGE/MGI	GXD	
HOXB8	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	











































































IGFBP5	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
JOSD2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
LHX1	 	 +	 	 	 +	 	 	 	 +	 +	 Arkell	lab	(Figure	4.7)	
LYPD6B	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MESP1	 	 	 	 	 +	 	 	 	 	 +	 EMAGE/MGI	GXD	
MIXL1	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
MLF1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MMP15	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
MNX1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
NODAL	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
NOGGIN	 	 	 	 	 +	 	 	 	 +	 	 EMAGE/MGI	GXD	
NOTCH1	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
NOTCH2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
NOTO	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
OTX2	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
PKD1L1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PIM1	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
PIFO	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PITX2	 	 	 	 	 +	 	 	 	 	 	 (Barratt	et	al.,	2014)	
PLET1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
POPDC2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PPP1R1A	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRICKLE2	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRNP	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PROX1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
PRRX1	 +	 	 	 	 +	 	 	 	 	 	 EMAGE/MGI	GXD	
RFX3	 	 	 	 	 	 	 	 	 +	 	 (Barratt	et	al.,	2014)	
SCARA3	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SHH	 +	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SMIM22	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SMOC1	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
SOX2	 +	 	 	 	 	 +	 	 	 	 	 (Wood	and	Episkopou,	1999)	
SOX3	 +	 	 	 	 +	 +	 	 	 	 	 (Wood	and	Episkopou,	1999)	
SOX17	 	 +	 	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
T	 	 	 	 +	 	 	 	 	 	 +	 EMAGE/MGI	GXD	











































































TRH	 	 +	 +	 	 	 	 	 	 	 	 EMAGE/MGI	GXD	
TMEM176A	 	 	 	 	 	 	 	 	 +	 +	 EMAGE/MGI	GXD	
VTN	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
WNT3A	 	 	 	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
WNT11	 	 	 	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
ZEB1	 	 	 +	 	 	 	 	 	 +	 	 EMAGE/MGI	GXD	
ZEB2	 	 	 +	 	 	 	 	 	 	 +	 EMAGE/MGI	GXD	
ZIC3	 +	 +	 	 	 +	 	 	 	 +	 +	 (Elms	et	al.,	2004)	


















Figure	 4.7:	 The	 expression	 pattern	 of	 candidate	 transcription	 factors	 during	 mouse	
gastrulation.	The	expression	patterns	of	Cdx2,	Foxa2,	Foxj1,	Lhx1,	Sox2,	Sox3,	Zic3	and	Zic5	were	
analysed	via	WMISH	and	compared	spatially	and	temporally	to	Zic2	expression.	In	all	pictures	
the	anterior	 is	 to	 the	 left	and	embryos	are	shown	 in	 lateral	view.	PrS/ES:	pre-streak	or	early	
streak,	5.5-6.5	dpc;	MS:	mid-streak,	6.75	dpc;	NB/EB:	no	bud	or	early	bud,	7.0-7.25	dpc;	MB:	
mid-bud,	7.25-7.5;	EHF:	early	head	fold,	7.75.	*	indicates	in	situs	performed	by	Ruth	Arkell	and	




















for	 target	 gene	 regulation.	 If	 the	 ZIC2	 NCE	 is	 confirmed	 to	 be	 an	 enhancer	 or	 repressor	 via	
experimental	methods,	it	will	be	interesting	to	investigate	whether	the	UCR	region	can	maintain	
this	activity	on	its	own	or	whether	the	entire	NCE	is	required	for	element	function.	Additionally,	





identified	 candidates	 are	 known	 to	 be	 required	 for	 correct	 embryo	 development,	 with	 a	
particular	 focus	 on	 gastrulation.	 Additionally,	 four	 of	 the	 nine	 candidates’	 binding	 sites	 are	
predicted	to	be	lost	when	SNVs	are	introduced	(CDX2,	SOX2,	SOX3	and	LHX1),	whilst	four	binding	
sites	are	predicted	to	be	created	upon	SNV	introduction	(FOXA2,	FOXJ1,	SOX2	and	SOX3).	This	
























any	 known	 binding	 motifs	 published	 and	 therefore	 their	 ZIC2	 3’UTR	 binding	 potential	 is	
unknown.	 Whilst	 this	 study	 focused	 on	 genes	 that	 met	 both	 bioinformatic	 and	 expression	
criteria,	 it	does	not	mean	 that	 identification	of	 candidates	 should	be	 restricted	 to	 the	genes	
listed	in	Section	4.2.4.	Analysis	of	enhancers	based	on	predicted	TFBSs	alone	is	often	dependant	
on	knowledge	of	the	preferred	binding	site	of	the	candidate	proteins.	The	binding	preferences	
of	many	 candidates	 are	 unknown	 at	 this	 stage	 and	 the	 difficulty	 of	 predicting	 candidates	 is	
further	 compounded	by	 the	 fact	 that	many	TF	 require	 a	 co-factor	 to	bind	DNA	 (reviewed	 in	




to	 genomic	 or	 even	 random	 DNA	 sequences	 (for	 example,	 each	 6	 bp	 long	 motif	 would	 be	










































as	 a	 repressor	 to	negate	 the	activity	of	 the	 first.	 Finally,	 a	 third	domain	which	overrides	 the	
repressor	 activity	 of	 the	 second	domain	was	 also	 identified	 (Herbst	et	 al.,	 1989).	Moreover,	
transcriptional	machinery	complexes	 form	at	 the	promoter	whether	or	not	an	ER	element	 is	
active,	and	act	as	a	docking	site	for	the	‘-somes’	bound	to	poised	ER	elements	(Vernimmen	et	
al.,	2007).	By	both	the	promoter	and	ER	element	existing	in	a	poised	state,	the	timing	of	gene	








For	 this	 to	 occur,	 developmental	 signalling	 pathways	 must	 adhere	 to	 three	 fundamental	
principles,	as	outlined	by	Barolo	and	Posakony	(2002).	First,	signalling	pathways	exhibit	activator	
insufficiency,	 whereby	 the	 binding	 of	 a	 single	 signal-modified	 TF	 to	 an	 ER	 element	 is	 not	
sufficient	to	activate	full	target	gene	expression.	This	prevents	a	pathway	from	activating	all	of	
its	targets	in	one	signalling	event,	reducing	promiscuous	activation.	Instead,	cooperative	binding	
of	 signal-independent	 local	 activators	 and	 signal-activated	 factors	 must	 occur	 for	 signal-
activated	elements	to	respond,	which	is	the	second	principle	(Barolo	and	Posakony,	2002).	This	
integration	 with	 different	 local	 activators	 that	 generates	 different	 and	 distinct	 expression	
patterns	of	 a	 target	 gene,	 as	 can	be	 seen	with	 the	NOTCH	 responsive	protein	 Suppressor	of	
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a	 signalling	 pathway	 specifies	 distinct	 cell	 fates	 via	 activation	 of	 different	 and	 overlapping	
subsets	of	target	genes.	Finally,	signalling	pathways	employ	default	repression	in	the	absence	of	
signalling,	ensuring	target	expression	remains	in	the	off	state	until	sufficient	signal	is	generated.	
This	 is	primarily	achieved	by	active	 repression	of	promoters	or	enhancers	of	 signal-activated	
target	 genes	 in	 any	 conditions	 deemed	 inappropriate	 (Barolo	 and	 Posakony,	 2002).	 Default	
repression	restricts	signalling	to	specific	tissues	or	zones	so	that	activation	of	a	signal	in	one	cell	
is	insufficient	to	cause	activation	of	all	of	its	targets	in	other	cells.	In	the	case	of	WNT	signalling,	









































node	 to	 form	mesodermal	 ‘wings’	 (Tam	and	Behringer,	 1997)	 via	 continuous	 recruitment	 of	







low	 levels	 of	 both	WNT	and	BMP	activity	 (reviewed	 in	Davidson	&	Tam	2000).	Downstream	
NODAL	targets	such	as	Gsc	and	Foxa2	are	also	expressed	 in	 the	node	tissue,	where	they	are	














availability	 of	 downstream	 TFs	 within	 a	 cell	 is	 dependent	 on	 specific	 morphogen	 dose	
requirements	being	met.	When	they	are	not	met,	an	embryo	will	 fail	 to	gastrulate	correctly.	
Wnt3-/-	murine	embryos	do	not	form	a	PS,	mesoderm	or	node	(Behringer	et	al.,	1999).	Similarly,	




that	 lack	 a	 functional	 APS,	 resulting	 in	 somite	 fusion,	 and	 absent	 AME	 and	 severe	 anterior	
truncation	(Ang	and	Rossant,	1994;	Weinstein	et	al.,	1994).		
The	cells	of	the	APS	can	be	considered	to	form	either	the	early	gastrula	organiser	(EGO;	6.5	dpc)	
or	 the	 mid-gastrula	 organizer	 (MGO;	 6.75	 dpc),	 before	 the	 morphologically	 distinct	 node	
emerges.	Briefly,	the	EGO	consists	of	a	group	of	40	cells	capable	of	inducing	a	secondary	axis	like	
that	developed	by	the	node,	though	murine	fate	mapping	studies	showed	that	the	EGO	on	its	






precursors	 for	 the	whole	 anterior	 axial	mesoderm	 and	much,	 but	 not	 all,	 of	 the	 notochord	
(Kinder	et	al.,	2001),	and	expresses	many	similar	transcription	factors	and	signalling	components	
to	 the	EGO.	Unlike	 the	EGO,	however,	Nog	 is	also	expressed	 to	 inhibit	BMP	signalling	 in	 the	
anterior	notochord,	and	T	is	expressed	to	promote	WNT	signalling	in	the	notochord	(Bachiller	et	
al.,	2000;	Belo	et	al.,	1998,	1997;	Kinder	et	al.,	2001;	Pfister	et	al.,	2007).	Additionally,	signalling	





















2007).	 Despite	 this,	 WNT11	 and	 BMP7	 are	 active	 in	 the	 mid-gastrula	 node	 (Arkell	 and	
Beddington,	1997;	Madabhushi	and	Lacy,	2011;	Robb	and	Tam,	2004;	Sinha	et	al.,	2015).	The	
expression	 of	WNT11	 in	 this	 tissue	 thought	 to	 be	 due	 to	 a	 role	 in	 regulating	 the	migration	
direction	of	cells	from	the	APS	through	the	node,	as	Wnt5-/-;	Wnt11-/-	mutants	exhibit	reduced	
migration	of	PS	stem	cell	descendants	(Andre	et	al.,	2015;	Cambray	and	Wilson,	2007).	As	the	
late-streak	node	 is	 the	presumed	site	of	ZIC2	 requirement	and	 its	expression	 in	 this	 tissue	 is	
critical	for	the	prevention	of	HPE,	the	medium-high	NODAL	environment,	along	with	low	WNT	
and	BMP,	will	affect	the	types	of	TFs	that	are	available	to	bind	or	interact	with	the	ZIC2	NCE.	As	
such,	any	 investigations	 into	ability	of	 the	ZIC2	NCE	 to	drive	gene	expression	must	 take	 into	
consideration	the	environment	that	its	activity	is	being	assayed	in.	
5.1.2 Model	systems	for	studying	developmental	genes	during	gastrulation		
The	 best	 approach	 to	 evaluate	 the	 pathogenicity	 of	 the	 ZIC2	 NCE	 variants	 is	 via	 direct	
manipulation	 of	 the	 mouse	 genome.	 This	 would	 assess	 causality,	 and	 enable	 assay	 of	 the	
direction	of	change	(if	any)	in	Zic2	gene	expression,	but	does	not	establish	the	mechanism	by	
which	the	variants	disrupt	expression.	Mechanistic	studies	would	be	assisted	by	the	production	




Cells	 that	are	 taken	 from	the	 inner	cell	mass	of	 the	mouse	blastocyst	 (3.5	dpc)	and	cultured	
under	appropriate	conditions	form	undifferentiated	ES	cells	(Evans	and	Kaufman,	1981;	Martin,	






continuously	propagated,	 can	differentiate	 into	most	embryonic	 cell	 types	under	 the	correct	
conditions,	 and	 exhibit	 relatively	 good	 transfection	 rates	 (~85%)	 (Nichols	 and	 Smith,	 2009;	
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Tamm	et	al.,	2016;	Tesar	et	al.,	2007).	Issues	arise,	however,	when	attempting	to	use	either	cell	
type	 to	model	 specific	embryonic	 structures	 such	as	 the	node.	Differentiation	of	ES	or	EpiSC	





resulting	 cells,	 however,	 exhibited	 markers	 and	 morphology	 of	 both	 node	 and	 notochord	






or	organ,	 therefore	 they	are	 the	closest	 cell	 type	 to	an	 in	 vivo	model	available.	Additionally,	
primary	cell	lines	have	a	relatively	low	mutation	rate,	therefore	false	interactions	with	the	genes	




Transformed	 cell	 lines,	 such	 as	 the	 human	 embryonic	 kidney	 (HEK293T)	 line,	 are	 a	 viable	
alternative	and	have	several	advantages.	They	are	easily	transfectable,	which	enables	the	rapid	
analysis	 of	multiple	 conditions.	 It	 is	 often	 argued	 that	 transformed	 cell	 lines	 do	 not	 contain	
relevant	 tissue-specific	proteins/processes	and	 therefore	provide	 little	value	 for	 the	 study	of	
tissue-specific	mechanism.	On	the	other	hand,	these	cells	can	be	considered	‘test-tubes	with	a	




Ad(5)	 DNA,	 but	 is	 thought	 to	 potentially	 be	 derived	 from	neural	 or	 adrenal	 cells	within	 this	
population	(Lin	et	al.,	2014;	Shaw	et	al.,	2002).	The	cells	were	subsequently	modified	to	express	
the	 SV40	 Large	 T-antigen	 (DuBridge	 et	 al.,	 1987),	 which	 interacts	 with	 the	 SV40	 origin	 of	
replication	 present	 on	 the	 expression	 constructs	 used	 in	 this	 project	 to	 drive	 episomal	





























amplified	 from	 plasmid	 pKS:β-globin:lacZ	 (Yee	 and	 Rigby	 1993;	 Ahmed	 et.	 al.,	 2017,	 under	
review)	and	a	Hsp68	promoter	(Hamada	laboratory;	Adachi	et	al.	1999)	were	chosen	based	on	
their	proven	ability	 to	 interact	with	NCEs	and	drive	 reporter	expression	 in	 transgenic	mouse	
models	(Shiratori	et	al.,	2006).	An	untested	putative	human	ZIC3	promoter	(Muenke	laboratory,	
NHGRI,	 NIH)	 was	 chosen	 based	 on	 the	 knowledge	 that	 ZIC3	 and	 ZIC2	 share	 high	 levels	 of	
sequence	conformation	and	regions	of	co-expression,	therefore	the	ZIC2	NCE	would	most	likely	
be	able	to	recognise	and	activate	the	ZIC3	promoter.	The	wildtype	ZIC2	NCE	(pCRW-8-TOPO-





The	presence	of	 the	wildtype	ZIC2	NCE	significantly	 reduced	 the	 levels	of	 luciferase	 reporter	
transcription	(Figure	5.3	A	and	B)	compared	to	the	empty	vector,	irrespective	of	the	promoter	










shown	 in	 Figure	 5.3	 C.	 Each	HPE-associated	 SNV	 produced	 a	 significant	 increase	 in	 reporter	






associated	 SNVs	 in	 basal	 culture	 conditions.	 (a-b)	HEK293T	 cells	were	 transfected	with	 the	
reporter	constructs	pGL-DEST	(No	Prom),	pGl-b-globin-DEST	(pb),	pGl-Hsp68-DEST	(pHsp68)	and	





















NODAL	 and	 BMP	 pathways,	 respectively.	 In	 unstimulated	 HEK293T	 cells,	 background	
luminescence	levels	of	the	BMP	BRE	reporter	were	considerably	higher	than	the	NODAL	reporter	
(CAGA)12	 or	 the	 WNT	 reporter	 TOPFLASH,	 indicating	 that	 NODAL	 and	 WNT	 signalling	 are	
endogenously	low	in	HEK293T	cells,	whilst	BMP	signalling	is	endogenously	high	(Figure	5.4	A	and	
B,	lanes	with	no	ALK4	and	NOGGIN	added).	Furthermore,	transfection	of	HEK293T	cells	with	the	












however,	was	deemed	to	be	high	 in	 the	absence	of	NODAL	stimulation,	 thus	 the	addition	of	
ALK4	 resulted	 in	 a	 reduction	 of	 BMP	 signalling	 by	 approximately	 half.	 The	 addition	 of	 ALK4	
therefore	 results	 in	 the	 environment	 changing	 from	 a	 low	NODAL,	 high	 BMP	 and	 low	WNT	
environment	to	a	high	NODAL,	medium	BMP	and	low	WNT	environment	(designated	the	‘red’	










addition	 of	 ALK4-HA	 and	V5-NOGGIN	 inhibits	 BMP	 and	WNT	 signalling	 in	HEK293T	 cells	 and	
stimulates	NODAL	signalling	to	create	a	high	NODAL,	low	BMP	and	low	WNT	environment.	Error	
bars	=	S.E.M	of	three	external	repeats;	**:	p<0.01,	Student’s	T-Test.	(c-d)	Representative	NODAL	







amounts	 (small,	 medium	 and	 large)	 were	 determined	 by	 the	 comparative	 amounts	 of	
luminescence	and	relative	luciferase	activity	for	each	pathway.	
	
Signalling	 NODAL	 BMP	 WNT	

















the	 construct’s	 promoter	 activity	 (Appendix	 Figure	 A3.7),	 a	 change	 in	 luciferase	 activity	 is	
observed.	In	the	‘red’	signalling	environment,	the	wildtype	NCE	shows	further	repression	(Figure	





and	M5	NCEs	 act	 as	 repressors,	 similar	 to	 the	wildtype	 NCE	 (Figure	 5.5	 A,	 Figure	 5.6	 A).	 In	
contrast,	the	M2,	M4	and	M6	NCEs	show	no	further	repression,	suggesting	that	the	mutations	









also	 represent	 only	 a	 small	 effect	 size.	 This	 may	 be	 due	 to	 the	 use	 of	 a	 non-endogenous	
promoter,	or	the	limited	expression	or	absence	of	endogenous	TFs	in	HEK293T	cells	that	would	
normally	interact	with	the	NCE	in	embryonic	tissues.	Therefore,	candidate	TFs	that	are	predicted	










NCE	 (WT	NCE-luc),	and	 the	mutated	constructs	pGl-pZic3-M1	ZIC2	NCE	 to	pGl-pZic3-M6	ZIC2	
NCE	(M1-M6	NCE-luc),	as	well	as	(a)	ALK4-HA	to	create	a	high	NODAL,	medium	BMP	and	low	
WNT	environment,	(b)	ALK4-HA	and	V5-NOGGIN	to	create	a	high	NODAL,	low	BMP	and	low	WNT	
environment,	 or	 an	 empty	 control	 vector	 (V5-DEST).	 Reporter	 activity	 was	 measured	 as	
luminescence.	Fold	values	were	calculated	relative	to	p-luc	and	converted	to	the	relative	percent	




that	 the	mutation	 responds	 differently.	Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	





NCEs	 in	 different	 signalling	 environments.	HEK293T	 cells	 were	 transfected	 with	 the	 empty	
reporter	 construct	 pGl-pZic3-DEST	 (p-luc),	 pGl-pZic3-WT	 ZIC2	 NCE	 (WT	 NCE-luc),	 and	 the	



















Similarly,	 the	 introduction	 of	 each	 HPE-associated	 SNV	 alters	 the	 NCE’s	 response	 to	






environment)	 are	 capable	 of	 responding	 to	 FOXJ1	 (Figure	 5.7	 C	 and	 E,	 Figure	 5.8	 C	 and	 E),	
suggesting	the	introduction	of	the	mutations	creates	new	FOXJ1	binding	sites	or	binding	sites	




















Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	 denote	 statistical	 significance	of	p<0.05	











V5-NOGGIN	 to	 inhibit	 BMP	 signalling,	 and	 (A)	 V5-ZIC2,	 (B)	 V5-FOXA2	or	 (C)	 V5-FOXJ1,	 or	 an	
empty	control	vector	(V5-DEST).	Reporter	activity	was	measured	as	luminescence.	In	each	case,	
a	 single	 representative	 experiment	 is	 shown,	 with	 error	 bars	 =	 S.D.,	 N=3	 internal	 repeats.	
Western	 blots	 correspond	 to	 the	 transfections	 shown.	 a-GAPDH	 (cytoplasmic)	 and	 a-TBP	
























Figure	 5.10:	 Representative	 experiment	 and	 western	 blots	 for	 the	 addition	 of	 TFs	 to	 the	
wildtype	 and	 mutant	 ZIC2	 NCE	 in	 a	 high	 NODAL,	 medium	 BMP	 and	 low	 WNT	 signalling	
environment.	HEK293T	 cells	were	 transfected	with	 the	 empty	 reporter	 construct	 pGl-pZic3-
DEST	(p-luc),	pGl-pZic3-WT	ZIC2	NCE	(WT	NCE-luc),	and	the	mutated	constructs	pGl-pZic3-M1	
ZIC2	 NCE	 to	 pGl-pZic3-M6	 ZIC2	 NCE	 (M1-M6	 NCE-luc),	 in	 addition	 to	 ALK4-HA	 to	 stimulate	
NODAL	signalling	and	(A)	V5-ZIC2,	(B)	V5-FOXA2	or	(C)	V5-FOXJ1,	or	an	empty	control	vector	








site	 for	 the	FOX	 family	of	 transcription	 factors,	whilst	 the	 introduction	of	M6	 is	predicted	 to	
create	a	new	FOX	binding	site.	It	can	therefore	be	hypothesised	that	any	response	seen	in	the	
M1-M3	NCEs	from	the	overexpression	of	FOXA2	or	FOXJ1	is	most	likely	due	to	indirect	(i.e.	co-






To	 assess	 whether	 the	 manipulation	 of	 signalling	 pathways	 in	 HEK293T	 cells	 mimics	 gene	
expression	 in	 the	node,	 the	 relative	change	 in	mRNA	expression	 levels	 in	endogenous	 target	
genes	was	measured.	Embryos	homozygous	for	the	Kumba	allele	of	Zic2	exhibit	decreased	Foxa2	
and	Foxj1	expression	in	the	node	(Barratt	et	al.,	2014;	Warr	et	al.,	2008),	suggesting	that	ZIC2	
functions	 upstream	 of	 both	 genes.	 On	 the	 other	 hand,	 overexpression	 of	 zic2	 in	 Xenopus	
embryos	also	results	 in	a	 loss	of	foxa2	expression	in	the	dorsal	blastopore	lip	(the	equivalent	




‘red’	 (high	 NODAL,	 medium	 BMP	 and	 low	WNT)	 and	 ‘yellow’	 signalling	 environments	 (high	







signalling	 environment	 is	 an	 adequate	 model	 for	 this	 tissue.	 From	 these	 results,	 we	 can	
prediction	the	behaviour	of	the	ZIC2	NCE	in	this	tissue.	For	example,	the	addition	of	ZIC2	results	








Figure	 5.11:	 HEK293T	 cells	 can	 be	 induced	 to	 mimic	 the	 signalling	 environment	 of	 the	
embryonic	 node.	 HEK293T	 cells	 were	 transfected	 with	 V5-ZIC2,	 V5-FOXA2	 or	 V5-FOXJ1	
transcription	 factors.	Results	were	normalised	 to	ABCE1	 or	USP39	 via	 the	DDCT	method,	 and	
















Multiple	mechanisms	 combine	 to	 precisely	 control	 target	 gene	 transcription	 during	 embryo	
development.	The	binding	of	specific	TF	complexes	to	ER	elements	to	either	enhance	or	repress	










assays	under	 the	 control	of	 the	wildtype	NCE	 consistently	 reported	a	 reduction	 in	 luciferase	
activity	when	compared	to	background	reporter	activity,	 regardless	of	 the	signalling	context.	
Moreover,	the	addition	of	TFs	that	are	candidates	to	 interact	with	the	NCE	(ZIC2,	FOXA2	and	
FOXJ1)	 did	 not	 alleviate	 this	 repressive	 role.	 This	 result	 was	 unexpected,	 as	 the	majority	 of	
identified	ER	elements	function	primarily	as	enhancers	both	in	cell	culture	and	in	vivo.	Though	
these	 elements	 can	 switch	 between	 enhancing	 and	 repressing	 roles	 in	 a	 context	 dependant	





with	 a	 construct	 containing	 the	 HMGA2	 3’UTR	 situated	 3’	 to	 a	 reporter	 gene,	 a	 12.7-fold	







still	 did	 not	 result	 in	 enhancer	 activity,	 suggesting	 that	 there	 remained	 a	 repressor	 element	
influencing	reporter	transcription	as	well	as	stability.	Whilst	the	HMGA2	3’UTR	luciferase	results	
are	similar	to	those	achieved	with	the	wildtype	ZIC2	NCE	in	this	chapter,	and	the	ZIC2	3’UTR	is	














function	 independent	 of	 orientation.	 It	 remains	 to	 be	 determined	 whether	 the	 repressor	








FOXA2	may	 prime	 the	 ZIC2	 NCE	 for	 the	 formation	 of	 an	 enhanceosome,	 but	 cannot	 recruit	
sufficient	 endogenous	 proteins	 to	 create	 a	 functioning	 enhanceosome,	 either	 due	 to	 under	
expression	or	complete	lack	of	expression	in	HEK293T	cells.	This	does	seem	unlikely,	however,	
as	 this	 scenario	 would	 presumably	 lead	 to	 a	 small	 but	 detectable	 increase	 in	 activity	 upon	
addition	 of	 exogenous	 TFs.	 In	 contrast,	 addition	 of	 exogenous	 TFs	 consistently	 resulted	 in	
stronger	repression	of	reporter	activity	by	the	ZIC2	NCE.	Nevertheless,	transfection	of	multiple	
TFs	 into	 the	 above	 assays	 at	 the	 same	 time	 can	 be	 undertaken	 to	 determine	 whether	 a	
combination	of	proteins	elicits	a	stronger	response	from	the	ZIC2	NCE.		










2009).	When	Cdx2	 is	mutated,	 posterior	 truncations	 result	 (Chawengsaksophak	et	 al.,	 2004,	
1997).	 In	 contrast,	 overexpression	 of	 the	 ZICs	 has	 been	 shown	 to	 inhibit	WNT	 signalling	 in	
HEK293T	cells	and	Xenopus	embryos	(Fujimi	et	al.,	2012;	Pourebrahim	et	al.,	2011).	A	repressive	
interaction	between	ZIC2	and	CDX2	is	suggested	by	the	inverse	expression	pattern	of	both	genes	






























The	 finding	 that	 each	 individual	 SNV	 confers	 different	 NCE	 activity	 in	 a	 context-dependant	
manner	 supports	 the	 hypothesis	 that	 the	 NCE	 is	 made	 up	 of	 multiple	 domains	 that	 work	
together	 to	confer	net	 regulation,	 rather	 than	one	total	element.	Moreover,	 the	 finding	 that	
each	 SNVs	 elicits	 a	 different	 response	 to	 overexpression	 of	 TFs	 predicted	 to	 bind	 the	 NCE	
suggests	a	mechanism	is	at	play	whereby	the	SNV	alters	the	enhanceosome	or	repressosome	
that	 interacts	 with	 that	 specific	 region	 of	 the	 3’UTR.	 Additionally,	 it	 suggests	 that	 some	












the	 NCE	 directly	 interacts	 with	 the	 ZIC2	 promoter.	 This	 can	 be	 achieved	 via	 chromosome	
conformation	 capture	 (3C)	 coupled	 with	 sequencing	 (4C),	 which	 would	 map	 genome-wide	
interactions	with	the	ZIC2	promoter	 (Sahlén	et	al.,	2015).	Enrichment	of	 the	ZIC2	NCE	 in	this	









pathways	and	upstream	effectors.	This	 is	particularly	 important	 for	expression	of	Zic2	 in	 the	
node	of	the	gastrulating	embryo,	where	alterations	in	expression	are	known	to	lead	to	HPE.	In	a	
















levels.	 It	 is	 estimated	 that	 40-50%	of	 the	 changes	 in	 gene	expression	 in	 response	 to	 cellular	
signals	occurs	due	to	regulation	of	mRNA	stability	(Garneau	et	al.,	2007).	Transcript	degradation	
occurs	 via	 multiple	 cis-acting	 regulatory	 regions	 (such	 as	 AU-rich	 elements	 [ARE],	 GU-rich	





and	 a	 3’	 poly(A)	 tail	 (Figure	 6.1).	 Both	 are	 incorporated	 into	 the	 mRNA	 strand	 during	
transcription	(Garneau	et	al.,	2007)	and	both	protect	the	transcript	from	degradation.	Once	the	
capped	 and	 polyadenylated	 transcripts	 are	 transported	 to	 the	 cytoplasm	 and	 P-bodies,	 the	
poly(A)	tail	and	5’	cap	act	synergistically	to	initiate	translation.	The	5’	cap	binds	the	Translation	
Initiation	Complex	(TIC)	whilst	the	poly(A)	tail	is	bound	by	Poly(A)	Binding	Protein	(PABP).	Bound	
PABP	 also	 associates	with	 the	 TIC,	 forming	 a	 closed	 loop	 and	 increasing	 the	 integrity	 of	 the	












Figure	 6.1:	 The	 eukaryotic	mRNA	decay	pathway.	 (a)	 A	 5’	 cap	 is	 added	 to	 the	 5’	 end	of	 all	
eukaryotic	mRNA	during	the	elongation	step	of	transcription,	where	it	confers	protection	from	
early	 degradation	 onto	 a	 transcript.	 Following	 cleavage	 of	 a	 transcript	 at	 a	 poly(A)	 site,	 a	
homopolymeric	string	of	25-2000	adenine	nucleotides	termed	the	poly(A)	tail	is	added	to	the	3’	
end	by	Poly(A)	Polymerase	(PAP)	(Garneau	et	al.,	2007).	The	poly(A)	tail	protects	the	mRNA	from	
degradation,	 aids	 in	 the	 export	 of	 the	mature	mRNA	 to	 the	 cytoplasm,	 and	 is	 required	 for	
stabilizing	transcripts	to	facilitate	translation	initiation	(Garneau	et	al.,	2007;	Weill	et	al.,	2012).	
The	transcript	is	then	either	converted	into	protein,	stored	in	P-bodies	for	later	use	or	directed	
through	a	deadenylation	pathway	to	be	decayed.	 (b)	A	 transcript	 is	directed	 for	decay	when	
RBPs	and	miRNAs	bind	to	recognition	sites	in	the	3’UTR	of	a	transcript,	usually	located	in	an	ARE,	
and	form	an	exosome.	Deadenylases	such	as	PAN2-3/CCR4-NOT	or	Poly(A)-specific	Ribonuclease	




3’	 end	 is	 degraded	 via	 an	 exosome	 consisting	 of	 six	 proteins	 with	 homology	 to	 a	 3’-5’	
phosphorolytic	exoribonuclease	and	several	accessory	proteins.	Once	the	body	of	the	transcript	





the	 transcript	 is	 decayed	 in	 the	 5’-3’	 direction	 via	 the	 exoribonuclease	 XRN1.	 The	 choice	 of	
pathway	 is	 dependent	 on	 the	 individual	 transcript	 undergoing	 decay	 and	 the	 available	
machinery.	 Both	 the	 5’-3’	 and	 3’-5’	 pathways	 are	 involved	 in	 the	 decay	 of	 unstable	 ARE-
containing	mRNA	transcripts	in	mammals	(Garneau	et	al.,	2007;	Wu	and	Brewer,	2012).	A	less	







These	elements	can	be	 located	 in	 the	5’UTR,	 introns	and	coding	regions	of	genes,	but	 in	 the	
3’UTR	 they	 are	 shielded	 from	 ribosomes	 and	 other	 translational	machinery	 (Garneau	 et	 al.,	




























level	 of	 insulin	 resistance	 and	 type	 2	 diabetes	 amongst	 Pima	 Indians	 compared	 to	 control	
populations	(Hitti,	2012).	
Approximately	~7%	of	human	genes	contain	AREs,	with	the	majority	located	in	3’UTRs.	AREs	are	





surrounded	 by	 predominately	 U	 rich	 regions,	 whilst	 Class	 II	 transcripts	 contain	 multiple	
overlapping	 copies	 of	 the	 pentamer	 in	 a	 U	 rich	 region.	 In	 contrast,	 Class	 III	 transcripts	 lack	
pentamers	and	instead	contain	only	A	and	U	rich	sequences	(Chen	and	Shyu,	1995;	Halees	et	al.,	
2008).		




et	al.,	 2008).	 In	 comparison,	 9.90%	of	 short-lived	 transcript	 contain	 a	Class	 I	ARE	and	5.21%	
contain	 a	Class	 II	ARE	 (Vlasova	et	al.,	 2008).	Upon	 introduction	of	GREs	 from	c-jun,	 jun	B	 or	



















be	 deadenylated.	 Moreover,	 AUF1,	 KSRP	 and	 TTP	 recruit	 exosomes	 to	 AREs	 after	 the	
deadenylation	process	to	promote	further	decay	(Chen	et	al.,	2001;	Loflin	et	al.,	1999).	AREBPs	
can	also	confer	stability	by	removing	mRNA	transcripts	from	decay	sites	or	by	competing	with	
destabilizing	 factors	 for	 binding	 substrates,	 preventing	 decay.	 It	 is	 also	 hypothesised	 that	



















with	 RISC	 itself.	 The	 TTP/RISC/miRNA	 complex	 that	 forms	 cooperates	 to	 recognise	 ARE	
		 193	




















introduction	of	polymorphisms	or	mutations	may	not	prevent	 the	miRNA	 from	regulating	 its	
target	mRNA,	it	will	change	the	strength	of	the	regulation.	This	has	been	demonstrated	in	miR-
189	and	SLITRK1	 in	humans	with	Tourette’s	syndrome,	whereby	a	 loss-of-function	frameshift	
mutation	 results	 in	 shorter	dendrites	due	 to	 inhibition	of	miRNA-mediated	mRNA	repression	
(Abelson	et	al.,	2005).		
Alternative	polyadenylation	
Cleavage	 of	 a	 transcript	 can	 occur	 at	 more	 than	 one	 PAS	 in	 a	 3’UTR.	 More	 than	 half	 of	
mammalian	 transcripts	 contain	 multiple	 sites	 to	 allow	 for	 the	 creation	 of	 different	 length	
transcripts	(Tian	et	al.,	2005).	For	cleavage	to	occur,	a	PAS	must	sit	~15-30	bp	upstream	of	the	
cleavage	 site	 and	 a	 U/GU	 rich	 sequence	 must	 be	 ~30	 bp	 downstream	 of	 the	 cleavage	 site	
(Beaudoing	et	al.,	2000;	Weill	et	al.,	2012).	Cleavage	and	polyadenylation	specific	factors	such	







make	 up	 73.1%	 of	 all	 identified	 PAS’s	 in	 the	 genome.	 In	 contrast,	 the	 proximal	 PAS’s	 are	













by	 transfection	 of	 in	 vitro	 transcribed,	 capped	 and	 polyadenylated	 mRNAs	 and	 analysis	 of	
transcripts	with	a	chloramphenicol	acetyltransferase	reporter	in	Cos-7	cells	(Touriol	et	al.,	1999).		
Mutations	 anywhere	 in	 the	 PAS	 region	 may	 disrupt	 poly(A)	 processing	 as	 successful	
polyadenylation	requires	a	functional	PAS,	GU	rich	region	and	cleavage	site	(Beaudoing	et	al.,	
2000).	The	majority	of	mutations	found	within	a	transcripts	cleavage	site	or	in	the	GU	rich	region	
are	gain-of-function.	 In	contrast,	mutations	 that	occur	 in	or	near	 the	PAS	are	usually	 loss-of-
function	 (Danckwardt	 et	 al.,	 2008).	 For	 example,	 two	 thalassemias	 in	 humans	 have	 been	
attributed	to	mutations	in	the	‘AAUAAA’	PAS	of	both	the	a-globin	and	b-globin	genes,	resulting	
in	 inactive	 or	 severely	 inhibited	 gene	 expression	 and	 defective	 haemoglobin	 production	
(Harteveld	et	al.,	1994;	Higgs	et	al.,	1983;	Jankovic	et	al.,	1990;	Orkin	et	al.,	1985).		
6.1.3 Enhancer	elements	transcribe	RNA	
Enhancer	 RNAs	 (eRNAs)	 are	 short-lived	 nuclear	 RNAs,	 50-2000	 bp	 long	 on	 average,	 and	
transcribed	 from	 regions	 of	 enhancer	 elements	 devoid	 of	 H3K4me3	 (Darrow	 and	 Chadwick,	
2013;	Kim	et	al.,	2010).	eRNAs	are	commonly	bidirectionally	transcribed	from	an	enhancer	in	
low	levels	and	contain	a	5’	cap	(Djebali	et	al.,	2012;	Kim	et	al.,	2010;	Lam	et	al.,	2013),	but	in	








of	 enhancer	 activity	 and	 identifier	 of	 target	 genes	 than	 conventional	 bioinformatics	 such	 as	
sequence	 conservation,	 chromatin	 modifications	 and	 TF	 binding	 (Andersson,	 2014).	 The	
function	of	eRNAs	is	still	under	investigation,	however	targeted	degradation	of	eRNAs	via	RNAi	
or	RNase-H	results	in	reduced	expression	of	nearby	protein	coding	genes	in	mouse	macrophages	
(Lam	 et	 al.,	 2013),	 suggesting	 eRNAs	 contain	 some	 functional	 role	 in	 gene	 regulation.	
Additionally,	studies	in	multiple	human	and	mouse	cell	lines	have	proposed	a	role	for	eRNA	in	












to	 be	 a	 Class	 I	 ARE	 was	 identified	 in	 both	 species	 (Figure	 6.2).	 The	 motif	 has	 ‘AUUUA’	
pentameters	 at	 both	 the	 5’	 and	 3’,	 but	 only	 the	 3’	 pentamer	 contains	 the	 known	minimum	






AREs.	 Thus,	 the	ZIC2	 3’UTR	 sequence	was	 analysed	 for	 the	presence	of	 a	GRE	based	on	 the	
conserved	‘UGUUUGUUUGU’	motif,	allowing	for	one	mismatch.	The	11	bp	motif	was	not	found	




















Figure	 6.2:	 The	 ZIC2	 3’UTR	 contains	 multiple	 predicted	 transcript	 stability	 elements.	 An	
alignment	of	the	mouse	and	human	ZIC2	3’UTRs.	A	64	bp	region	was	identified	as	a	putative	ARE	
based	on	the	presence	of	two	‘AUUUA’	pentamers	and	a	region	high	in	A/U	nucleotides	in	both	
the	 (a)	mouse	 and	 (b)	 human	ZIC2	 3’UTR.	 This	ARE	 region	overlaps	with	 the	 identified	HPE-
associated	 SNVs	 M3	 and	 M4.	 Upon	 analysis	 for	 poly(A)	 sites,	 the	 murine	 Zic2	 3’UTR	 was	
predicted	to	contain	four	poly(A)	sites	(designated	mP0,	mP1,	mP2	and	mP3,	with	P0	unlikely	to	


















	 Nucleotides	 Observed	 Expected	



















RBP	 Frequency	 RBP	 Frequency	
A1CF	 4*	 PABPC	 7	
A2BP	 1	 PCBP	 10	
BRUNOL	 1	 PTBP	 20*	
CNOT	 1*	 PUM	 12*	
CPEB	 8	 QKI	 1*	
CUGBP	 6	 RALY	 11	
EIF4B	 3*	 RBM	 14*	
ELAVL	 14	 RBMX	 8*	
ESRP	 1	 SART	 5	
FUS	 3	 SFPQ	 4	
G3BP	 2	 SRSF	 29*	
HNRNP	 21	 TARDBP	 12	
HNRPLL	 2	 TRA	 24	
HUR	 11	 TUT	 1*	
IGF2BP	 2	 U2AF	 7	
KHDRBS	 14*	 YBX	 3	
KHSRP	 2	 YTHDC	 1	
MATR	 2	 ZC3H	 8	
MBNL	 31*	 ZCRB	 3*	





Enrichment	of	 predicted	RBP	binding	 sites	 occurs	 at	 five	 out	 of	 the	 six	HPE-associated	 SNVs	









(Betel	et	 al.,	 2008;	 John	et	 al.,	 2004),	miRNASNP	 (Gong	et	 al.,	 2015)	 and	DIANA-microT-CDS	




enriched	 at	 the	 six	 HPE-associated	 SNVs	 (p<0.01).	 Along	 with	 the	 lack	 of	 RBP	 binding	 site	





six	 SNVs	 into	 the	 3’UTR	 did	 not	 create	 new	 or	 remove	 any	 existing	 miRNA	 binding	 site	
predictions.	Their	introduction,	however,	did	result	in	a	change	in	the	predicted	strength	of	the	
miRNAs	binding	to	the	ZIC2	3’UTR,	as	those	sites	with	a	higher	 level	of	complementation	are	
more	 strongly	 bound	 by	miRNA	 than	 those	 with	 lower	 complementation	 (Brennecke	 et	 al.,	
2005).	The	introduction	of	M1	and	M6	are	predicted	to	result	in	an	increase	in	binding	strength	
for	four	miRNAs,	whilst	the	introduction	of	M2	and	M4	are	predicted	to	result	in	a	decrease	in	












element	 (ARE;	 64	 bp)	 compared	 to	 the	 remaining	 ZIC2	 3’UTR	 (1035	 bp).	 (c)	 Binding	 site	
enrichment	at	the	individual	HPE-associated	SNVs	(1	bp)	compared	to	the	non-mutated	3’UTR	
(1089	bp).	Observed	and	expected	values	are	indicated.	Degrees	of	freedom	=	1	for	all	analyses.		
A	 Observed	(n=316)	 Expected	 !2	 p	
Non-conserved	
region	 153	 160.74	 0.759	 0.3838	
NCE	 163	 155.26	
	 	 	 	 	




	 	 	 	 	
C	 Observed	(n=316)	 Expected	 !2	 P	
M1	 3	 0.29	 25.348	 0.0001**	
M2	 3	 0.29	 25.348	 0.0001**	
M3	 3	 0.29	 25.348	 0.0001**	
M4	 0	 0.29	 0.290	 0.5900	
M5	 4	 0.29	 47.506	 0.0001**	










































miRNA	 Freq.	 miRNA	 Freq.	 miRNA	 Freq.	
hsa-let-7	 2	 hsa-miR-182	 1	 hsa-miR-520d-5p	 3*	
hsa-let-7a-2-3p	 2	 hsa-miR-185-5p	 1	 hsa-miR-522-3p	 2*	
hsa-let-7c-3p	 1	 hsa-miR-191-3p	 1	 hsa-miR-524-5p	 3*	
hsa-let-7g-3p	 2	 hsa-miR-204-3p	 1	 hsa-miR-539	 1	
hsa-miR-7-1-3p	 1	 hsa-miR-205	 1	 hsa-miR-539-3p	 1	
hsa-miR-7-2-3p	 1	 hsa-miR-212	 1	 hsa-miR-543	 5*	
hsa-miR-10b-3p	 1	 hsa-miR-224-3p	 2*	 hsa-miR-548	 4*	
hsa-miR-18a-5p	 1	 hsa-miR-297	 1	 hsa-miR-548aa	 3	
hsa-miR-18b	 1	 hsa-miR-302a-5p	 2	 hsa-miR-548aj-3p	 5	
hsa-miR-23a-3p	 3	 hsa-miR-320a	 3	 hsa-miR-548aj-5p	 1	
hsa-miR-23b-3p	 3	 hsa-miR-320b	 3	 hsa-miR-548ap-3p	 3	
hsa-miR-23c	 3	 hsa-miR-320c	 3	 hsa-miR-548ar-3p	 4	
hsa-miR-30a	 1	 hsa-miR-320d	 3	 hsa-miR-548as-3p	 3	
hsa-miR-30c	 1	 hsa-miR-323a	 1	 hsa-miR-548aw	 1	
hsa-miR-30d	 1	 hsa-miR-323a-3p	 3	 hsa-miR-548c-3p	 5	
hsa-miR-30e	 1	 hsa-miR-335-3p	 4	 hsa-miR-548e-5p	 3	
hsa-miR-32	 2*	 hsa-miR-337	 1	 hsa-miR-548f-5p	 1	
hsa-miR-33a	 1	 hsa-miR-340-5p	 1*	 hsa-miR-548g-5p	 1	
hsa-miR-33b	 1	 hsa-miR-371b-5p	 1	 hsa-miR-548t-3p	 3	
hsa-miR-92a-2-5p	 1	 hsa-miR-373-5p	 1	 hsa-miR-548u	 1	
hsa-miR-96-5p	 1	 hsa-miR-374b-3p	 1	 hsa-miR-548x-3p	 5	
hsa-miR-105-5p	 3*	 hsa-miR-374c	 2*	 hsa-miR-548x-5p	 1	
hsa-miR-125	 1	 hsa-miR-377-3p	 3	 hsa-miR-564	 2	
hsa-miR-125b-2-3p	 3	 hsa-miR-421	 1	 hsa-miR-582	 1	
hsa-miR-126-5p	 1	 hsa-miR-451b	 1*	 hsa-miR-583	 2	
hsa-miR-129-5p	 2	 hsa-miR-485-3p	 1	 hsa-miR-586	 2	
hsa-miR-1292-5p	 1	 hsa-miR-491	 3	 hsa-miR-590-3p	 2	
hsa-miR-1305	 2	 hsa-miR-491-5p	 1	 hsa-miR-607	 2	
hsa-miR-132	 1	 hsa-miR-493-5p	 2*	 hsa-miR-608	 1	
hsa-miR-1321	 1	 hsa-miR-494	 2	 hsa-miR-609	 3	
hsa-miR-133a-5p	 1	 hsa-miR-494-3p	 3	 hsa-miR-616-5p	 1	
hsa-miR-136-3p	 1	 hsa-miR-497	 1	 hsa-miR-620	 1	
hsa-miR-138	 1	 hsa-miR-497-3p	 3	 hsa-miR-624-3p	 1	
hsa-miR-140-3p	 1	 hsa-miR-499	 2	 hsa-miR-639	 1	
hsa-miR-145	 1	 hsa-miR-499a-3p	 2	 hsa-miR-655	 3*	
hsa-miR-149-3p	 1	 hsa-miR-499b-3p	 2	 hsa-miR-659-3p	 1	
hsa-miR-153-5p	 4	 hsa-miR-500a-5p	 1	 hsa-miR-663a	 1	
hsa-miR-181	 1	 hsa-miR-503-3p	 1	 hsa-miR-675-3p	 2	
hsa-miR-181a	 2*	 hsa-miR-513	 2	 hsa-miR-765	 2	
hsa-miR-181b	 2*	 hsa-miR-513b	 3	 hsa-miR-766-5p	 1	
hsa-miR-181c	 2*	 hsa-miR-513b-5p	 3	 hsa-miR-873-5p	 1	





miRNA	 Freq.	 miRNA	 Freq.	 miRNA	 Freq.	
hsa-miR-876-3p	 1	 hsa-miR-3928	 1	 hsa-miR-4749-5p	 2	
hsa-miR-1237-3p	 1	 hsa-miR-4253	 1	 hsa-miR-4756-5p	 1	
hsa-miR-1238	 2	 hsa-miR-4262	 3	 hsa-miR-4761-5p	 1	
hsa-miR-1238-3p	 1*	 hsa-miR-4270	 2	 hsa-miR-4766-5p	 2	
hsa-miR-1246	 2*	 hsa-miR-4282	 1	 hsa-miR-4775	 2*	
hsa-miR-1252	 1	 hsa-miR-4306	 1	 hsa-miR-4784	 1	
hsa-miR-1255b-2-3p	 1	 hsa-miR-4311	 2	 hsa-miR-4788	 1	
hsa-miR-1261	 1*	 hsa-miR-4419a	 1	 hsa-miR-4789-5p	 1	
hsa-miR-1270	 1	 hsa-miR-4422	 3	 hsa-miR-5008-5p	 1	
hsa-miR-1271-5p	 1	 hsa-miR-4423-5p	 1	 hsa-miR-5582-3p	 3	
hsa-miR-1277-5p	 2*	 hsa-miR-4429	 3	 hsa-miR-5583-3p	 1*	
hsa-miR-1284	 1	 hsa-miR-4432	 1	 hsa-miR-5680	 3	
hsa-miR-1289	 1	 hsa-miR-4441	 2	 hsa-miR-5688	 1	
hsa-miR-1292-5p	 1	 hsa-miR-4446-3p	 1	 hsa-miR-6071	 1	
hsa-miR-1305	 2	 hsa-miR-4457	 3	 hsa-miR-6074	 1	
hsa-miR-1321	 1	 hsa-miR-4463	 1	 hsa-miR-6125	 2	
hsa-miR-1323	 2	 hsa-miR-4464	 1	 hsa-miR-6127	 1	
hsa-miR-1908	 1	 hsa-miR-4476	 1	 hsa-miR-6129	 1	
hsa-miR-3115	 1	 hsa-miR-4485	 1	 hsa-miR-6130	 1	
hsa-miR-3137	 1*	 hsa-miR-4490	 1	 hsa-miR-6133	 1	
hsa-miR-3148	 1	 hsa-miR-4495	 2	 hsa-miR-6504-3p	 3*	
hsa-miR-3150b-3p	 1	 hsa-miR-4633	 2	 hsa-miR-6510-5p	 1	
hsa-miR-3152-5p	 1	 hsa-miR-4633-5p	 1	 hsa-miR-6515-3p	 1	
hsa-miR-3153	 1	 hsa-miR-4644	 1	 hsa-miR-6715a-3p	 2	
hsa-miR-3154	 5	 hsa-miR-4646-5p	 1	 hsa-miR-6715b-3p	 1	
hsa-miR-3162-5p	 1	 hsa-miR-4651	 1	 hsa-miR-6748-5p	 2	
hsa-miR-3163	 1	 hsa-miR-4668-3p	 2	 hsa-miR-6754-5p	 2	
hsa-miR-3173-3p	 1	 hsa-miR-4670-3p	 1	 hsa-miR-6756-5p	 3	
hsa-miR-3177-3p	 1	 hsa-miR-4672	 1	 hsa-miR-6759-5p	 2	
hsa-miR-3179	 1	 hsa-miR-4694-3p	 5*	 hsa-miR-6766-5p	 2	
hsa-miR-3180	 1	 hsa-miR-4699-3p	 2*	 hsa-miR-6776-3p	 2	
hsa-miR-3196	 1	 hsa-miR-4706	 2	 hsa-miR-6780a-3p	 1*	
hsa-miR-3200-5p	 1	 hsa-miR-4719	 3	 hsa-miR-6793-5p	 2	
hsa-miR-3202	 4	 hsa-miR-4721	 1	 hsa-miR-6796-5p	 1	
hsa-miR-3622b-5p	 1	 hsa-miR-4728-5p	 1	 hsa-miR-6835-3p	 2	
hsa-miR-3650	 1	 hsa-miR-4731-5p	 1	 hsa-miR-6839-3p	 1	
hsa-miR-3658	 1	 hsa-miR-4734	 1	 hsa-miR-6875-3p	 2*	
hsa-miR-3671	 1	 hsa-miR-4735-3p	 1	 hsa-miR-7159-5p	 2	
hsa-miR-3679-3p	 1	 hsa-miR-4739	 1	 hsa-miR-7515	 4	
hsa-miR-3692-3p	 1	 hsa-miR-4742-3p	 2*	 hsa-miR-7849-3p	 1	
hsa-miR-3692-5p	 2	 hsa-miR-4747-5p	 1	 hsa-miR-7853-5p	 3*	




Table	 6.6:	 Predicted	miRNA	 binding	 sites	 are	 enriched	 at	 the	 HPE-associated	 SNVs	 in	 the	
wildtype	ZIC2	3’UTR.	A	two-tailed	Chi-squared	goodness	of	fit	test	was	performed	to	determine	





site	 enrichment	 at	 the	 individual	HPE-associated	 SNVs	 (1	 bp)	 compared	 to	 the	non-mutated	
3’UTR	(1089	bp).	Observed	and	expected	values	are	indicated.	Degrees	of	freedom	=	1	for	all	
analyses.		




	 	 	 	 	




	 	 	 	 	
C	 Observed	(n=420)	 Expected	 !2	 p	
M1	 10	 0.38	 243.76	 0.0001**	
M2	 12	 0.38	 355.65	 0.0001**	
M3	 6	 0.38	 83.19	 0.0001**	
M4	 5	 0.38	 56.22	 0.0001**	
M5	 9	 0.38	 195.71	 0.0001**	












Mutation	 miRNA	 Energy	when	WT	 Energy	 When	
Mutated	
Direction	of	Change	
M1	 hsa-miR-3163	 -16	kcal/mol	 -39.4	kcal/mol	 Increased		
M1	 hsa-miR-4694	 0	kcal/mol	 -40.1	kcal/mol	 Increased	
M2	 hsa-miR-3148	 -41.3	kcal/mol	 -17.3	kcal/mol	 Decreased	
M2	 hsa-miR-4476	 -15.29	kcal/mol	 -12.42	kcal/mol	 Decreased	
M4	 hsa-miR-3137	 -15.77	kcal/mol	 -15.04	kcal/mol	 Decreased	*	
M6	 hsa-miR-582	 -13.9	kcal/mol	 -40.8	kcal/mol	 Increased	















and	may	 be	 a	 sequence	 artefact.	 Nevertheless,	 the	 high	 level	 of	 conservation	 between	 the	
mouse	and	human	P3	suggests	this	PAS	is	worth	investigating	further.	Three	additional	PAS	were	















published	 ZIC2	 EST	 transcripts	 on	 UniGene	 (Pubmed)	 with	 known	 tissue	 of	 origin	 were	
assembled	 and	 their	 transcript	 length	 compared	 in	 multiple	 tissues.	 The	 sequence	 of	 each	


















hP0.1	 239	 AATAAA	 0.499	 No	
hP0.2	 246	 AATAAA	 0.505	 No	
hP0.3	 254	 AATAAA	 0.520	 No	
hP1	 810	 AATAAA	 0.969	 No	
hP2	 891	 ATTAAA	 0.705	 Yes	
hP3	 1062	 AATAAA	 0.092	 Yes	
mP0	 85	 ATTAAA	 0.238	 No	
mP1	 562	 ATTAAA	 0.883	 No	
mP2	 895	 ATTAAA	 0.673	 Yes	








Table	 6.9:	 The	 six	HPE-associated	 SNVs	 are	 predicted	 to	 influence	ZIC2	 transcript	 stability.	
SNVs	 that	 are	 predicted	 to	 alter	 the	 destabilising	 or	 stabilising	 influence	 conferred	 by	 each	
element	onto	the	ZIC2	mRNA	are	denoted	with	an	X.	
Stability	element	 M1	 M2	 M3	 M4	 M5	 M6	
ARE	region	 	 	 X	 X	 	 	
RBPs	 X	 X	 X	 X	 X	 X	
miRNA	 X	 X	 	 X	 	 X	
















of	 the	 3’UTR,	 which	 contains	 the	 putative	 ARE	 region,	 will	 alter	 steady-state	 levels	 of	 ZIC2	
transcript	and	significantly	 increase	the	rate	of	decay.	Optimization	of	 the	RT-qPCR	protocol,	
selection	 of	 appropriate	 reference	 genes	 and	 oligonucleotide	 efficiency	 testing	 were	 all	
performed	 in	 conjunction	 with	 Kathryn	 Dickson	 (Appendix	 Section	 4.1-4.3).	 Total	 RNA	 was	
extracted	 from	HEK293T	cells	 transfected	with	pV5-ZIC2	or	pV5-ZIC2-3’UTR	 (Appendix	Figure	
A4.3)	and	checked	for	integrity	and	lack	of	gDNA	contamination	prior	to	RT-qPCR	analysis.	Cells	
transfected	with	pV5-ZIC2	were	exhibited	a	significantly	higher	fold	change	in	ZIC2	expression	
above	 background	 levels	 than	 cells	 transfected	 with	 pV5-ZIC2-3’UTR	 (Figure	 6.3	 A	 and	 B),	
indicating	that	the	presence	of	the	3’UTR	decreased	steady-state	ZIC2	transcript	levels.	
To	determine	if	this	difference	was	due	to	transcript	degradation,	transcription	was	halted	via	






vehicle	 only	 treated	 cells	 from	 the	 equivalent	 time	 point,	 and	 plotted	 over	 time.	 The	 fold	
changes	of	ZIC2	expression	quantified	in	cells	treated	with	fresh	DRB	were	lower	than	those	in	











AI458310.1	 IMAGE:2150307	 414	 -	 Lung	 41	bp	upstream	(5’)	of	M1	
AA885663.1	 IMAGE:1500176	 482	 -	 Lung	 26	bp	downstream	(3’)	of	
M1	
95	bp	upstream	(5’)	of	M2	
AA900219.1	 IMAGE:1604674	 588	 -	 Lung	 10	bp	downstream	(3’)	of	
M2	
BE219194.1	 IMAGE:3176777	 624	 -	 Lung	 46	bp	downstream	(3’)	of	
M2	
BF594212.1	 IMAGE:3564059	 1075	 PA3	 Brain	 3’	transcript	end	at	1082	
BF438724.1	 IMAGE:3275267	 1081	 PA3	 Brain	 3’	transcript	end	at	1082	
BU619638.1	 UI-H-FH1-bfq-o-
01-0-UI	
1082	 PA3	 Bone	 3’	transcript	end	at	1082	
CA427434.1	 UI-H-FH1-bfi-b-
11-0-UI	
1082	 PA3	 Bone	 3’	transcript	end	at	1082	
AA491603.1	 IMAGE:910539	 1082	 PA3	 Bone	 3’	transcript	end	at	1082	
R42515.1	 IMAGE:29730	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	
AI359104.1	 IMAGE:2012588	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	
R61372.1	 IMAGE:	37980	 1082	 PA3	 Brain	 3’	transcript	end	at	1082	





























cells	 transfected	 with	 pV5-ZIC2-3’UTR	 was	 found	 to	 have	 a	 shorter	 half-life	 than	 in	 cells	
transfected	with	 pV5-ZIC2	 (Figure	 6.3	 E),	 indicating	 that	 the	 inclusion	 of	 the	 3’UTR	 leads	 to	




To	 determine	 which	 of	 the	 three	 mouse	 PASs	 were	 most	 likely	 to	 be	 used	 during	 embryo	






























Error	 bars	 =	 S.E.M	of	 three	 external	 repeats;	 letters	 denote	 statistical	 significance	of	p<0.05	
calculated	 via	 a	 one-way	 ANOVA	 with	 Fischer’s	 unprotected	 post	 ad	 hoc	 test.	 The	 letter	 a	






was	detected	 from	7.5	 -	9.5	dpc.	Whilst	a	peak	such	as	 this	may	 indicate	non-specific	mRNA	
amplification	at	off-target	 sites	or	primer	dimers	 (investigated	 in	Appendix	 Section	A4.5	and	
























During	 embryo	 development,	mRNA	 transcripts	 and	 proteins	 are	 required	 in	 a	 spatially	 and	









































Not	 all	 of	 the	 PASs	 predicted	 in	 the	 3’UTR	 appear	 to	 be	 active	 during	 the	 early	 stages	 of	
embryogenesis.	The	distal	3’	PAS	is	considered	the	default	site	for	most	transcripts	due	to	the	
availability	of	regulatory	sites	within	the	full	length	3’UTR	(Beaudoing	et	al.,	2000;	Weill	et	al.,	
2012).	 A	 preference	 for	 the	 distal	 PAS	 at	 gastrulation	 agrees	 with	 the	 idea	 that	 Zic2	 is	 a	
transiently	expressed	TF	that	must	undergo	carefully	controlled	rapid	expression	followed	by	
rapid	decay	to	pattern	the	embryo.	Whether	P3	remains	the	default	PAS	at	other	embryonic	or	
adult	 stages	 remains	 to	 be	 elucidated,	 however.	 Single-Molecule	 sequencing	 chemistry	with	
Real-Time	detection	(SMRT;	PacBio)	and	Full-length	Isoform	Sequencing	(Iso-Seq;	PacBio)	can	
be	employed	to	determine	the	precise	PAS	and	cleavage	sites	that	are	utilised	in	both	human	




via	 priming	 with	 Anchored	 Oligo(dT)20	 oligonucleotides.	 A	 SMRTbell	 sequencing	 library	 is	
generated,	 with	 templates	 complexed	 to	 polymerases	 and	 bound	 to	 magnetic	 beads.	 DNA	
sequencing	is	then	carried	out	with	a	PacBio	RS	II	sequencer,	producing	transcriptome	data	that	
can	 then	 be	 analysed.	 This	 technique	 is	 optimised	 to	 pick	 up	 any	 polyadenylated	 lncRNA	
molecules	 (Tombácz	 et	 al.,	 2016)	 produced	 from	 the	 ZIC2	 3’UTR	 and	 can	 presumably	 be	
employed	on	total	RNA	extracts	for	detection	of	bidirectional	un-polyadenylated	lncRNAs	such	
as	 eRNA.	 Additionally,	 the	 sensitivity	 of	 the	 techniques	 will	 allow	 for	 the	 analysis	 of	 finely	
dissected	 embryonic	 tissues	with	 relatively	 few	 cells,	 such	 as	 the	 node.	 Identification	 of	 the	
predominant	transcript	in	the	node	will	aid	in	narrowing	down	regions	of	the	Zic2	3’UTR	where	























a	 T>C	 substitution	 in	 a	 conserved	 PAS	 in	 the	 b-globin	 3’UTR	 that	 sufficiently	 disrupts	




the	 cells	 for	 longer	 than	 necessary,	 resulting	 in	 an	 increase	 in	 protein	 above	 the	 threshold	
required.	To	circumvent	the	cloning	difficulties	encountered	in	this	chapter,	the	mutant	V5-ZIC2-






and	 Sandelin,	 2004),	 it	 is	 presumed	 that	 the	 rate	 of	 true	 RBP	 binding	 sites	 is	 similar.	





















(Roessler	 and	Muenke,	 personal	 communication).	 Comparatively,	 no	mutations	 in	ZIC5	 have	
been	 linked	to	human	hydrocephaly	despite	homozygous	Zic5	 cDNA	mutations	 in	 the	mouse	







Post-transcriptional	 regulation	 of	 mRNA	 is	 used	 by	 cells	 to	 strictly	 control	 the	 spatial	 and	
temporal	expression	of	genes.	Via	transcript	decay	mechanisms,	gene	expression	can	be	rapidly	
turned	off	when	the	protein	is	no	longer	required.	Defects	in	this	process,	however,	can	lead	to	
exogenous	 gene	 expression	 or	 levels	 of	 protein	 above	 the	 required	 threshold,	 resulting	 in	
disease.	From	the	analysis	shown	in	this	chapter,	it	appears	that	ZIC2	expression	and	transcript	
half-life	 is	 regulated	by	multiple	mRNA	stability	elements	 residing	within	 the	3’UTR	 including	
AREs,	 alternative	 poly(A)	 sites	 and	 eRNAs.	 The	 use	 of	 the	 most	 3’	 PAS	 during	 gastrulation	


















individual	HPE-associated	 SNVs	were	also	 inserted.	Despite	 a	high	 level	 of	 transgenesis,	GFP	








exhibit	 relatively	 low	 success	 rates,	 and	 can	 take	 9-12	 months	 before	 viable	 offspring	 are	
available	for	analysis.	Over	the	past	decade,	however,	new	genome	editing	technologies	have	






A	 transposon	 consists	 of	 two	 elements	 –	 a	 DNA	 transgene	 consisting	 of	 the	 desired	 cargo	
sequence	flanked	on	either	side	by	two	inverted	terminal	repeats	(ITRs),	and	a	transposase	that	
catalyses	 the	 insertion	of	 the	DNA	component	 into	 the	target	genome	via	a	genetic	 ‘cut	and	
paste’	 method	 (Figure	 7.1).	 This	 system	 can	 be	 modified	 for	 transgenesis	 through	 the	 co-
		 222	
injection	 of	 the	 synthesized	 transposase	 mRNA	 with	 the	 circular	 transgene	 DNA	 (the	 cargo	
component	and	 ITRs)	 into	 the	pronuclei	of	zygotes	of	 the	preferred	model	organism	(Mátés,	
2011).	 Genome	 integration	 is	 essentially	 random,	 although	 PiggyBac	 does	 require	 a	 TTAA	
nucleotide	sequence	 in	order	 to	correctly	 insert	 its	DNA	cargo	 into	 the	genome	(Bjork	et	al.,	
2010;	Fraser	et	al.,	1996).		
Transposons	are	commonly	used	for	transgenesis	and	insertional	mutagenesis	in	a	wide	range	
of	 model	 organisms	 (e.g.	 Drosophila,	 Caenorhabditis	 elegans	 and	 plants).	 Due	 to	 a	 lack	 of	
naturally	active	transposons	in	mammals,	however	it	is	only	recently	that	they	have	begun	to	be	
utilized	 in	 transgenic	 mice	 and	 rats	 (Dupuy	 et	 al.,	 2002;	 Mátés,	 2011).	 Two	 transposases	
previously	used	to	generate	transgenic	mice	are	SleepingBeauty	and	PiggyBac.	SleepingBeauty	






2011;	Mátés	et	 al.,	 2009).	 In	 contrast,	 the	PiggyBac	 transposase,	 isolated	 from	 the	 cabbage	
looper	moth	(Trichoplusia	ni)	is	unique	due	to	its	high	efficiency	rate,	large	cargo	capacity,	and	
ability	to	form	functional	protein	fusions	and	restore	a	donor	site	to	its	original	condition	upon	





Transposons	 have	 greatly	 reduced	 the	 production	 time	 required	 to	 generate	 mutated	
mammalian	 germlines	 (Horie	 et	 al.,	 2003),	 and	 have	 allowed	 for	 the	 production	 of	 forward	
genetic	screens	in	vivo	to	identify	genes	involved	in	diseases	such	as	solid	tumours	(Collier	et	al.,	
2005).	 Transgene	 genomic	 integration	 is	 often	 subject	 to	 position	 effects,	 however,	 where	
































elements	 and	 allows	 for	 the	 mutation,	 insertion	 and	 removal	 of	 components	 of	 the	 target	












manipulation	 of	 the	 cells	 endogenous	 homology-directed	 repair	 (HDR)	 mechanisms.	 By	




protospacer	adjacent	motif	 (PAM)	sequence	 (defined	as	NGG)	and	be	complementary	 to	 the	
sgRNA	sequence	(Yang	et	al.,	2014).	
Whilst	 extremely	 versatile,	 CRISPR-aided	 mutagenesis	 can	 also	 be	 unpredictable,	 with	
superfluous	sequence	changes	routinely	found	at	the	site	of	repair	due	to	the	error	prone	NHEJ	
repair	system.	Furthermore,	founder	animals	are	frequently	mosaic	for	the	introduced	mutation	
(Jacobi	 et	 al.,	 2017;	 Mianné	 et	 al.,	 2017).	 Off-target	 effects,	 which	 occur	 when	 the	 guide	


















As	 previous	 attempts	 to	 model	 the	 activity	 of	 the	 ZIC2	 3’UTR	 in	 zebrafish	 have	 failed,	 the	




• To	 generate	 a	 highly	 efficient	 system	 for	 the	 creation	 of	mouse	 transgenics	 via	 the	
PiggyBac	transposase.		
		 226	


































with	 Xbal	 in	 the	 MCS	 (Figure	 7.3,	 Chapter	 2,	 Appendix	 Table	 A1.2,	 Appendix	 Figure	 A5.3).	
Following	isolation	and	large-scale	prepping,	pBB262-ZIC2	NCE	constructs	were	digested	with	



























Contains	 the	 Pbase	 (PiggyBac)	 transposase	 open	




pBB256	 Delivery	of	desired	transgene	cargo.	 Yes	 None	
pBB259	 Delivery	of	desired	transgene	cargo.	 Yes	 Two	 in	 total,	 one	
copy	 on	 either	 side	
of	the	MCS.	














amplicon	 and	 linearized	pBB262	 vector	were	 joined	 via	 an	 In-Fusion	 (Clontech)	 reaction,	 (d)	
resulting	in	pBB262-NCE.	pBB262-NCE	was	digested	with	NotI	and	XhoI	to	linearize	the	vector.	
(e)	Simultaneously,	p1229	was	digested	with	NotI	and	XhoI,	 resulting	 in	release	of	a	b-globin	
minimal	 promoter-lacZ/SV40	 PolyA	 cassette.	 (f)	 The	 b-globin-lacZ/SV40	 PolyA	 cassette	 was	





















































transgene	 constructs	 (pBB262-mNet-lacZ,	 pBB262-lacZ	 and	pBB262-NCE-lacZ)	 linearized	with	
XmnI	were	co-injected	into	the	pronucleus	by	Gene	Elliot	at	the	NIH	Transgenic	Core	Facility.	A	
total	of	19	transgenesis	rounds	were	conducted,	with	the	concentrations	of	transposase	mRNA	
and	 reporter	 DNA	 for	 each	 injection	 outlined	 in	 Table	 7.2.	 Tn(pb-pBB262-mNet-lacZ)Ark	 transgenic	
embryos	were	dissected	at	8.5	dpc	as	this	is	the	known	time	of	mNet	enhancer	activity,	whilst	
Tn(pb-pBB262-NCE-lacZ)Ark	and	Tn(pb-pBB262-lacZ)Ark	embryos	were	dissected	at	7.5	dpc,	9.5	dpc	or	12.5	dpc.	
All	 recovered	 embryos	were	 genotyped	 for	 the	 presence	 of	 lacZ.	 In	 total,	 23	 embryos	were	
recovered	following	pBB262-mNet-lacZ	pronuclear	injection	and	261	embryos	were	recovered	
following	 pBB262-NCE-lacZ	 injection.	 As	 shown	 in	 Table	 7.2,	 the	 concentration	 of	 DNA	 and	
mRNA	injected	appeared	to	influence	the	rate	of	transgenesis	for	pBB262-NCE-lacZ	(rounds	1-2	


















Table	 7.2:	 PiggyBac	 transgenic	 injections.	 The	 expected	 number	 of	 lacZ/+	 embryos	 was	
calculated	as	68%	of	the	total	number	of	viable	embryos,	as	this	was	the	value	reported	in	the	






























































































































1	 10	 4	 34	 23	 14	 9.5	 0	 0	 7-7.5	 0.0	 39.1	
2	 7	 4	 34	 28	 18	 12.2	 2	 0	 7-7.5	 11.1	 35.7	
5	 13	 2	 23	 52	 31	 21.1	 25	 0	 6-7.5	 80.6	 40.4	
6	 9	 2	 23	 30	 10	 6.8	 8	 0	 7-7.5	 80.0	 66.7	
7	 7	 2	 23	 35	 27	 18.4	 9	 0	 7-7.5	 33.3	 22.9	
9	 11	 2	 23	 40	 19	 12.9	 10	 0	 7-7.5	 52.6	 52.5	
10	 17	 2	 23	 59	 23	 15.6	 17	 0	 8.5-9.5	 73.9	 61.0	
11	 8	 2	 23	 22	 9	 6.1	 4	 1	 12.5	 44.4	 59.1	
13	 3	 2	 23	 16	 12	 8.1	 4	 0	 12.5	 33.3	 25.0	
14	 5	 2	 23	 11	 6	 4.0	 2	 1	 8.5	 33.3	 45.5	
15	 5	 2	 23	 9	 2	 1.4	 0	 0	 9.5	 0.0	 77.8	
16	 5	 2	 23	 27	 18	 12.2	 ND	 0	 7.5	 ND	 33.3	
17	 13	 2	 23	 49	 18	 12.2	 ND	 0	 9.5	 ND	 63.3	
18	 10	 2	 23	 40	 18	 12.2	 ND	 0	 8.5	 ND	 55.0	
19	 10	 2	 23	 64	 36	 24.5	 ND	 3	 12.5	 ND	 43.8	
Total:	 133	 	 	 505	 261	 177.4	 81	 5	 Avg:	 40.2	 48.1	
	 	 pBB262-mNet-lacZ	(positive	control)	
3	 6	 4	 34	 12	 8	 5.4	 7	 0	 8-8.5	 87.5	 33.3	
4	 6	 4	 34	 21	 11	 7.5	 10	 0	 8-8.5	 90.9	 47.6	
8	 6	 2	 23	 11	 4	 2.7	 4	 0	 8-8.5	 100.0	 63.6	




round	 8),	 suggesting	 the	 transgenesis	 rate	 was	 construct	 dependant.	 Overall,	 the	 average	
transgenesis	rates	for	both	constructs	(92.8%	for	pBB262-mNet-lacZ	and	40.2%	for	pBB262-NCE-
lacZ;	Table	7.2)	suggests	the	PiggyBac	transposase	is	highly	effective	at	introducing	transgenes	

















Design	 of	 the	 CRISPR	 guide	 strands,	 as	 well	 as	 pronuclei	 injection	 and	 implantation,	 and	
genotyping	of	pups,	was	carried	out	in	conjunction	with	the	Transgenesis	Facility	(JCSMR,	ANU,	
Canberra).	Eight	guides	targeting	the	Zic2	3’UTR	were	initially	designed	and	selected	using	the	
algorithms	available	 via	 the	 Zhang	CRISPR	design	 site	 (Zhang	 Lab	 and	MIT,	 2015)	 (Table	7.3,	
Figure	7.8).	Of	the	eight	selected	guides	(Table	7.3),	two	that	were	situated	either	side	of	the	
Zic2	NCE	(designated	G2	and	G3)	were	initially	chosen	for	the	mutagenesis	experiments.	G2	and	
G3	DNA	 sequences	were	 cloned	 into	 the	 guide	 plasmid	 constructs	 and	 the	 isolated	 plasmid	
incorporated	 into	 pronuclei	 of	 fertilized	 zygotes	 (either	 by	 injection	 or	 electroporation)	
(Appendix	 Figure	 A5.6).	 These	 experiments	 formed	 part	 of	 the	 Transgenesis	 Facility’s	
optimisation	of	CRISPR-Cas9	protocols,	resulting	in	inter-experimental	variation	in	the	method	
of	 zygote	 incorporation,	 the	 form	 in	 which	 reagents	 were	 used,	 and	 the	 concentration	 of	
reagents	(Table	7.4	and	Table	7.5).	The	stage	at	which	the	transferred	embryos	developed	to	
before	 analysis	 also	 varied.	 A	 total	 of	 25	 CRISPR-Cas9	 rounds	 sessions,	 in	 which	 ~20	 2-cell	









expression	 was	 detected.	 Lateral	 view	 of	 (e)	 Tn+/+	 and	 (f-g)	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 8-8.5	 dpc	
embryos	 following	X-Gal	 staining.	Anterior	 is	 to	 the	 left.	 (h)	Ventral	 view.	One	Tn(pb-pBB262-NCE-
lacZ)Ark/+	embryo	(g-h)	exhibited	lacZ	expression	in	the	node	and	midbrain	(black	arrows).	Lateral	
view	 of	 (i)	 Tn+/+	 and	 (j-k)	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 embryos	 at	 12.5	 dpc	 following	 X-gal	 staining.	
Anterior	is	to	the	left.	(j)	X-gal	stain	trapping	was	detected	in	some	Tn(pb-pBB262-NCE-lacZ)Ark/+	embryos	
(black	 arrow),	 but	 this	 was	 not	 true	 lacZ	 expression.	 Four	 Tn(pb-pBB262-NCE-lacZ)Ark/+	 embryos	 (k,	
Appendix	 Figure	 A5.5)	 exhibited	 lacZ	 expression,	 however	 the	 expression	 pattern	 was	
inconsistent	between	embryos.	S:	somites.		 	
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to	 total	 number	 of	 decidua.	 The	 preparation	 of	 the	 Cas9	 protein,	 guide	 strands,	 zygote	























































































































































































































































































































































































































































































to	 total	 number	 of	 decidua.	 The	 preparation	 of	 the	 Cas9	 protein,	 guide	 strands,	 zygote	
harvesting	and	electroporation	were	all	performed	by	 the	 JCSMR	Transgenesis	Facility	 (ANU,	







































































































































































































































































































































































































































































NCE.	 To	 exclude	 the	 possibility	 that	 modification	 of	 the	 NCE	 leads	 to	 in	 utero	 lethality,	
genotyping	of	microinjected	2-cell	embryos	and	sequencing	of	the	genotyping	amplicons	was	







number	 of	 pups	 were	 recovered	 (Figure	 7.10).	 All	 three	 pups,	 however,	 carried	 a	 variant	




identified	 as	 possible	mutants	 via	 genotyping.	 Those	 embryos	 at	 the	mid-streak	 stage	were	
analysed	via	WMISH	to	Zic2	and	compared	to	wildtype	littermates,	whilst	those	at	early	somite	
stages	 were	 analysed	 with	 WMISH	 to	 SHH.	 Each	 modified	 embryo	 showed	 expression	











the	 Zic2	 3’UTR	 deletions,	 and	 phenotyped	 for	 Zic2-associated	 defects	 such	 as	 HPE,	 LR	
randomization	and	spina	bifida.	As	the	deletions	occur	upstream	of	the	NCE	region,	it	is	expected	
that	homozygote	pups	from	these	lines	will	not	exhibit	HPE.	If	this	is	correct,	these	lines	can	act	









gel,	 G6,	 G7,	 G8	 and	 G10	 were	 found	 to	 successful	 cleave	 the	 Zic2	 3’UTR	 amplicon	 (*).	 L:	
HyperLadder	50	bp	(Bioline).	
A	
Guide	 UTR	amplicon	 Band	1	expected	size	 Band	2	expected	size	
G5	 730	bp	 99	bp	 631	bp	
G6	 730	bp	 109	bp	 621	bp	
G7	 730	bp	 175	bp	 555	bp	
G8	 730	bp	 373	bp	 357	bp	
G9	 730	bp	 423	bp	 307	bp	














of	 the	 genotypes	 shown.	 The	 pZic2+/DNCE	 embryo	 exhibited	 a	 discontinued	 notochord	 and	
expanded	node	staining	(black	arrowheads).	(c-d)	Lateral	view	of	7s	embryos	of	the	genotypes	
shown.	 The	 pZic2+/DNCE	 embryo	 exhibited	 a	 discontinued	 notochord	 (black	 arrowhead)	 and	
reduced	Shh	expression	(*).	(e-f’)	Lateral	view	of	mid-streak	stage	embryos	of	the	genotypes	
shown	with	WMISH	to	Zic2.	The	pZic2+/DNCE	embryo	appeared	to	have	either	expanded	Zic2	in	
the	 node	 and	 surrounding	 endoderm,	 or	 a	 reduced	 endoderm	 layer	 (black	 arrowhead).	 (g-i)	




































integration	 at,	 and	 interruption	 of,	 an	 essential	 gene	within	 the	murine	 genome,	 or	 due	 to	




construct	 that	 combines	 both	 the	 transposase	 and	 transpositioning	 transgene.	 By	 sharing	 a	
single	poly(A)	 sequence,	 the	 transposase	 self-inactivates	after	 the	 initial	 transposition	event,	
preventing	further	events	from	occurring	(Chakraborty	et	al.,	2014).	Genotoxicity	is	expected	to	
result	 in	 a	 decrease	 transgenic	 efficiency	 only,	 however,	 and	 is	 unlikely	 to	 account	 for	 the	
complete	lack	of	lacZ	expression	in	the	positive	control.		






but	 different	 sub-strains.	 It	 is	 mostly	 likely	 a	 combination	 of	 the	 events	 discussed	 above,	




(YAC)	 artificial	 chromosomes	 may	 be	 a	 suitable	 alternative	 to	 transposons.	 BAC	 and	 YAC	





specific	 since	 (i)	 the	 introduction	 of	 deletions	 via	 incorporation	 of	 multiple	 guides	 typically	
achieves	high	mutagenesis	efficiencies	 (Meyer	et	al.,	 2015;	 Sanjana	et	al.,	 2016;	 Zhou	et	al.,	
2014)	and	(ii)	the	JCSMR	Transgenesis	Facility	report	that	50%	of	NHEJ-dependant	projects	are	
successful	after	 the	 first	microinjection	session	 (Burgio	 laboratory,	personal	communication).	
The	presence	of	only	a	few	NGG	PAM	sites	within	the	NCE	itself	present	difficulties,	especially	if	
the	 guides	 sequences	 flanking	 these	 sites	 cannot	 sufficiently	 target	 Cas9	 to	 this	 region.	 An	











Based	on	 the	 results	 shown	 in	 this	Chapter	 and	Chapters	4,	 5	 and	6	of	 this	 thesis,	 it	 can	be	
concluded	 that	 the	wildtype	 ZIC2	 NCE	 possess	 two	main	 roles:	 transcription	 repression	 and	
promotion	of	mRNA	decay.	In	its	role	as	an	ER	element,	the	NCE	acts	to	repress	transcription	of	







to	 be	 eRNA,	 suggests	 a	 third,	 as	 yet	 unknown	 role	 for	 the	ZIC2	 3’UTR.	 From	 these	 results,	 I	
conclude	that	the	Zic2	NCE	likely	controls	Zic2	expression	during	gastrulation.		




NCE	and	can	be	used	 to	determine	 if,	 and	how,	a	 single	nucleotide	change	can	 lead	 to	HPE.	
Additionally,	it	would	be	prudent	to	delete	minimal	sections	of	the	NCE	to	determine	the	exact	
function	of	each	region.	It	 is	expected	that	certain	regions	of	the	NCE	would	produce	a	more	































phenotype:	 the	 loss	 of	 foxa2	 organizer	 expression	 and	 defects	 in	 embryo	 development	
(Houtmeyers	 et	 al.,	 2016).	 It	 is	 therefore	 feasible	 that	mutation	 of	 the	 ZIC2	 3’UTR	 leads	 to	
elevated	ZIC2	transcript	and	HPE.	Potentially,	a	‘Goldilocks	zone’	of	ZIC2	expression	is	required	
for	 normal	 embryo	 development	 (Figure	 7.12).	 If	 ZIC2	 expression	 is	 too	 little,	 or	 too	much,	
defects	such	as	HPE	will	occur.		
It	 is	 possible	 that	 hypermorphic	 mutations	 occur	 more	 frequently	 than	 thought,	 but	 are	
obscured	by	embryonic	 lethality.	This	correlates	with	known	features	of	Zic2-associated	HPE,	
such	as	the	positive	correlation	between	ZIC2	mutation	and	HPE	severity	or	lethality	(Table	1.2)	



























































































































































































































































































































promoters	 (Akan	 and	 Deloukas,	 2008;	 Antequera	 and	 Bird,	 1999).	 Blue:	 promoter	 regions	
predicted	 by	 Proscan,	 TSSG,	 TSSW	 and	 the	 UCSC	 Genome	 Browser	 (Prestridge,	 1995;	







Figure	A3.2:	Attempts	 to	clone	 the	putative	ZIC2	promoter.	Previous	attempts	by	myself	 to	
amplify	the	putative	ZIC2	promoter	for	cloning	were	unsuccessful.	As	such,	(a)	the	putative	ZIC2	
promoter	sequence	with	BglII	and	HindIII	restriction	sites	flanking	either	end	(b)	was	synthesised	
into	pUC57	 by	 Genscript.	 The	 resulting	 plasmid	 and	 pGL-DEST	were	 digested	with	BglII	 and	
HindIII	to	release	the	ZIC2	promoter	and	ccdb	resistance	fragments.	Ligation	of	the	digested	ZIC2	








globin-DEST:	pGL-DEST	with	a	b-globin	promoter	 cloned	between	attR2	and	 luc	 via	BglII	 and	
HindIII	sites,	(d)	pGL-Hsp68-DEST:	pGL-DEST	with	a	Hsp68	promoter	cloned	between	attR2	and	





















WNT	environment.	HEK293T	cells	were	 transfected	with	 the	NODAL	 reporter	 (CAGA)12,	BMP	
reporter	BRE	or	WNT	reporter	TOPFLASH,	as	well	as	V5-NOGGIN	to	inhibit	BMP	signalling,	or	an	
empty	 control	 vector	 (V5-DEST).	 Cells	 were	 cultured	 in	 DMEM	 with	 LiCl	 to	 promote	 WNT	
signalling,	or	DMEM	on	its	own	as	a	control.	Reporter	activity	was	measured	as	luminescence.	









































different	 signalling	 environments.	HEK293T	 cells	 were	 transfected	with	 the	 empty	 reporter	
construct	 pGl-pZIC3-DEST	 (p-luc)	 and	 (a-c)	 transfected	 with	 ALK4-HA	 to	 stimulate	 NODAL	






















































To	 accurately	measure	 the	mRNA	decay	 levels	 of	ZIC2	 transcripts	 in	 vitro,	 it	 is	 important	 to	
optimise	 the	 RT-qPCR	 assay	 before	 quantification	 can	 begin.	 This	 requires	 the	 selection	 of	
reference	genes	that	are	expressed	in	a	similar	manner	to	ZIC2.	Reference	genes	should	have	
minimal	variation	in	expression	in	the	cell	or	tissue	type	examined	and	be	expressed	at	a	similar	
level	 to	ZIC2	 to	 ensure	 there	 is	 adequate	overlap	between	 their	 amplification	 levels.	 Similar	






previously	 been	 used	 in	 other	 RT-qPCR	 assays:	 PPP1R8,	 ABCE1,	 MAD2L2	 and	 USP39.	 The	










assay	will	 produce	 an	 efficiency	 of	 90-105%,	where	 100%	 represents	 a	 doubling	 of	 the	 PCR	
product	every	cycle	(Bustin	et	al.,	2009).	A	linear	standard	curve	with	a	regression	line	(R2)	of	
0.98	or	higher	also	indicates	an	optimised	reaction.	To	create	standard	curves	for	the	ZIC2	and	
reference	 gene	 assays,	 a	 log10	 dilution	 series	 of	 total	 RNA	 template	 (extracted	 from	
untransfected	HEK	293T	cells)	were	used,	ranging	from	100	ng	to	0.01	ng	per	reaction.	For	each	
concentration,	 the	 mean	 CT	 value	 was	 plotted	 against	 the	 log	 of	 the	 dilution	 factor.	 The	

















cells	 prevents	 this,	 retaining	 a	 clear	 cytoplasm	 (Strober,	 2001).	 The	 proportion	 of	 viable	 to	
nonviable	cells	 can	be	determined	visually	based	on	 the	colour	of	 the	cells.	Cell	 suspensions	
were	 obtained	 by	 detaching	 adherent	 cells	 with	 Trypsin-EDTA	 (0.5	 g/L;	 Life	 Technologies),	
neutralized	in	an	equal	volume	of	supplemented	DMEM	as	described	in	section	2.4.1.	An	equal	
volume	 of	 Trypan	 Blue	 stain	 (0.4%	 Trypan	 Blue	 [Matheson,	 Coleman	 and	 Bell]	 in	 1	 X	 PBS	
[Amresco])	was	added	to	the	cell	suspension	and	gently	mixed.	A	10	μL	aliquot	of	the	cell/Trypan	
Blue	mix	was	loaded	onto	a	clean	haemocytometer	and	visualised	under	a	light	microscope	at	


































(Snow	 1977).	 Transcriptome	 mining	 of	 murine	 embryos	 revealed	 genes	 involved	 in	 cellular	
metabolism	and	RNA	transcription	are	upregulated	at	this	stage,	reflecting	a	requirement	for	
the	acceleration	of	 cell	 proliferation	 (Kojima	et	 al.	 2014).	 This	 rapid	 turnover	of	 cells	 can	be	
attributed	to	the	need	for	a	constant	source	of	progenitor	cells	for	germ	layer	formation	(Power	
and	 Tam	 1993),	 the	 specialisation	 of	 tissues	 within	 the	 embryo,	 and	 multiple	 signalling	
pathways,	such	as	TGFb	superfamily,	WNT	and	FGF,	working	to	establish	the	major	embryonic	
axes	and	direct	cell	movements	 in	a	spatially	and	temporally	restricted	manner	(Pfister	et	al.	









By	 8.5	 dpc,	 the	 embryo	 has	 doubled	 in	 size	 compared	 to	 7.5	 dpc.	 Here,	 neurulation	 genes	
maintain	 their	 high	 level	 of	 expression,	 accompanied	 by	 enrichment	 of	 vasculogenesis	 and	
organogenesis	genes,	an	increase	in	transcript	diversity,	and	the	downregulation	of	cell	cycling	









qPCR,	 however,	 affords	 the	 user	 the	 ability	 to	 quantify	 the	 small	 and	 rapid	 transcriptional	




expressed	 ‘reference	 gene’	 to	minimise	 error.	 Stability	 in	 this	 context	 refers	 to	 the	 balance	
between	 the	 decay	 rate	 of	 already	 transcribed	 mRNA	 and	 the	 rate	 of	 gene	 transcription,	
resulting	in	a	steady	state	level	of	available	mRNA.	The	assumptions	made	when	choosing	stable	
reference	 genes	 are	 that	 target	 and	 reference	 genes	 are	 expressed	 at	 a	 similar	 level,	 that	
expression	of	 the	 reference	gene	will	be	consistent	between	samples	 tested,	and	 that	 it	will	
undergo	 the	 same	 errors	 as	 the	 target	 during	 cDNA	 preparation	 and	 subsequent	 analysis	
(Vandesompele	et	al.	2002;	Bustin	et	al.	2009;	Guenin	et	al.	2009;	Chapman	and	Waldenström	
2015).	 In	 reality,	 the	 expression	 of	 any	 reference	 gene	 can	 vary	 considerably	 between	
experimental	conditions	 (Guenin	et	al.	2009).	Previous	publications	have	found	that	the	best	
candidate	reference	gene	was	context	dependent	and	changed	between	the	different	tissues	
being	examined.	Additionally,	as	 reference	genes	are	considered	 ‘housekeeping	genes’,	 their	
expression	is	generally	strong,	which	can	result	in	large	discrepancies	in	transcript	abundance	
relative	to	the	target	being	analysed	(Hruz	et	al.	2011).	These	issues	are	compounded	when	you	
consider	 that	 it	 is	 total	mRNA	being	evaluated,	and	enzymatic	 reactions	 (such	as	 the	 rate	of	
reverse	transcription	or	PCR)	can	introduce	variations	that	effect	the	strength	of	the	detected	
signals.	By	not	addressing	these	factors,	significant	biases	can	be	introduced	into	an	experiment,	




A	 recent	study,	however,	 identified	 that	 these	guidelines	are	not	 routinely	 followed,	with	an	
average	 of	 1.23	 reference	 genes	 used	 in	 normalisation	 in	 published	 papers	 (Chapman	 and	
Waldenström	2015).	To	enable	the	informed	selection	of	reference	genes,	algorithms	such	as	
geNorm	(Vandesompele	et	al.	2002;	Mestdagh	et	al.	2009),	Bestkeeper	(Pfaffl	et	al.	2004)	and	




Previous	 studies	by	Willems	et	al	 (2006)	and	Veazey	et	al	 (2011)	have	attempted	 to	address	
these	issues	by	recommending	stable	reference	genes	suitable	for	comparisons	of	embryonic	
and	extra-embryonic	stem	cells	(Veazey	and	Golding	2011),	or	reference	genes	that	are	stable	

























Nagel)	 according	 to	 the	manufacturer’s	 instructions	 and	 quantified	 via	 nanodrop.	 Additional	
DNaseI	 treatment	 (#04716728001,	 10U,	 Roche)	 was	 performed	 to	 ensure	 no	 genomic	 DNA	

















assay	 for	each	gene	consisted	of	 three	 internal	 replicates	per	gene	per	embryo	age.	At	 least	






























inter-	 and	 intra-	 group	 variation,	 a	 stability	 value	 is	 calculated.	 The	 most	 stably	 expressed	
candidate	gene	during	gastrulation	was	 calculated	 to	be	Gapdh	 (stability	 value	0.212)	 (Table	
A4.3).	Ubc	(0.247)	and	H2afz	(0.251)	were	comparatively	unstable	on	their	own	and	therefore	
would	not	be	good	choices	for	normalisation	of	a	target	individually.	Normfinder	does,	however,	
predict	 that	 a	 combination	 of	 both	Ubc	 and	H2afz	 (with	 a	 joint	 stability	 value	 of	 0.151)	will	























and	 1	 and	 3	 respectively	 in	 Bestkeeper,	 they	were	 chosen	 as	 the	most	 stable	 of	 the	 tested	
reference	genes	to	normalise	further	gene	expression	studies	to.	It	should	be	noted	that	Gapdh	
performed	 comparatively	well	 to	Ubc,	 and	 thus	 could	 act	 as	 a	 sufficient	 substitute	 in	 future	
		 300	
analysis.	Actb	and	Tbp,	however,	were	consistently	ranked	the	least	stable	of	the	genes	tested	
and	 are	 thus	 not	 recommended	 for	 use	 in	 further	 gene	 expression	 studies	 which	 span	
gastrulation.	Taken	together,	the	data	from	all	three	algorithms	predict	Ubc	and	H2afz	as	stable	


















expression	 of	 Zic1	 was	 relatively	 undetectable	 from	 6.5-8.5	 dpc	 and	 peaked	 at	 9.5	 dpc,	
consistent	 with	 the	 known	 expression	 pattern	 of	 Zic1	 mRNA	 during	 embryogenesis.	




dpc	 encompasses	 the	majority	 of	 the	 embryo	 (being	 expressed	 in	 the	 extra	 embryonic	 and	









attempting	 to	 analyse	 gene	 expression	 at	 specific	 stages.	 In	 this	 study,	 we	 evaluated	 and	












stable	 in	 each	 of	 the	 three	 algorithms	 used.	 This	 difference	 in	 recommendation	 from	 both	
studies	 can	 presumably	 be	 attributed	 to	 the	 wider	 range	 of	 embryonic	 stages	 covered	 by	
Willems	et	al,	suggesting	that	whilst	Actb	and	Tbp	are	stable	when	comparing	large	changes	in	
embryonic	development	 stage,	 they	are	not	 stably	expressed	during	 the	 restricted	period	of	
gastrulation.	The	contrasting	results	presented	here,	and	those	contrasting	results	achieved	by	
other	studies	(Meller	et	al.	2005;	Zhang	et	al.	2005;	Hruz	et	al.	2011),	reflect	the	importance	of	













































Gene	 	 Primer	sequence	(5’	–	3’)	 Primer	location	 Product	size	(bp)	 Slope	 R2	 Efficiency	
Actb	 F	 ATG	AGC	TGC	CTG	ACG	GCC	AGG	TCA	TC	 Exon	3	 192	 -3.34	 0.99	 99.17%	
R	 TGG	TAC	CAC	CAG	ACA	GCA	CTG	TGT	TG	 Exon	4	
Gapdh	 F	 TGA	CGT	GCC	GCC	TGG	AGA	AA	 Exon	4	 98	 -3.28	 0.99	 101.81%	
R	 AGT	GTA	GCC	CAA	GAT	GCC	CTT	CAG	 Exon	5	
H2afz	 F	 GCG	CAG	CCA	TCC	TGG	AGT	A	 Exon	3	 202	 -3.30	 0.99	 101.00%	
R	 CCG	ATC	AGC	GAT	TTG	TGG	A	 Exon	5	
Tbp	 F	 GAA	GAA	CAA	TCC	AGA	CTA	GCA	GCA	 Exon	5	 128	 -3.36	 0.99	 98.29%	
R	 CTT	ATG	GGG	AAC	TTC	ACA	TCA	CAG	 Exon	5	
Ubc	 F	 CGT	CGA	GCC	CAG	TGT	TAC	CAC	CAA	GAA	GG	 Exon	1	 112	 -3.33	 0.99	 99.47%	
R	 CCC	CCA	TCA	CAC	CCA	AGA	ACA	AGC	ACA	AG	 Exon	1	
Zic2	 F	 TCG	TTG	CGG	AAG	CAC	ATG	AA	 Exon	2	 178	 -3.27	 0.98	 102.34%	
R	 ACA	GGT	TGG	AGC	TGC	TTT	GT	 Exon	3	






and	 Bestkeeper.	 For	 Normfinder,	 a	 low	 stability	 value	 indicates	 a	 stably	 expressed	 gene	
(Andersen	et	al.,	2004),	whilst	for	Bestkeeper,	a	ranking	close	or	equal	to	1	indicates	the	most	











1	 Gapdh	 0.212	 H2afz	 0.540	 0.095	 H2afz	 0.999	
2	 Ubc*	 0.247	 Ubc	 0.674	 0.247	 Gapdh	 0.986	
3	 H2afz*	 0.251	 Gapdh	 0.770	 0.311	 Ubc	 0.775	
4	 Tbp	 0.254	 Tbp	 0.812	 0.351	 Tbp	 0.773	
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of	 primer	 dimers	 forming,	 it	 does	 not	 discount	 non-specific	 off-target	 amplification.	 Primer-
BLAST	was	utilised	to	check	for	off-target	oligonucleotide	binding	for	P2	oligonucleotides	(Ye	et	






most	3’	nucleotides	 for	each	 target.	 It	 is	well	 documented	 that	mismatches	 in	 the	3’	 end	of	
oligonucleotides	affect	target	amplification	significantly	more	than	mismatches	 in	the	5’	end.	
Whilst	two	nucleotide	mismatches	have	been	shown	to	prevent	amplification	at	the	3’	end,	a	
single	nucleotide	mismatch	will	 result	 in	reduced	amplification	efficiency	 (Stadhouders	et	al.,	
2010;	Ye	et	al.,	2012).	As	such,	it	is	possible	that	the	increase	that	is	seen	at	P2	could	be	due	to	
off-target	 amplification.	 It	 should	 be	 noted,	 however,	 that	 each	 Zic2	 3’UTR	 poly(A)	

















Zic2	 101	 0	 0	 0/0	
Pcca,	 transcript	
variant	X1	
2438*	 3	 2	 1/1	
Clstn3		 2222*	 4	 2	 1/0	
Tnrc6a,	transcript	
variant	X15	




169	 3	 4	 1/0	
113	 4	 5	 0/1	
Cacna1c	 832*	 3	 4	 1/0	
Slc35d1	 212	 4	 3	 1/0	
Htr4	 364	 3	 4	 1/1	





























Figure	A5.2:	 Plasmid	maps.	 (a)	pBB232,	 (b)	pBB256,	 (c)	pBB259,	 (d)	pBB262.	 cHS4:	 Chicken	





















Figure	 A5.4:	 lacZ	 expression	 is	 detected	 Sox10	 embryos.	 (a)	 Sox10+/+	 and	 (b)	 Sox10(lacZ/+)	







lacZ)Ark/+	 with	 varying	 lacZ	 expression	 patterns.	 Expression	 patterns	 were	 inconsistent	 and	
unreplicable	amongst	lacZ	positive	embryos.	Photographs	taken	by	Gene	Elliot,	NIH	transgenic	
Core	Facility	(Maryland,	USA).		
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Figure	A5.6:	CRISPR	guide	plasmid	maps.	(a)	pCR-Blunt	II-TOPO-G2	(b)	pCR-Blunt	II-TOPO-G3.		
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